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: 
If you're down and confused 
And it's hard to do what you have to 
Concentration slips away 
'cos your baby is so far away 
Don't be angry, don't be sad 
Don't sit crying over good times you had 
'cos there's a rose in a fisted glove 
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Aims. 
The aim of this project was to synthesise three novel analogues of the naturally 
occurring lipid, dolichyl phosphate (Do]-P). All of these lipids were designed to be 
multi-functionalised. An ester substituent was incorporated into the backbone of the 
lipid chain in order to increase their solubilities in water. Two of the lipids had an N-
phthalamido group at the o>-end of the chain, while the third bore a fluorescent probe at 
this point. The requirements for chain length and polyisoprenoid structure were then to 
be tested. It was reasoned that the fluorescent label would be of some aid in 
characterising the interactions of Dol-P or its glycosylated derivatives with enzymes 
which utilise these substrates or proteins participating in sugar transport across the cell 
membrane. 
A phytanyl-linked monosaccharide was to be prepared to provide a cheaper alternative 
route to phytanyl pyrophosphoryl chitobiose. This compound was to be subsequently 
used to investigate the unknown mannosyltransferases active in the early stages of N-
glycan biosynthesis. 
Finally, fluorescent] y-labelled asparagine-linked chitobiose allowed research into the 
availability of an enzyme that could be used in the synthesis of an asparagine-linked 
trisaccharide. 
Abstract. 
Our research has been based on the biosynthetic pathway to N-linked glycoproteins; 
species which are comprised of an oligosaccharide moiety attached to the side chain 
nitrogen atom of an asparagine residue in a peptide. In order to effectively study the 
steps involved in the biosynthesis of lipid-linked oligosaccharides and their subsequent 
transfer to a nascent protein in co-translational modification processes, it was essential to 
have a source of pure dolichols in sufficient quantities to allow the synthesis of both 
biosynthetic intermediates and synthetic analogues in the pathways responsible for the 
biogenesis of glycoproteins. Since supplies of naturally occurring dolichols are scarce 
and as they are difficult to synthesise, a number of lipid substrates were prepared instead 













Two novel analogues of the naturally occurring lipid, dolichyl phosphate, were 
synthesised. The first of these, lipid 99, was synthesised in seven steps from 
commercially available citronellol. The key step in this synthetic route involved creating 
an ester substituent in the backbone of the lipid chain to generate 8-benzyloxy-2,6-
dimethyloct-2-en-1-yl 12-bromododecanoate, 106, in 87% yield. Lipid 99 was found to 
exhibit 77% activity relative to phytanyl phosphate, 98, in the biological assay with Dol-
P-Man synthase. 
A new synthetic route had to be devised in order to attach a fluorescent probe to the w-
end of lipid 99 so that the dansyl amide lipid, 100, could be prepared. Lipid 100 was also 
prepared from commercially available citronellol in an eight step route. The key 
transformations here were the introduction of an azide moiety at the 0)-end of the chain 
to afford 8-hydroxy-2,6-dimethyloctyl 12-azidododecanoate, 121, in a yield of 89% and 
the reduction of the azide by a Staudinger reaction, followed by attachment of the dansyl 
sulfonamide to generate the fluorescent lipid di-tert-butyl 3,7-dimethyl-8-[12-(4'-
dimethyl ami non aphthalene- I '-sulfonamido)dodecano'1oxy}octyl phosphate, 123, in 
44% yield. Although lipid 100 showed only 14% activity relative to phytanyl phosphate 
in the biological assay with Doi-P-Man synthase, it was nevertheless clearly recognised 
and mannosylated by the enzyme. In addition, a fluorescence study of lipid 100 showed 
that this substrate is indeed strongly fluorescent. The environmentally sensitive 
fluorescent quantum yields and emission spectra that a dansyl amide provides will be 
useful for further study of the unknown mannosyltransferases active in the early 
pathway of N-glycan biosynthesis. 
Finally, work towards the synthesis of an analogue of lipid 99, namely lipid 127, which 
incorporates an extra isoprene unit, was conducted. 
Many of the enzymes involved in the biosynthesis of N-linked glycoproteins have 
already been isolated and characterised. However, some of those enzymes involved in 
the early stages of N-glycan biosynthesis remain unidentified. In order to gain more 
information about the unknown mannosyltransferases that are active in the early stages 
of N-glycan biosynthesis, a phytanyl-linked monosaccharide (glucosamine), 163, and 
disaccharide (chitobiose), 75, were prepared. 
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The synthesis of phytanyl-linked chitobiose, 75, from commercially available chitobiose 
octaacetate, 70, was successfully achieved in five steps. The most important step in this 
process was the synthesis of the a-chitobiosyl phosphate dibenzyl ester, 72, in 66% 
yield. Once this compound had been made it was coupled to phytanyl phosphate to 
generate the acetyl protected phytanyl pyrophosphoryl chitobioside, 74, in 73% yield. 
Enzymatic transformation of this substrate was performed to generate a phytanyl-linked 
trisaccharide, 76, which will be useful for providing biosynthetic intermediates for the 
studies of subsequent glycosyltransferases of the biosynthetic pathway of N-linked 
oligosaccharides. 
A new method for preparing phytanyl-linked glucosamine, 163, in an overall yield of 
34% has also been developed. The yield obtained for each step in this synthetic route 
was excellent, with the exception of the anomeric deacetylation of peracetylated 
glucosamine. The low yield of this reaction is counteracted by the ease with which large 
quantities of 1-0-deacetylated glucosamine can be prepared. Although the attempted 
enzyme-catalysed transformation of phytanyl-linked glucosamine, 163, to phytanyl- 
linked chitobiose failed, it shows that the phytanyl-linked monosaccharide is not a 
suitable acceptor substrate for the first glycosyltransferase (N- 
acetyiglucosaminyltransferase) in the biosynthetic pathway to N-linked glycoproteins. 
Finally, work towards the preparation of a fluorescently-labelled asparagine-linked 
chitobiosyl substrate, 166, is reported. Commercially available glucosamine 
hydrochloride, 176, was converted into O-(2-phthalimido-2-deoxy-3,4-O-acetyl-6-
benzyl-f-D-gIucopyranosy1)-( I ,4)-2-phthalimido-2-deoxy-3-O-acetyl-6-benzyl- I- 
thiophenyl-I3-D-glucopyranoside, 184, in eight steps and an overall 16% yield. This 
work has formed the basis for the synthesis of a fluorescently-labelled asparagine-linked 
chitobiose substrate, 166, that will be used to find a -mannosyltransferase capable of 
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Abbreviations. 
There follows a list of common abbreviations used in the text of this thesis. 
AIBN 2,2'-Azobisisobutyronitrile 
ALO Asparagine-linked glycosylation 
Asn Asparagine 
br Broad 
BSTFA N, O-Bis(tri methylsi lyl)trifluoroacetamide 
BuLi n-Butyl lithium 
CAN Ceric ammonium nitrate 
CDCI3  Deuterochloroform 
CDI NN'-Carbonyldiimidazole 
d Doublet 
DAST Diethylarninosulfur trifluoride 
DBU I ,8-Diazabicyclo[5,4.O]undec-7-ene 
DCC Dicyclohexylcarbodiimide 
DCM Dichioromethane 
dd Doublet of doublets 





DNasel Deoxyribonuclease I 
Dol-P Dolichyl phosphate 
DPM1 Dolichyl phosphate mannose synthase 
B. Coli Escherichia Coli 
e.e. Enantiomeric excess 
ER Endoplasmic reticulum 
FAB Fast atom bombardment 




GDP Guanosine 5'-diphosphate 
Gic Glucose 
GlcNAc N-Acetylglucosamine 
GPT N-Acetylglucosamine phosphate transferase 
h Hour 
hCG human chorionic gonadotropin 
His Histidine 
HRMS High resolution mass spectrometry 
Hz Hertz 
J Spin coupling constant 
kg Kilogram 
Km Michaelis constant 
LDA Lithium diisopropylamide 
LH Luteinizing hormone 
LRMS Low resolution mass spectrometry 
m Multiplet 
MAG Myelin-associated glycoprotein 
Man Mannose 
mCPBA meta-Chloroperbenzoic acid 
min Minute 
Mp Melting point 
NBS N-Brornosuccinimide 
NDP Nucleoside diphosphate 
NeuAc N-Acetylneuraminic acid 
NIS N-Iodosuccinimide 
nm Nanometre 
NMR Nuclear magnetic resonance 
NTP Nucleoside triphosphate 
OT Oligosaccharyl transferase 
P Para 
PP Pyrophosphate 
ppm Parts per million 
q Quartet 
RER Rough endoplasmic reticulum 




TBABr Tetra-N-butylammonium bromide 
TBPP Tetrabenzyl pyrophosphate 
td Triplet of doublets 
TES Triethylsilane 
TFA Trifluoroacetic acid 




TLC Thin layer chromatography 
tm Triplet of multiplets 
TrisHCl Tris(hydroxymethyl)aminomethane 
TSR Thyroid-stimulating hormone 
T.JDP Uridine 5'-diphosphate glucose 




Glycoproteins are complexes in which carbohydrate structures are covalently 
attached to the backbone of a peptide chain. Although only seven or eight 
monosaccharides are commonly found as building blocks in mammalian systems, the 
multifunctionality of these monomers enables an immense variety of complex 
structures to be assembled.' Each of these commonly occurring monosaccharides is 
polyvalent and thus has the potential to be extended by glycosidic linkages to as 
many as five other sugar residues giving rise to the characteristic branched structures. 
In addition, each of the constituent monosaccharides may exist in one of two 
different anorneric conformations (a— or ii-), and may adopt either pyranose or 






Fig 1.1 Ribose has the potential to exist as a five-membered oxygen heterocycle 
(furanose form), in an open-chain fonn or as a six-membered oxygen heterocycle 
(pyranose formn).2 
Consequently, the potential for structural diversity in oligosaccharides is immense, 
making them ideal for coding vast amounts of information in various biological 
recognition processes. 
1.1.1. The structure and diversity of 0- and N-linked oligosaccharides. 
Despite the huge variations in the oligosaccharide side chains of glycoproteins, these 
compounds can be classified into two main categories: 0- or N-glycans. Thus, the 
carbohydrates of glycoproteins are most commonly attached to either the side chain 
01 
oxygen atom of serine or threonine residues by O-glycosidic linkages (O-glycan) or 
to the side chain nitrogen of asparagine by N-glycosidic linkages (N-glycan), Fig 1.2. 
X=H, serine linked 
X=Me, threonine linked 
OH 
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Fig 1.2 : The two major types of glycosidic linkage found in eukaryotic 
glycoproteins. 
N-glycans are generally constructed around a common pentasaccharide core which 
consists of three mannose and two N-acetylglucosamine residues, 1, Fig 1.3. 
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Fig 1.3: The structure of the pentasaccharide core of N-glycans. 
N-linked oligosaccharides can be further classified as high-mannose-, complex-, 
hybrid-, or poly-N-acetyllactosamine-type depending upon the composition of the 
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Fig 1.4 : Three subgroups of N-glycans: High mannose-, complex- and hybrid-type. 
The structure within the dashed line represents the pentasaccharide core found in all 
N-glycan species. 
High mannose-type glycans contain only a-mannosyl residues attached to this 
trimannosyl core. Complex-type glycans contain no mannose residues other than 
those in the trimannosyl core, but have branches with N-acetylglucosarnine residues 
at their reducing termini attached to the core.4 The number of branches usually 
ranges from two in a bi-antennary structure to four in a tetra-antennary structure. 
While various monosaccharides can be found in the branches, the presence or 
absence of fucose and a bisecting GlcNAc on the core contributes yet further to the 
enormous structural variation of complex-type glycans.4 
The hybrid-type N-glycans have the characteristic features of both complex-type and 
high mannose-type glycans .4 Here, one or two a-mannosyl residues are linked to the 
Manal-6 arm of the trimannosyl core and usually one or two branches are linked to 
the Manal-3 arm of the core .4 The fourth group is the poly-N-acetyllactosamine N-
glycans containing repeating units of (Galf 1-4GlcNAc 1-3-) attached to the core. 
These repeats may also be branched. Poly-N-acetyllactosamine extensions are most 
frequently found in tetra-antennary glycans.' First discovered on erythrocyte 
membrane glycoproteins, these polylactosamine oligosaccharides may be substituted 
in various ways and have been shown to carry ABH and I, blood group antigens.5  
3 
In contrast to N-linked glycans, 0-linked glycans do not share a common core 
structure. They are based around a number of different core structures which can be 
categorised into at least six groups, as illustrated in Fig 1.5. 
core 1 GaII31-3GaNAca-Ser (Thr) 
GIcNAc3 1\ 
core 2 GaINAca-Ser (Thr) 
GaII31"  
core 3 GIcNAc1-3GaINAca-Ser (Thr) 
core 4 GtcNAcf1-6GaINAca 
GIcNAc1\ 
core 5 
/3  GaINAca-Ser (Thr) 
GIcNAc31 
core 6 GaINAc31-3GaINAcc 
Fig 1.5 : Six types of core structures found in 0-linked glycans.4  
Although these glycans are often linked to serine or threonine residues through 
GalNAc, the linkages may also be through other residues such as fucose.4 Since our 
research has been based around N-linked glycans, further discussion of 0-glycans 
will not take place. 
1.1.2. The role of oligosaccharides in modulating the biology of glycoforms. 
The 0- and N-glycans may contain different core structures but in each case it is the 
outer chain oligosaccharides attached to these cores that are known to control the 
biodistribution and biological properties of the parent protein or peptide.' 
Oligosaccharides can modify the intrinsic properties of the proteins to which they are 
attached by altering their stability,6 protease resistance or quaternary structure .4 The 
large size of oligosaccharides may allow them to cover functionally important areas 
of proteins, to modulate the interactions of glycoconjugates with other molecules, 
and to affect the rate of processes which involve conformational changes.' In the 
next few sections some examples of the functions of oligosaccharides will be 
discussed in order to highlight their importance as biological molecules. 
1.1.3. Oligosaccharides and lectins: Their role in intercellular recognition and 
adhesion. 
Essential roles for oligosaccharides have been identified in a number of intercellular 
recognition and adhesion events. Lectins are carbohydrate specific proteins that 
mediate cellular recognition.7 Each lectin molecule contains two or more 
carbohydrate-combining sites. When they react with cells, for example erythrocytes, 
they will not only combine with the sugars on their surfaces, but also cause 
crosslinking of the cells and their subsequent precipitation; a process known as cell 
agglutination. This erythrocyte agglutinating, or haemagglutinating, activity of 
lectins is used routinely for their detection and characterisation.8  
Lectins also act as recognition determinants in other diverse biological processes. 
These include clearance of glycoproteins from the circulatory system, control of 
intracellular traffic of glycoproteins, adhesion of infectious agents to host cells, 
recruitment of leukocytes to inflammatory sites and intercellular interactions in the 
immune system in malignancy and metastasis.8  
Most lectins can be classified into one of three categories: (1) Simple, (2) mosaic (or 
multi-domain) and (3) macromolecular assemblies, although borderline cases exist.8  
Within each category, lectins can be grouped into distinct families with similar 
sequences and structural properties.8  
Simple lectins consist of a small number of sub-units, not necessarily identical, 
which may contain an additional domain besides their carbohydrate binding site(s). 
This class comprises practically all known plant lectins as well as the galectins, a 
family of galactose-specific animal lectins.8  
Included in the mosiac (or multi-domain) group are a number of diverse proteins 
from different sources, ranging from viral haemagglutinins to C-, P- and I-type 
animal lectins.8 They are all composite molecules with a wide range of molecular 
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weights, consisting of several kinds of protein modules or domains, only one of 
which possesses a carbohydrate binding site.8  
Viral and microbial surface lectins mediate the adhesion of the organisms to host's 
cells, a pre-requisite for infection to occur.9 This was first demonstrated in the 1940's 
for the influenza virus haemagglutinin. This lectin is specific for N-acetylneuraminic 
acid, a sialic acid. Removal of this sugar from the cell membranes by sialidase 
abolishes viral binding and prevents infection, while enzymatic re-attachment of N-
acetylneuraminic acid or insertion of sialic acid-containing oligosaccharides (for 
example in the form of glycolipids) into the membranes of sialidase-treated cells 
restores the ability of the cells to bind the virus and be infected.7 
I-type lectins are characterised by variable numbers of extracellular immunoglobulin-
like domains.8 The most important and well-characterised lectins of this type are the 
sialoadhesins, a family of sialic acid specific type I membrane glycoproteins.'° They 
include the macrophage receptor that mediates the adhesion of these cells to 
erythrocytes (sialoadhesin), the lymphocyte surface antigen CD22 found only on B 
cells, CD33 present on early myeloid cells, and a myelin-associated glycoprotein, 
MAG.8 1-type lectins have been implicated in cell-cell interactions: Sialoadhesin and 
CD22 in those of the immune system and MAG in the maintenance of myelin and in 
neuronal regeneration. 8, II 
C-type lectins require Ca2 for activity.  12  This class of lectins includes over fifty 
members in three different families, namely endocytic lectins, collectins and 
selectins. The selectins mediate the adhesion of circulating leukocytes to endothelial 
cells of blood vessels, a pre-requisite for the exit of leukocytes from the circulatory 
system and their migration into tissues.13 They, thus, control leukocyte trafficking to 
sites of inflammation and the migration of lymphocytes to specific lymphoid 
organs. '3 There are three types of selectins: E-selectin, P-selectin and L-selectin, all 
highly asymmetric membrane-bound proteins.8 L-selectin is found on all leukocytes 
and is involved in the re-circulation of lymphocytes, directing them specifically to 
peripheral lymph nodes. E- and P-selectins are expressed on endothelial cells only 
when these cells are activated by inflammatory mediators released from tissue cells 
in response to infection. In cases of microbial infection, the selectin-mediated 
adhesion of leukocytes to activated endothelial cells is a major factor in clearance of 
the infectious agents.  14  It therefore plays an important role in immune defence by 
recognising and targeting carbohydrates on invading pathogens. 14 
Macromolecular assembly-type lectins are common in bacteria in the form of 
fimbriae (or pili).8 These are heteropolymeric organelles present on the surface of the 
bacteria, consisting of helically arranged sub-units of several different types.8 Only 
one of the sub-units possesses a carbohydrate binding site. The lectin-carbohydrate 
interactions in bacterial infections were investigated by experiments which showed 
that blocking lectins using suitable sugars provided protection against bacterial 
infection.  14  It was found that mannose and methyl-c-mannoside specifically 
inhibited infection of the urinary tract of mice and rats by different strains of type 1 
fimbriated E. Co/i and Kiebsiella pneumoniae respectively, while N-
glycosylneuraminic acid containing glycopeptides, administered orally, protected 
colostrum-deprived newborn calves against lethal doses of enterotoxigenic E. Co/i 
K99.'4 Similarly, N-acetylneuraminic acid considerably reduced colonisation of the 
lung, liver and kidney by Pseudoinonas aeruginosa administered intravenously to the 
animal.  14  These findings illustrate the great potential of carbohydrates in the 
prevention of infections caused by bacteria that express surface lectins and provide a 
basis for the development of anti-adhesion therapy of microbial infections. 
1.1.4. Function of sugar chains of glycoprotein hormones. 
Four glycoprotein hormones have been found in a variety of mammals. Three of 
these are produced in the anterior pituitary: Luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) are produced by the gonadotrophs, while thyroid-
stimulating hormone (TSH) is synthesised by thyrotrophs.15' 16  LH and FSH have 
general biological roles in the stimulation of testicular and ovarian functions, while 
TSH regulates the synthesis and secretion of thyroid hormones.  17  The fourth 
glycohormone, human chorionic gonadotropin (hCG), is produced by trophoblasts in 
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the placenta. These hormones, with their diverse physiological functions, are closely 
related in structure with each consisting of two peptide chains designated a and 3. ' 
Both sub-units are glycosylated at specific residues and are highly cross-linked 
internally by disulphide bonds. 17 
Much research has been conducted to investigate the role of the sugar portion of 
glycoprotein hormones.  17  The effect that deglycosylation of hCG had on the activity 
of glycohormones was studied by Kalyan and Bahl.18 It was found that partial 
removal or modification of the carbohydrate portion of hCG resulted in impairment 
of the biological activity without affecting its binding to the receptor.  18  Complete 
removal of carbohydrate from hCG, without any detectable adverse effect on the 
polypeptide chains, was achieved by treating the sub-units with trifluoromethane 
sulfonic acid. The deglycosylated hCG failed to stimulate hormonal activity and, in 
addition, the deglycosylated material was found to compete with native hCG for 
receptor sites and act as a potent inhibitor of biological activity.  18  
Further study of the functional role of the sugar moiety of hCG was conducted. The 
adenyl cyclase of rat corpora luteal membrane was increased in a linear fashion in 
response to the addition of hCG.19 Addition of glycopeptides, obtained from hCG by 
exhaustive pronase digestion, to this reaction mixture inhibited the adenyl cyclase 
activation by hCG in a dose-dependent manner. This indicated that a membrane 
lectin, which binds to the sugar chains of hCG, may be involved in the regulation of 
luteal cell hCG-stimulated adenyl cyclase. '9 
For the remaining glycohormones, LH, FSH and TSH, studies have shown that 
deglycosylation was associated with increased binding to the receptor sites and that 
the deglycosylated hormones were potent competitive inhibitors of binding of the 
native hormone.  20 These data suggest that the N-linked oligosaccharides of 
glycohormones play a crucial role in regulating the biological activity of hormones 
by participating in signal transduction once the hormone has been bound to the 
receptor.20 
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1.1.5. Oligosaccharides and the transport and folding of proteins. 
The carbohydrate side chains of glycoproteins are known to influence the early 
stages of polypeptide folding, to ensure correct secretion and to maintain subsequent 
solubility and conformation of the polypeptide.2' The endoplasmic reticulum (ER) is 
the site of synthesis of membrane and secretory proteins. As they enter the lumen of 
the ER during the translocation process, newly synthesised membrane and secretory 
proteins are subjected to the action of enzymes and molecular chaperones that assist 
their conformational maturation. 22 
Among the molecular chaperones of the ER are two related lectin-like chaperones, 
calnexin and caireticulin. Calnexin is a type I membrane protein which has been 
demonstrated to bind transiently to several glycoproteins via partially trimmed N-
linked oligosaccharide chains which carry a single glucose residue .22' 23  The 
association of calnexin with its substrate glycoproteins facilitates their folding and 
oligomerisation, and supports quality control .24 
Caireticulin is a soluble, luminal protein of the ER that possesses chaperone and 
quality control functions similar to those of calnexin.  25  It is a highly conserved 
ubiquitous protein and has been implicated in Ca2 storage and intracellular 
signalling in the ER.25 The chaperone function of caireticulin is assisted by two 
enzymes with contrasting catalytic activities: UDP-glucose: glycoprotein 
glucosyltransferase and glucosidase.26 The sequential action of glucosidase I and II 
removes two glucose residues from Glc3Man59GlcNAc2 of N-linked glycoproteins in 
the ER, whereas UDP-glucose: glycoprotein glucosyltransferase catalyses the 
addition of glucose to the non-reducing end of mannose of the al-3 arm of Man5  
9GIcNAc2 chains in unfolded glycoproteins, thereby acting as a folding sensor. 26, 27 
Repeated cycles of re-glucosylation by the glucosyltransferase lead to prolonged 
association of calreticulin with the unfolded protein until its appropriate folding 
occurs.  26  Should this process fail, the protein is retrotranslocated to the cytosol and 
subsequently degraded by the proteasome.28 Substrate studies have identified the 
single terminal glucose residue as a critical determinant recognised by caireticulin 
because oligosaccharides containing 0, 2 or 3 glucose residues fail to bind.2' 
Oligosaccharide binding is critical for the formation of complexes between 
glycoproteins and caireticulin. 
The occurrence of substrate-calnexin-caireticulin ternary complexes for an 
endogenous protein in the ER of live cells was investigated using newly synthesised 
thyroglobulin (Tg).22 Results indicated that, in FRTL-5 cells (a continuous, cloned 
line of thyroid differentiated cells), calnexin and caireticulin interact with Tg in a 
carbohydrate-dependent manner, with largely overlapping kinetics that are 
concomitant with the mutation of Tg intrachain disulphide bonds, preceeding Tg 
dimerisation and exit from the ER .22 Caireticulin was found to co-precipitate more 
with newly synthesised Tg than calnexin did. However, both were found in ternary 
complexes with Tg Treatment with thapsigargin (a specific inhibitor of ER Ca 2+_
ATPases) induced the premature exit of Tg from the calnexin/calreticulin cycle, 
while stabilising and prolonging interactions of Tg with BiP (immunoglobulin heavy 
chain binding protein) and GRP94 (glucose-regulated protein 94), two chaperones 
whose binding is not carbohydrate-dependent.  22  This indicates that calnexin and 
calreticulin, acting in ternary complexes with a large glycoprotein substrate such as 
Tg, might be engaged in the folding of distinct domains while Ca  2+  influences the 
folding of exportable glycoproteins, in part by regulating the balance of the substrate 
binding to different molecular chaperone systems within the ER .22 
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1.2. Biosynthesis of N-linked oligosaccharides. 
The N-linked protein glycosylation pathway in eukaryotes can be divided into two 
different processes: (1) The assembly of the lipid-linked oligosaccharide at the 
membrane of the endoplasmic reticulum (ER); and (2) the transfer of the 
oligosaccharide from the lipid anchor, dolichyl pyrophosphate, to selected asparagine 
residues of nascent polypeptides. 
1.2.1. The lipid carrier for oligosaccharide assembly. 
Dolichyl phosphate (Dol-P), 2, acts as the carrier in the assembly of pyrophosphate-
linked oligosaccharides, and is also the acceptor in the synthesis of the sugar donors 
dolichyl phosphate mannose (Dol-P-Man) and dolichyl phosphate glucose (Dol-P-
Glc), from guanosine 5'-diphosphate mannose (GDP-Man) and uridine 5'-
diphosphate glucose (UDP-Glc) respectively.  29 The availability of dolichyl 
phosphate represents a key factor in the assembly of lipid-linked oligosaccharides, 
Fig 1.6.29 
2 
OOH n = 4-16
OH  
Fig 1.6: The lipid carrier for oligosaccharide assembly, dolichol phosphate. 
The dolichols are a family of naturally occurring polyisoprenoids of varying chain 
length. Dolichol is synthesised from farnesyl pyrophosphate by sequential additions 
of the activated isoprene unit, isopentyl pyrophosphate. The length of dolichol 
molecules is species-dependent, but the mechanism determining the length is not 
known.  29  It has been proposed that chain elongation is terminated by the addition of 
isopentenol instead of isopentenyl pyrophosphate.  30 Alternatively, chain elongation 
may simply be terminated when the product contains a certain number of isoprene 
units and is therefore no longer a substrate for the cis-isoprenyltransferase.3' 
Phosphorylation of dolichol is catalysed by the enzyme sec59p. 
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1.2.2. Construction of the lipid-linked heptasaccharide in the cytoplasm. 
The biosynthesis of the lipid-linked oligosaccharide begins at the cytoplasmic side of 
the ER membrane with the addition of an N-acetylglucosamine phosphate (GlcNAc 
phosphate) residue to Dol-P and concomitant release of uridine 5'-monophosphate 
(UMP) as shown in Fig 1.7. This key process is mediated by N-acetylglucosamine 
phosphate transferase (GPT), an enzyme encoded by the ALG7 locus. The GlcNAc 
phosphate, which is added to the Dol-P moiety, is derived from the activated sugar 
nucleoside phosphate UDP-GlcNAc.29 Studies have shown that the synthesis of 
GlcNAc-PP-Dol is a vital step in the synthesis of glycoproteins containing N-linked 
oligosaccharides.  32  When this reaction was inhibited by incubation of cells with the 
antibiotic tunicamycin, glycoproteins containing no N-linked oligosaccharides were 
formed .12 
The next stage in the biosynthesis of N-linked glycoproteins is the addition of a 
second 3-1,4-N-acetylglucosamine residue to produce the chitobiosyl-
pyrophosphoryl-dolichyl unit, GlcNAc2-PP-Dol. This step has not been characterised 
in yeast nor in higher eukaryotic cells.  29  Expression studies in E. Co/i have shown 
that ALG1 encodes a -1,4-mannosyltransferase, which catalyses the next step in the 
synthesis, the transfer of the first mannnose residue from GDP-Man to G1cNAc2-PP-
Dol.33 This enzyme is unique, introducing the only -mannose residue known to 
exist in mammalian oligosaccharides. The preference for f3-linked mannose at this 
point in the common structure of N-glycans may have arisen because the -glycoside 
contributes significantly to the structural rigidity of the pentasaccharide core.  14  It has 
also been shown that the ALG 1 protein accepts chitobiose attached to a phytanyl 
rather than a dolichyl carrier as a substrate, suggesting that dolichol is of limited 
importance for substrate recognition by this enzyme. 35 
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Fig 1.7 : Biosynthesis of N-linked glycoproteins. 
The next few steps in the biosynthesis of N-linked glycoproteins that occur on the 
cytoplasmic side of the ER involve the attachment of four mannose residues to the 
lipid-linked trisaccharide, Man-GlcNAc2-PP-Dol, leading to the synthesis of a lipid-
linked heptasaccharide, Man5GlcNAc2-PP-Do1. Studies have shown that a192 mutant 
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cells accumulate Man2GIcNAc2-PP-Dol, suggesting that the ALG2 protein is a 
mannosyltransferase active in the early pathway of oligosaccharide assembly. 36, 37 
Studies have also resulted in the characterisation of ALG1 1, a yeast glycosylation 
mutant that is defective in the last step of the synthesis of the Man5GlcNAc2-PP-Dol 
core oligosaccharide on the cytosolic face of the ER.37 Analysis of lipid-linked 
oligosaccharides and those on ALG1 1 glycoproteins define ALG1 I  to be involved 
in adding the final a-1,2-linked Man to Man4GlcNAc2-PP-Dol.37 Additional 
mannosyltransferases required for the assembly of Man5GlcNAc2-PP-Dol remain to 
be identified. Within this heptasaccharide can be seen the pentasaccharide core 
common to all N-linked oligosaccharides, Fig 1.8. 
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Fig 1.8 : The dolichyl pyrophosphate-linked heptasaccharide, Man5GlcNAc2-PP-
Dol. The linkage of each individual glycosyl residue and the known loci coding for 
the corresponding glycosyltransferases are indicated. The structure within the 
dashed line represents the pentasaccharide core found in all N-glycan species. 38 
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1.2.3. Completion of the lipid-linked tetradecasaccharide in the lumen. 
Once the lipid-linked heptasaccharide has been synthesised on the cytoplasmic face 
of the ER, it is translocated across the lipid bilayer to the lumenal side of the ER. The 
mechanism of transrnembrane migration is not fully understood although protein-
catalysed translocation has been postulated.29' In the lumen of the ER, a further 
seven sugar residues (four Man and three Glc) are added to the lipid-linked 
heptasaccharide. The addition of four mannose residues followed by three glucose 
residues is believed to occur in a stepwise fashion .40 The late glycosyltransferases 
operating in the ER lumen differ from the glycosyltransferases that catalyse the 
reactions on the cytoplasmic side.  29  The former use dolichol-bound monosaccharides 
instead of nucleotide-activated monosaccharides as sugar donors and the genes 
coding for these transferases are non-essential for viability. 29 
The ALG3 gene encodes the enzyme that initiates the dolichyl-P-monosaccharide-
dependent glycosylation reactions at the lumenal side of the ER.4' This enzyme is a 
Do1-P-Man dependent cc-i ,3-mannosyltransferase and is involved in the addition of 
the first mannose residue to the heptasaccharide on the lumenal side.  41  It is 
postulated that ALG9 encodes an a-1,2-mannosyltransferase which adds a mannose 
residue to the a-1,3-linked mannose .40 The addition of the ct-1,6-linked mannose is 
probably catalysed by the ALG12 protein because a1gl2 cells accumulate 
Man7GIcNAc2-PP-Do1 which contains the (x-1,3-a-1,2 dimannose antenna.29 The 
locus encoding the mannosyltransferase which adds the ct-1,2-linked mannose 
residue to the ct-1,6- arm has not yet been identified .29 The resulting 
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Fig 1.9 The dolichyl pyrophosphate-linked undecasaccharide, Man9GlcNAc2-PP-
Dol. The lipid-linked heptasaccharide that was synthesised on the cytoplasmic face is 
illustrated within the dashed lines. The four mannose residues that were 
subsequently added on the lurn.enal side of the ER are shown in bold type. The 
linkage of each indivual glycosyl residue and the known loci coding for the 
corresponding glycosyitransferases are indicated. 
Finally, three D-glucose units, derived from the monosaccharide lipid phosphate, GIc-
P-Do!, are transferred to the oligosaccharide. The ALG6 protein catalyses the 
transfer of the first glucose residue, while addition of the second a-1,3-glucose is 
catalysed by ALG8.29 ALG1O aids in the attachment of the terminal a-1,2-glucose 
yielding the fully assembled core oligosaccharide. 29 
Several studies have shown that the glucose residues on the lipid-linked 
oligosaccharide facilitate the in vitro transfer of the oligosaccharide to the protein, 
but the presence of glucose residues is not an absolute requirement for transfer.  42' 43 It 
has been shown that yeast mutants, defective in various steps in the synthesis of 
lipid-linked oligosaccharides, transfer non-glucosylated oligosaccharides ranging in 
size from Man9G1cNAc2 to Man12GlcNAc2 to a protein.44 While glucose residues 
facilitate oligosaccharide transfer to protein in some cell types, the number of 
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mannose residues has little effect on protein glycosylation.5 In protozoa, the 
completed lipid-linked oligosaccharides contain nine mannoses,45 seven mannoses46 
and six mannoses.47  
Although an incompletely assembled lipid-linked oligosaccharide can be transferred 
to the protein, the efficiency of transfer is much less than if the lipid-linked 
oligosaccharide had been correctly constructed .29 It has also been proposed that 
glucosylation protects the lipid-linked oligosaccharides from degradation.  4' A study 
of intact rat spleen lymphocytes which incorporate nucleotide sugars into lipid-linked 
oligosaccharides found that the non-glucosylated lipid-linked oligosaccharides were 
selectively degraded by a phosphodiesterase.48  
1.2.4. N-linked protein glycosylation and processing. 
Once synthesised, the sugar chain is ready to be delivered from the lipid anchor to 
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Fig 1.10 : OT catalysed transfer of the dolichyl pyrophosphate-linked 
tetradecasaccharide to an asparagine side chain within a nascent polypeptide in the 
lumen of the RER 49 
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N-linked glycosylation is catalysed by oligosaccharyl transferase (OT), a membrane 
associated, multimeric enzyme localised in the lumen of the ER.50 In the reaction 
catalysed by OT, a complex oligosaccharide is transferred from a lipid-linked 
pyrophosphate donor to a nascent polypeptide chain as the peptide is translocated 
into the lumen of the ER.39 
The peptide primary sequence requirements for glycosylation are minimal; the 
asparagine residue must be within the consensus sequence Asn-Xaa-Thr/Ser 
(NXT/S) where Xaa can be any of the 20 natural amino acids except proline.5' The 
exclusion of NPT/S sequences suggests that local secondary structures play an 
important role in determining the outcome of glycosylation.  5' This theory is 
reinforced by the fact that 10-30% of all NXT/S sequences remain unglycosylated in 
mature proteins, even though they meet the primary sequence requirements. 52 
Proteins that are destined for glycosylation are synthesised by membrane-associated 
ribosornes with an initial signal peptide, which guides the newly synthesised protein 
through the intracellular membrane bilayer into the lumen of the ER.5° The signal 
peptide is subsequently cleaved by a signal peptidase.50 The NXT/S sequence must 
clear the lumenal side of the membrane bilayer by 12-14 residues before 
glycosylation can occur. However, the nascent polypeptide remains bound to the 
membrane of the ER and is likely to be only locally folded during OT mediated 
catalysis. 50' 53  
In addition to the asparagine residue, the absolute requirement for an unmodified 
hydroxyl amino acid implies a direct role for the hydroxyl group in catalysis. 50 
Studies have found that formation of a hydrogen bond with the side chain of the 
hydroxyl amino acid was an absolute requirement in the glycosylation reaction 
mechanism. 5, 54A model has been proposed in which a hydrogen-bond interaction 
between the amide of asparagine (the hydrogen-bond donor) and the oxygen of the 
hydroxyl group of the hydroxyl amino acid (the hydrogen acceptor) increased the 
nucleophilicity of the amide electron pair, resulting in a higher reactivity toward the 
glycosyl donor.5 It was also observed that n-turns represent spatial arrangements of 
the peptide chain that favour the required hydrogen bonded contacts.5' 51  Proline- 
IV 
containing peptide analogues that did not serve as acceptors were unable to achieve a 
conformation that allowed the necessary hydrogen bonding.5  
It would appear that the ability of the peptide to achieve a favourable conformation is 
necessary, not alone to provide the correct hydrogen bonding, but to provide 
adequate accessibility to the OT enzyme.5 Since glycosylation occurs co-
translationally, the asparagine that is to be glycosylated is part of a growing peptide 
chain that is in the process of folding.5 Consequently, the period of time during 
which glycosylation can occur may be quite brief. Once the protein has folded, 
potential glycosylation sites are no longer accessible to the UT enzyme.55  
Another factor in determining the level of glycosylation is the availability of the 
lipid-linked oligosaccharide donor.5 Carson et al. found that added Dol-P increased 
the glycosylation of secreted RNase from 12% to 90% in bovine pancreas tissue 
slices.56 Thus, Dol-P availability may regulate asparagine-linked glycosylation under 
some circumstances. 
In summary, efficient glycosylation of proteins is dependent on a sufficient pool of 
completely assembled and glucosylated lipid-linked oligosaccharide donor, an 
adequate activity of UT, and a properly oriented and accessible Asn-Xaa-lhrlSer 
sequence in the acceptor.5  
Following the transfer to an asparagine residue within the protein, the core 
tetradecasaccharide, G1c3-Mang-OlcNAc2, is immediately processed in a series of 
reactions which invariably cleave the three terminal glucose and four mannose 
residues. Processing is initiated by the removal of the terminal glucose residue by a-
1,2-glucosidase I which is specific for this cleavage.5 The two inner glucose residues 
are then removed by a-1,3 specific glucosidase 11.5  Glucosidase I has been purified 
from calf liver while glucosidase II has been purified from rat liver and kidney. 57' 58  
Evidence that glucosidase H removes both a-1,3-glucose residues from 
Glc2Man9GlcNAc2 has come from studies with the purified enzyme and from the 
finding that extracts of a glucosidase 111-deficient mouse lymphoma cell line are 
19 
unable to remove glucose from either G1c2Man9G1cNAc2 or Glc1 Man9GlcNAc2.59 
These glucosidases are located in the membranes of the RER, as is a specific a-
mannosidase which catalyses the removal of at least one a-1,2-linked mannose 
residue.5  
The processed glycoprotein, Man58GlcNAc2-Asn, is subsequently translocated to the 
Golgi apparatus where glycosyltransferases catalyse the elaboration of the 
glycoprotein through transfer of additional monosaccharides such as fucose, 
galactose and sialic acid from the corresponding nucleotide diphosphates.50 These 
reactions act in concert to produce the diverse N-linked glycoconjugate structures 
characteristic of mature proteins. It is the final oligosaccharide sequence that often 
determines the cellular destination of the assembled glycoprotein.50 
It has been shown that some of the essential enzymes in N-linked protein 
glycosylation, for example N-acetylglucosamine phosphate transferase, are highly 
conserved between lower and higher eukaryotes.29' 60 OT enzymes from yeast and 
higher eukaryotes also contain components with significant sequence similarity, 
suggesting a conservation of the enzyme.  6' Thus, it is believed that the process of N-
glycosylation follows a highly conserved pathway.  29 This is also demonstrated in the 
fact that the asparagine-linked oligosaccharide structures have the common 
pentasaccharide core structure, as they all arise from the same biosynthetic precursor 
lipid-linked oligosaccharide. 
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1.3. Chemical synthesis of oligosaccharides. 
The abundance of carbohydrates in Nature and their diverse roles in biological 
systems make them attractive subjects for chemical and biological research. As has 
already been discussed, oligosaccharides play essential roles in a number of 
intercellular recognition and adhesion events. Carbohydrate residues can influence 
the stability, conformation, protease lability, thermal properties and solubility of 
proteins.62 They have been implicated in regulation of peptide folding, viral 
replication, infection, immune response, and in general are known to control the 
biodistribution and biological properties of their carrier molecule.4 
The synthesis of oligosaccharides, however, is not an easy task. The structural 
diversity that makes oligosaccharides such appealing target molecules brings with it 
problems of regio- and stereoselectivity unique to this field of chemistry. A 
comprehensive strategy must be decided upon prior to each novel synthesis, for 
oligosaccharide formation does not depend only on the size of the target structure but 
also on its linkages and the composition of its building blocks. 
In the formation of a glycosidic linkage, two polyfunctional reaction partners (a 
donor and an acceptor) must be coupled .63 Orthogonal protection of these substrates 
is necessary to allow selective blocking and unblocking of reactive sites and thus 
ensure regioselectivity of the glycosidation reaction. The reactivities at the anomeric 
centre of the glycosyl donor and the hydroxyl group in the glycosyl acceptor depend 
heavily on the nature of the protecting groups in each component sugar. 
Conformational and steric factors, as well as the molecular size of the coupling 
sugars, also influence reactivity. The stereoselectivity of the glycosidation process 
may be controlled by the correct choice of reagents and conditions. The basic 
principles of oligosaccharide synthesis are shown in Fig 1.11 .  38 
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Fig 1.11 : Coupling of a donor and an acceptor to generate a glycosidic linkage. 38 
The donor molecule, 3, must be activated at the anomeric centre. Various activating 
groups and synthetic strategies have been used to achieve this, including halides 
(Koenigs-Knorr),64 trichloroacetimidates63 and thioalkyl moieties.  65  The acceptor 
molecule, 4, must be selectively protected at all but the reacting hydroxyl and this 
functionality must be reactive enough to enable coupling to occur.  38  Nucleophilic 
displacement of a leaving group at the anomeric position of the donor by the 
hydroxyl functionality of the acceptor molecule, 4, generates a disaccharide. 38 
The different types of 1,4-glycosidic linkage, with respect to the substituent at C-2, 
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Fig 1.12: The different stereochemical results of glycosylation reactions. 
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P-1,4-cis-linked mannose, 8, is an integral part of the pentasaccharide core common 
to all N-glycan species. As our research has been focussed on the synthesis of N-
linked glycans some of the means used in the construction of 3-1,2-cis-mannosyl 
linkages are of interest and will therefore be discussed in detail. 
1.3.1. Chemical synthesis of [3-1,2-cis-mannosyl linkages. 
[3-1 ,4-cis-mannosyl linkages are notoriously difficult to synthesise. As can be seen in 
Fig 1. 13, the location of an axial acyl protecting group at C-2 in mannose that can 
participate in the glycosidation reaction (neighbouring group participation) leads 
predominantly to the a-mannoside, 9•66 
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Fig 1.13 : Neighbouring group participation in mannose sugars and oxoniuin ion, 
10, both give the a-anoiner.66 
The anomeric effect also favours the formation of the cx-mannoside over the 0-
mannoside. The anomeric effect in pyranosides can be seen as the propensity of an 
electronegative substituent to adopt an axial orientation.  66  The axial conformer is 
stabilised by the 7E —* ? interaction of the axial orientated lone pair of electrons of 
the ring oxygen, with the antibonding orbital of the anomeric carbon bonded to an 
electronegative group.  66  Thus ot-mannosides are thermodynamically and kinetically 
favoured, and are the major product when the oxonium ion 10 is an intermediate in 
the glycosylation reaction, Fig 1.13.66 
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A vast array of methodologies has been developed to overcome these problems so 
that -1,4-cis-mannosy1 linkages can be constructed by chemical means. In order to 
give an overview of the synthesis of 13-mannosides, details of some of the earliest 
methods up to more modem applications will be discussed. 
1.3.2. Epimerisation of f3-D-glucosides. 
Manipulation of 3-D-glucopyranosides, to indirectly give the desired 13-D-
mannopyranosides, by oxidation of 2-011 to a ketone followed by reduction was first 
investigated by Jeanloz et al.67 Condensation of 2-0-acetyl-3,4,6-tri-O-benzyl-ct-D-
glucopyranosyl bromide, 11, with benzyl 2-acetamido-4,6-0-benzylidene-2-deoxy-
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Fig 1.14 Key steps in the synthesis of 2-acetamido-.2-deoxy-3-O-13-D- 
maflflopyranosyl-D-glucose.67 
Following deacetylation of 13 to give 14, oxidation with dimethyl sulfoxide-acetic 
anhydride gave benzyl 2-acetamido-4,6-0-benzylidene-2-deoxy-3-0-(3 ,4,6-tri-O- 
RE 
benzyl-3-D-arabino-hexopyranosyl-2-u1ose)-c-D-g1ucopyranoside, 15.67 
Stereospecific reduction of the hexosidulose, 15, with sodium borohydride gave the 
protected -D-mannopyranosyl disaccharide 16, which was partially hydrolysed to 
give Hydrogenolysis of 17 in the presence of PcIJC gave the desired 2-
acetamido-2-deoxy-3-0- 3-D-mannopyranosyl-D-glucose, 18.67 
A modified version of this approach involved the use of an imidazylate in the 
synthesis of the f3-mannosidic linkage.  68  1 ,2,4,6-Tetra-0-acety1-3-0-benzy1-3-D-
glucopyranose 19 was used as a precursor of the -D-manno residue. Condensation of 
19 with a sugar derivative partially protected with benzyl groups, 20, in the presence 
of trimethylsilyl triflate as promotor, gave the -D-glucopyranoside 21, Fig 1.15.68 
Deacetylation of 21 followed by acetal protection of C4 and C6, and derivatisation 
with NN'-sulfuryl diimidazole gave the imidazylate 23.68  Treatment with 
tetrabutylammonium benzoate or sodium azide in toluene at 80 °C, afforded the D- 
benzoate, 25, or the 2-azido-2-deoxy-D-manno derivative, 24, respectively. 68 
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Fig 1.15 : Preparation of oligosaccharides with /3-D-mannopyranosyl and 2-azido-2-
deoxy-fl-D-mannopyranosyl residues. 68 
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Another method by which f3-mannosides can be obtained from the corresponding - 
glucosides, via an inversion of configuration at C-2, is by the introduction of the 
oxygen nucleophile intramolecularly, in the sense of a neighbouring group effect. 69 
The neighbouring group was introduced by formation of the 3-N-phenylurethane 
derivative of 1 ,2,5,6-di-O-isopropylidene-a-D-glucofuranose to generate the glycosyl 
donor, 26. Glycosylation of 26 with a sugar (R'OH) in the presence of silver triflate 
resulted in the formation of the f3-glucoside 27, Fig 1.16 .69 The first step in 
transforming the -gluco compound 27, into the -manno compound 31, required 
removal of the 0-acetyl groups with K2CO3  in methanol. The resulting sugar 28 was 
protected at positions C4 and C6 using a benzylidene acetal to give 29.69  The free 2-
OH of -glucoside 29 was activated with trifluoromethanesulfonic anhydride and 
pyridine for the inversion of configuration to give an insoluble triflate 30, which was 
converted directly into -mannoside 31 by heating to 75°C in pyridinelDMF.69 The 
inversion at C-2 proceeded smoothly and without side-reactions because the 
intramolecular attack of the carbamoyl oxygen is favoured entropically.69 
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Fig 1.16 : fi-mannosides from /3-glucosides by intramolecular nucleophilic 
substitution. 69 
Anomeric inversion of a-mannopyranosides to 3 by a radical translocation process 
has also been studied .7° In a standard procedure, a 0.05M solution of 32 was heated 
for 14h at 80°C with tributyltin hydride and 2,2'-azobisisobutyronitrile (AIBN). 
After workup with 1,8-diazabicyclo[5.4.0]undec-7-ene  (DBU) and 12,  three products 
were separated by flash column chromatography (Fig 1.17).70 Reduction of the o-
bromobenzyl derivative 32 provided two inverted products, the desired 13-mannoside 
26 
33 and the a-glucoside 34 as well as the directly reduced product 35•70  The f3-
mannose derivative 33 results from 1,6-hydrogen transfer followed by reduction of 
the anomeric radical with tributyltin hydride, while the a-glucose derivative 34 
results from 1,5-hydrogen transfer followed by reduction of the resulting radical at 
C-2.7° The directly reduced product 35 is believed to arise from bimolecular 
reduction of the aryl radical with tin hydride. 70 
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Fig 1.17 : Synthesis of,5-mannopyranosidesfroni a- epimers by radical inversion. 70 
1.3.3. Heterogeneous catalysis. 
A more direct method for producing the cis-f3- 1 ,4-mannosidic linkage was developed 
by Paulsen where an insoluble silver catalyst was used to promote the conversion of 
the a-halide to the 3-glycoside.62 When the reaction is carried out heterogenously, 
anomerisation to the reactive 13-halide is severely restricted and reaction of the a-
halide with inversion takes precedence.  64  However, a halide with the greatest 
possible reactivity and a hydroxyl group of sufficient reactivity should be used, so 
that selectivity can be retained. With unreactive hydroxyl groups the proportion of a-
glycoside isolated was found to increase. 64 
Donor 36 was activated at the anorneric centre by the presence of ether protecting 
substituents, while in acceptor 37, the reactivity of the 4-OH group was improved by 
conversion of the gluco configuration into the 1,6-anhydro form.62 Reaction of 36 
and 37 in the presence of silver silicate afforded the desired 13-linked disaccharide, 
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Fig 1.18 Direct synthesis of the /1-mannosidic linkage by heterogenous catalysis 
with silver silicate. 62 
The reaction of D-mannose derivatives with rhamnose derivatives in the presence of 
silver oxide and molecular sieves also produces the 13-mannosidic linkage. This 
process was used in the synthesis of the pentasaccharide repeating unit of the 0-
specific polysaccharide from Salmonella strasbourg.7' The key reaction involved 
glycosylation of benzyl 2,3-0-benzylidene-a-L-rhamnopyranoside, 40, with 








OBn 4A mol sieves  
91% 
Br C 
39 41 OBn 
Ph 1leO
0- ~Ph 
Fig 1.19 : Key step in the synthesis of the penrasaccharide repeating unit of the 0-
specific polysaccharide from Salmonella strasbourg.7' 
The success of this reaction may be attributed to the reactivity of the 4-OH group of 
the rhamnose derivative, which is comparable to that of a primary hydroxyl group. 64 
When other secondary hydroxyl groups of moderate activity are used, the yield on 
this type of reaction is lowered considerably. For example, coupling of the reactive 
halide 42 with the glucosamine derivative 43 in the presence of a silver silicate 
catalyst, results in formation of the undesired a-glycosidically linked product 44 in 
75% yield (Fig 1.20) .64 The 4-014 group in 43 is known to have low reactivity and 
this has the effect of severely reducing selectivity in the direction of the 13  product. 64 
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Fig 1.20: Coupling a reactive donor with a less reactive acceptor fails to produce /3- 
glycosidically linked disaccharide 64 
1.3.4. Intramolecular aglycon delivery. 
Another strategy to overcome the problems associated with the construction of the 
1,2-cis--D-mannopyranosidic linkage uses intramolecular aglycon delivery to 
synthesise f-mannopyranosides.72 The aglyconic alcohol, 45, is covalently attached 
to a group on the 0-2 position of a latent glycosyl donor, 46, in a coupling reaction 
where stereospecificity is not a concern, Fig 1.2  1.72  The aglycon is then delivered 
intramolecularly in a concerted reaction to produce the intermediate 47, which, on 
quenching with water, gives the -mannoside 48. Quenching with other nucleophiles, 
for example benzyl alcohol, allows the synthesis of 3-mannosides protected at 02.72 
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Fig 1.21 : hUramolecular aglycon delivery. 72 
There are many possibilities for the groups X, Y and Z. In the following example the 
activator, X, is N-iodosuccinirnide, the substituent, Y, at the anomeric position is a 
thioethyl group while Z represents a methyl group. Treatment of vinyl ether 49 with 
an equimolar amount of glycosyl acceptor 50 or 54 produced adduct 51 (51%) or 55 
(45%) respectively (Fig 1.22).72  Reaction of 51 or 55 with NIS in DCM gave the 3-
linked disaccharides (52 or 56) in 61% or 42% yield respectively, while no a-linked 
disaccharides could be detected. Further transformation of 52 and 56 resulted in 
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Fig 1.22 : Synthesis of /3-linked disaccharides by intramolecular aglycon delivery. 72 
1.3.5. Formation of -mannose linkages using glycosyl triflates and glycosyl 
phosphates. 
A protocol for the synthesis of J3-mannosidic linkages based on sulfoxide 
glycosylation was developed by Crich and Sun.  73  Activation of sulfoxide 58 with 
Tf2O at —78°C, followed by addition of the acceptor, 59, afforded -mannoside 60 in 
1  4 OMesOH. -40°C, 45% OBn 
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85% yield, together with only a minor amount of the corresponding a-anomer 61 
13 (8%) (Fig 1.23). 
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Fig 1.23: Synthesis of /3-inannopyranosides via glycosyl trflates.73 
Glycosylation of 58 with a range of glycosyl acceptors in this way was investigated 
with f:cx ratios as high as >20:1. Enhanced p3-selectivity and improved yields were 
observed when the steric bulk of the 0-2 protecting group of the acceptor was 
reduced and the coupling reaction was performed in a less ionising solvent than 
ether, for example DCM.73  
More recently, glycosyl phosphates were found to show high 3-selectivity in 
glycosylation reactions, even when a non-participating group was present in the C-2 
position.  74  Activation of tetra-0-benzyl mannosyl phosphate 62 by TMSOTf at - 
78°C resulted in rapid glycosylation of the hindered acceptor 63, to furnish 
disaccharide 64, Fig The selectivity of this reaction was strongly dependent 
on the nature of the glycosyl acceptor and the solvent used for the coupling reaction. 
In DCM, the desired -mannoside 64-0 was preferentially formed, but when the less 
hindered C-6 hydroxyl group of galactose served as an acceptor, the cc-linked 
disaccharide was obtained as the main product. 75 
When the coupling reaction was carried out in acetonitrile, a reversal in selectivity 
was observed .75 For the example shown, the disaccharide 64-a was the main product 
obtained under these conditions from reaction of donor 62 with acceptor 63. Even for 
the coupling of the less hindered galactose acceptor, enhanced (X-selectivity was 
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Fig 1.24 Formation of fi-mannose linkages using glycosyl phosphates. 75 
Although the syntheses outlined above show great ingenuity and planning in 
achieving the target oligosaccharides, they have the considerable drawbacks of 
requiring complicated protection and deprotection strategies and activating groups. A 
mixture of anomers is quite often obtained and this causes the additional problem of 
separating a- and j3-linked oligosaccharides, which can be difficult. 
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1.4. Chemoenzymatic synthesis of oligosaccharides. 
In view of the inherent problems associated with the chemical synthesis of 
oligosaccharides, a more practical approach may be the use of chemoenzymatic 
methodologies. The high regio- and stereoselectivity and mild reaction conditions 
offered by enzyme-catalysed procedures provides an opportunity to tackle many 
synthetic problems encountered in carbohydrate synthesis. Enzymatic 
oligosaccharide synthesis can also decrease the length and complexity of a synthetic 
route by eliminating the need for complicated protected strategies.76 
For in vitro enzymatic oligosaccharide synthesis three strategies are available. The 
first is the use of the glycosyltransferase enzymes of the Leloir pathway, which 
require sugar nucleotides as donors .77 The second is the use of the non-Leloir 
pathway enzymes, which require sugar- i-phosphates as donors.  76  The third is the use 
of glycosidase or glycosyl hydrolase-catalysed reactions. Glycosidases usually cleave 
glycosidic bonds. However, studies have found that these enzymes can also be used 
for the formation of glycosidic bonds in a kinetic or thermodynamic approach.78  
1.4.1. The Leloir pathway. 
Three fundamental steps constitute the Leloir pathway in vivo: Activation, transfer 
and modification.  78  In the first steps of the Leloir pathway for all sugars, except 
NeuAc and its derivatives, a sugar (for example N-acetylglucosamine, glucose, 
galactose or mannose) is transformed into the corresponding sugar- i-phosphate by a 
kinase.78 This sugar- i-phosphate reacts with a nucleoside triphosphate (NTP) in an 
enzyme-catalysed reaction and forms a chemically activated nucleoside diphosphate 
sugar (NDP-sugar) such as UDP-Glc, UDP-GlcNAc, UDP-Gai or UDP-Man.78 The 
enzymes which catalyse such a process are known as pyrophosphorylases, or 
nucleoside transferases (Fig 1.25).78 
Sugar-i-P + NTP ------ NDP-Sugar + PP 
Fig 1.25 : Formation of a chemically activated nucleoside diphosphate sugar. 78 
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The activation of sialic acid (NeuAc) is an exception, as in this case a nucleoside 
monophosphate sugar forms directly from NeuAc itself (Fig 1 .26).78 
NeuAc + CTP CMP-NeuAc + PP1 
Fig 1.26 : Direct formation of activated sialic acid. '78 
Once the activated sugars have been formed, they are transferred to a protein or lipid, 
or to the non-reducing end of a growing oligosaccharide.78 The enzymes which 
catalyse the transfer of an NDP-sugar are known as glycosyltransferases. For N-
linked glycoproteins, these steps occur in the RER and in the Golgi apparatus. 78 
The final stage in the Leloir pathway involves modification of the substrate. For N-
linked glycoproteins this modification occurs in two stages: The asparagine-linked 
tetradecasaccharide, G1c3-Mang-GlcNAc2, is firstly processed in a series of 
glycosidase-catalysed reactions which cleave the three terminal glucose and four 
mannose residues .5 The exposed inner core, Man5-G1cNAc2, is then elaborated by the 
transfer of sugars from NDP-sugar species under the influence of glycosyltransferase 
enzymes. 50 
The in vitro synthesis of oligosaccharides depends on the availability of sugar 
nucleoside phosphates and glycosyltransferases. All of the common NDP-sugars are 
available from commercial sources, but most are expensive. Many 
glycosyltransferases are difficult to isolate, especially from mammalian sources, 
because the proteins are present in low concentrations and are membrane-bound .78 if 
the enzyme is not readily available in sufficient quantities, the scale of the reaction is 
severely limited. 
1.4.2. The use of enzymes from the Leloir pathway in chemoenzymatic synthesis. 
The synthetic utility of many glycosyltransferases has been investigated and this has 
allowed the preparation and isolation of well-characterised oligosaccharides. One 
example of a combined approach using both chemical and enzymatic synthesis for 
the preparation of a variety of sialyloligosaccharides representing the terminal 
sequences in oligosaccharides of glycoproteins and glycolipids has been reported by 
Sabesan and Paulson.  79 Neutral oligosaccharides prepared by chemical synthesis 
were sialylated enzymatically with purified mammalian sialyltransferase to form the 
a-D-NeuAc-(2,6)-13-D-Gal or a-D-NeuAc-(2,3)--D-Gal linkages. 79 
A number of groups have focused in particular on the study of galactosyltransferases. 
For example, Palcic et al. found that bovine D-galactosyltransferase transferred D-
gal actose from UDP-Ga1 to 6-0-substituted 2-acetamido-2-deoxy-3-D-
glucopyranosides.80 The product of galactosylation of 65, namely, 8-
methoxycarbonyloctyl-2-acetamido-2-deoxy-6-0-u-L-fucopyranosyl-4-0-3-D- 
gaIactopyranosyl-3-o-g1ucopyranoside, 66, was conveniently isolated from a 
preparative scale reaction by virtue of its hydrophobic linking-arm using absorption 
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Fig 1.27 : Use of bovine D-galactosyltransferase to transfer D-galactose from UDP-
Gal to 6-0-substituted 2-acetamido-2-deoy-fl-D-glucopyranosides.80 
Such reactions of glycosyltransferases have the potential for the rapid production of 
milligram quantities of oligosaccharides for use in biological testing, especially 
where synthetic oligosaccharide substrates are unavailable. 80 
Zehavi et al. used 3- 1,4-galactosyltransferases for their polymer-supported 
oligosaccharide synthesis (Fig 1.28).81 
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Fig 1.28 : Use of /3-1,4-galactosyltransferases for polymer-supported 
oligosaccharide synthesis. 81 
A glucose residue was attached to the polymer via a photocleavable 4-(N-polymer-
amidocarbonyl)-2-nitrobenzyl linker to give solid-supported glucoside 67.81  The 
galactose moiety was transferred to glucoside 67 using f-1,4-galactosyltransferase 
and UDP-Gal to generate 68. Finally, irradiation of 68 released the lactose moiety, 
69, from the polymer. 81 
The chemoenzymatic synthesis of oligosaccharides using recombinant 
glycosyltransferases has also been successfully accomplished. 
The use of a combination of chemical and enzymatic techniques to synthesise the 
core trisaccharide j3-n-mannopyranosyl-( 1 ,4)-2-acetamido-2-deoxy-a-n- 
glucopyranose, 77, both regio- and stereoselectively in good yield, has been reported 
by Flitsch et al.82 A phytanyl-linked acceptor substrate 75 was prepared from 
commercially available chitobiose octaacetate, 70 (Fig 1.29). The chitobiose 
octaacetate was subjected to a selective anomeric deacetylation and then 
phosphorylated to give 72.82  Coupling of the deprotected chitobiose phosphate, 73, 
with phytanyl phosphate in the presence of NN'-carbonyl diimidazole (CDI), 
followed by deacetylation yielded the acceptor substrate 75•82  Incubation of the 
phytanyl-linked acceptor substrate 75 with GDP-mannose at 37°C in the presence of 
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the immobilised -mannosyltransferase and alkaline phosphatase gave the phytanyl-
linked trisaccharide 76, which was subjected to acid hydrolysis without isolation. 82 
Extraction of the cleaved lipids with chloroform was followed by gel-permeation 
chromatography of the aqueous phase to give the -niannosyl-linked trisaccharide 77 
in 80% yield.82 
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Fig 1.29 : Synthesis of the core trisaccharide of N-linked oligosaccharides.82  
1.4.3. The use of glycosidase enzymes in chemoenzymatic synthesis. 
Glycosidases are the enzymes responsible for the hydrolytic cleavage of glycosidic 
bonds in vivo. Two groups of glycosidases exist: The exoglycosidases, which cleave 
terminal glycosidic units, and the endoglycosidases, which cleave both terminal and 
non-terminal glycosidic linkages in oligo- and polysaccharide chains.  78  Additionally, 
there are retaining glycosidases that preserve the stereochemistry of the anomeric 
centre of the glycoside and inverting glycosidases that invert this centre. 76 
The advantage of utilising glycosidases instead of glycosyltransferases as catalysts 
for glycosyl transfer is that expensive sugar nucleoside donors are not required to 
achieve reaction. The glycosidases are generally more available and less expensive 
than the glycosyltransferases.76 
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A two step synthesis of the core trisaccharide of N-linked glycoproteins using 13-N-
acetyihexosaminidase and f3-mannosidase from Aspergillus oryzae has been 
accomplished by Singh et al. (Fig 1.30).83  A one step procedure for the preparation 
of di-N-acetylchitobiose, 85, was achieved by coupling the glycosyl donor p-
nitrophenyl 2-acetamido-2-deoxy-I3-D-glucopyranoside, 83, with the acceptor N-
acetylglucosamine, 84, using a partially purified 3-N-acetylhexosaminidase from 
Aspergillus oryzae. 83 
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Fig 1.30 : Two step synthesis of the core trisaccharide of N-linked glycoproteins 
using /3-N-acetylhexosaminidase and /3-mannosidasefroin Aspergillus oryzae. 83 
A 13-mannosidase was isolated from Aspergillus oryzae and used to catalyse the 
transfer of a 13-mannosyl unit from p-nitrophenyl 3-D-mannopyranoside, 86, 
specifically to the 4-OH of the non-reducing unit of the disaccharide, 85, to give the 
core trisaccharide, 77, of N-linked glycoproteins. 83 
The enzymatic synthesis of alkyl and hydroxylalkyl 13-D-mannopyranosides using a 
13-mannohydrolase enzyme from snails was undertaken by Taubken and Thiem.84 
Several 13-mannopyranosides of water soluble alcohols were prepared by incubating 
4-nitrophenyl f3-mannopyranoside, 86, with a high concentration of each alcohol in 
the presence of 13-mannohydrolase at 30°C for several hours, Fig 1.3 1.84  The 
resulting alkyl and hydroxyalkyl 13-mannopyranosides 87a-d were isolated in yields 
of up to 75% 84 
alcohol product yield(%) 
OH OH 




HO -mannohydroIase OR 




c PrOH R=1Pr 9 
pH4.0, 30°C 
d BuOH R=Bu 19 
Fig 1.31 : The enzymatic synthesis of alkyl and hydroxylalkyl /.3-D-mannopyranosides 
using a Ji-inannohydrolase enzyme from snails. 
The major drawback in the use of enzymes as catalysts in carbohydrate synthesis 
involves the availability of the range of enzymes required to accomplish tasks in this 
area, and the stability and breadth in substrate acceptability of these enzymes. As 
genetic engineering progresses and cloning techniques develop, enzymes are 
becoming available in sufficient qualities and quantities, enabling greater feats to be 
achieved in oligosaccharide synthesis. 
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1.5. The lipid carrier for oligosaccharide assembly: dolichyl phosphate. 
The polyisoprenoid dolichol is well established as being an essential cofactor in the 
biosynthesis of glycoconjugates.85 The N-linked oligosaccharides of glycoproteins 
are first biosynthesised on dolichol before transfer to the nascent protein chain in the 
lumen of the ER. 
By means of such hydrophobic vehicles the very hydrophilic glycoside chains can be 
attached to the specific target sites of the acceptor proteins in the hydrophobic 
membrane folds of the endoplasmic reticulum.86 The glycosyltransferases involved 
in the biosynthesis of N-linked glycoproteins are all membrane associated and act on 
lipid substrates. The extent of molecular recognition of the dolichol lipid by these 
transferases is poorly understood .87 The ability of the enzymes to recognise dolichols 
in vivo is assumed to reside in a portion of the protein in the membrane.  88  Indeed, 
comparison of the sequences of yeast glycosyltransferases, ALG7, ALG1 and DPM1, 
known to interact with Dol-P derivatives revealed that they shared a conserved 13-
amino acid peptide sequence in obvious membrane-spanning regions of the 
proteins. 89 
1.5.1. The occurrence, isolation and synthesis of dolichol species. 
In order to effectively study the steps involved in the biosynthesis of lipid-linked 
oligosaccharides and the subsequent transfer of the oligosaccharide to an asparagine 
residue of a growing peptide in co-translational modification processes, it is essential 
to have a source of pure dolichols in quantities sufficient to allow synthesis of both 
biosynthetic intermediates and synthetic analogues in the pathways responsible for 
the biogenesis of glycoproteins. Supplies of naturally occuring dolichols are scarce, 
and can only be isolated from eukaryotic cells in trace quantities by arduous isolation 
procedures. Dolichols have been extracted from pig liver, but following a long and 
tedious procedure, a mere 200mg of a mixture of homologues was isolated from 5kg 
of pig liver. 90 
The first synthetic preparation of optically active dolichols, 90, from a mixture of 
polyprenols isolated from the leaves of Ginkgo biloba was reported by Suzuki et al.9' 
The synthesis was achieved by the addition of the optically active saturated isoprene 
unit, 89, to a mixture of polyprenyl acetates, 88, using a grignard coupling reaction, 
Fig 1.32.' The main disadvantage of this synthetic preparation was the need for a 
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Fig 1.32 : The synthesis of lnamn1a/ial dolichois from plant polyprenols. 91 
A second synthetic route to dolichol involved ruthenium-based homogeneous 
hydrogenation of naturally occurring polyprenols with {(S)-BINAP}Ru"{CF3CO2 
}2}.92  Again, the starting polyprenols, 91, were extracted in the form of the 
corresponding acetates from the leaves of the Ginkgo biloba tree and then 
saponified.92 Asymmetric hydrogenation using a Noyori catalyst afforded the desired 
(S)-dolichols, 93, Fig 13192  The starting polyprenols had to be rigorously purified 
prior to saponification, to prevent traces of by-products poisoning the catalyst. 
Problems were also encountered with poor solubility of the purified polyprenols in 
the solvent medium of the reaction. 
im 
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Fig 1.33 Synthesis of dolichols via asymmetric hydrogenation of plant polyp renols. 
Although dolichols can be synthesised, they are usually obtained as a mixture of 
homologues that are difficult to manipulate. Therefore, what is needed is a readily 
available synthetic analogue of dolichol, which is an acceptor for 
glycosyltransferases. This would allow for the isolation and purification of 
unidentified transferases involved in the pathways of N-glycan biosynthesis, as well 
as providing a novel route to the pentasaccharide core. 
42 
1.6. Conclusion. 
Glycoproteins, along with glycolipids, are known to act as sites for the binding of 
other large biomolecules such as hormones, antibodies, enzymes, bacterial toxins and 
cell surface proteins. The impact of protein glycosylation can be seen in the 
important physical properties imparted to the molecule, for example, protease 
resistance, conformational stability, charge and water-binding capacity.  66  The 
number of monosaccharides and the possible ways of linking them together gives the 
glycal portion of glycoproteins immense diversity in structure compared with the 
protein, implicating them as the key elements in the complex subleties involved in 
physiological and pathological processes of living organisms. 66 
N-Linked glycoproteins originate from the biosynthetic precursor dolichol 
phosphate-linked glycal, Glc1Man9GlcNAc2-PP-Dol, in the ER of eukaryotic cells. 
Yeast genetic techniques have helped to identify many of the enzymes required for 
the stepwise assembly of Glc3Man9GlcNAc2-PP-Dol, yet some of those enzymes 
involved in the early stages of N-glycan biosynthesis remain unidentified. In order to 
gain more information about the unknown mannosyltransferases that are active in the 
early stages of N-glycan biosynthesis, a phytanyl-linked monosaccharide 
(glucosamine), 163, and disaccharide (chitobiose), 75, were prepared. These 
substrates should prove useful for providing biosynthetic intermediates for the 
studies of subsequent glycosyltransferases of the biosynthetic pathway of N-linked 
oligosaccharides. 
In order to effectively study the steps involved in the biosynthesis of lipid-linked 
oligosaccharides and their subsequent transfer to a nascent protein in co-translational 
modification processes, it was also essential to have a source of pure dolichols in 
sufficient quantities to allow the synthesis of both biosynthetic intermediates and 
synthetic analogues in the pathways responsible for the biogenesis of glycoproteins. 
Since supplies of naturally occurring dolichols are scarce and as they are difficult to 
synthesise, a number of lipid substrates were prepared instead as synthetic analogues 
of the naturally occurring dolichyl phosphate. 
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The aim of this project was to synthesise three novel analogues of the naturally 
occurring lipid, dolichyl phosphate (Dol-P). All of these lipids were designed to be 
multi-functionalised. An ester substituent was incorporated into the backbone of the 
lipid chain in order to increase their solubilities in water. Two of the lipids had an N-
phthalimido group at the w-end of the chain, while the third bore a fluorescent probe 
at this point. The requirements for chain length and polyisoprenoid structure were 
then to be tested. It was reasoned that the fluorescent label would be of some aid in 
characterising the interactions of Do1-P or its glycosylated derivatives with enzymes 
which utilise these substrates or proteins participating in sugar transport across the 
cell membrane. 
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2. Synthesis of Novel Lipid Analogues of Dolichyl Phosphate. 
2.1. Introduction to past research. 
A possible function of dolichol is to act as a lipophilic membrane anchor, and it was 
thought that this property could be effectively mimicked by more readily available 
and easily synthesised isoprenoid substrates. Early research has found that certain 
restrictions apply to the selection of suitable dolichol analogues.  93  A study of the 
formation of dolichol diphosphate-(N-acetylglucosamine)12, (Dol-PP-(GlcNAc)12) 
from uridine diphosphate-N-acetylglucosarnine (UDP-GlcNAc) and dolichyl 
monophosphate (Dol-P) revealed an obligatory requirement for a-saturated 
polyprenols.93 In addition, the substrate specificity of solubilised enzymes 
responsible for (1) the transfer of the chitobiosyl group from Do1-PP-(G1cNAc)2 to a 
hexapeptide containing an Asn-Leu-Thr-Ser sequence, and (2) the transfer of 
mannose from guanosine diphosphate mannose (GDP-Man) to Dol-P and from Dol-
P-Man to a threonine-containing tetrapeptide have been investigated .93 The activity 
of all the enzymes concerned depended strongly on the saturation of the a-isoprene 
unit and, furthermore, clear chain-length effects were also observed.93 For the ALG7 
protein the Michaelis constant, KM,  for Do1-P was found to be 3 1p.M.89 The 
Michaelis constant is defined as the substrate concentration in moles/L at which an 
enzyme-catalysed reaction proceeds at half its maximal rate.  94  As the isoprenoid 
chain length was decreased from 100 to 55 carbons, the KM increased to 1 17p.M 
while an isoprenoid derivative with only 35 carbons gave rise to very low activity in 
the assay.  89  For the DPM1 protein, the KM for Dol-P was approximately 1p.M. 
Decreasing the isoprenoid length to 35 carbons decreased the reaction velocity by 
10-fold.89 From this study it was concluded that a minimal chain length of seven 
isoprene units is required based on observations that a polyprenol phosphate of this 
size was either inactive or showed only about one tenth of the donor or acceptor 
specificity. 89 
Prior to this work, the fully saturated tetraprenyl phosphate, phytanyl phosphate, had 
been reported by Clark and Villemez to be an efficient analogue of dolichyl 
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phosphate in the enzyme mediated formation of the monosaccharide lipid phosphate 
Dol-P-Man using a mannosyl transferase from mung beans.  95  On the basis of this 
information, phytanol, 93, appeared to Taylor et al. to be a good starting point in the 
search for novel analogues of the natural lipid dolichol, since it is readily available in 
gram quantities from phytol by catalytic hydrogenation and it possesses the a-
saturated isoprene unit necessary for retention of mannosyl transferase activity. 35 
Given the previous observations on the effect of chain length,93 Taylor et al. hoped 
that the requirement for a dolichol chain of at least seven isoprene units would 
become less rigorous as the length of the oligosaccharide chain increased .35 Taylor et 
al. also anticipated that phytanol would be sufficiently lipophilic to be retained at the 
membrane surface and that it would be held within the dolichol binding site of the 
mannosyl transferase.38  
The simple, straight chain lauryl alcohol, 94, was also chosen by Taylor et al. to 
replace the natural dolichyl lipid.35 Although lauryl alcohol possesses none of the 
previously discussed structural requirements for transferase activity, it could provide 
useful information on the nature of the dolichol binding site.  38 Both of these lipids 
are illustrated in Fig 2.1. 
~OH 93 
OH 94 
Fig 2.1 : Phytanol and lauryl alcohol, the first two lipids chosen as dolichol 
analogues in the group. 38 
Biological assays of these two lipid phosphates showed that two mannosyl 
transferases in crude extracts of pig liver and yeast accepted phytanol analogues of 
dolichol-linked acceptor substrates.35 The fact that the branched phytanol, 93, but not 
the straight chain lauryl alcohol, 94, could act as a substitute for dolichol revealed the 
requirement for methyl branching in any new dolichol analogue.  35 Since the 
structural feature common to both dolichyl phosphate and phytanyl phosphate is the 
first saturated isoprene unit, it appeared that the methyl group nearest the phosphate 
headgroup was necessary for enzyme activity. 35 
In order to gain a better understanding of the role of the polyisoprenoid structure in 
substrate recognition by the transferases involved in N-glycan biosynthesis, further 
studies within our group focused on the synthesis of a number of functionalised 
lipids.  96  These lipids conform to the restrictions required for analogues of dolichol in 
that they fall within the predicted limits for chain length, bear an cc-saturated 
isoprene unit and contain two methyl branches close to the phosphate headgroup. 
Heteroatom modification of the lipophilic chain was introduced to improve substrate 
solubility in water and also to test the tolerance of the dolichol binding site to 
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Fig 2.2 : Multifunctionalised lipids synthesised to gain further information on the 
nature of the dolichyl binding site.96 
Enzymatic assays of these three lipids were conducted using dolichyl phosphate 
mannose synthase (Dol-P-Man synthase), one of the transferases under investigation 
that had been found to accept phytanol derivatives35 and to possess a putatively 
conserved dolichyl binding site.89 Dol-P-Man synthase is an endoplasmic reticulum 
resident membrane enzyme that catalyses the transfer of mannose from GDP-Man to 
dolichyl phosphate, Fig 2.3. This results in the formation of a key glycosyl donor in 
pathways for the synthesis of N-linked oligosaccharides and 0-linked 
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R is the lipid component attached to the phosphate headgroup. 
Fig 2.3 The transfer of mannose from GDP-Man to a lipid phosphate as catalysed 
by the enzyme Dol-P -Man synthase. The different lipid components represented by R 
are illustrated in Table 1 below. 98 
Each phospholipid was incubated in parallel with dolichyl phosphate, 2, and phytanyl 
phosphate, 98, with a crude enzyme system from yeast in the presence of a 
labelled GDP mannose co-factor.98 The relative levels of transfer of the radiolabelled 
mannose to the lipid were determined by scintillation counting of an organic extract 
of the reaction.  98  The enzymatic assay with Doi-P-Man synthase showed different 
levels of activity for the transfer of radiolabelled mannose to the different 
phospholipids, Table 1. 
Incorporation relative 
R to dolichyl phosphate 
I Dolichol 2 1 1.00 








No exogenous acceptor 0.00 
Table 1.96 
The greatest transfer of radiolabelled mannose to a lipid was observed for dolichyl 
phosphate, 2, and the activity for this process was set at 100%. Phytanyl phosphate, 
98, was found to be the best synthetic analogue showing 62% activity relative to 
dolichyl phosphate. The results in Table 1 show that the transfer of mannose was not 
observed in the presence of compound 9796  This novel lipid phosphate was not 
found to be a suitable acceptor substrate for mannosyl transferase enzymes. This 
suggested that the structural variations in the lipid backbone of compound 97, such 
as the incorporation of the bulky cyclobutadione and two amino groups, were not 
compatible with the dolichyl binding site.  96  However, the soluble acceptor lipids 9598 
and 9696  compared well to phytanyl phosphate, 98, as a substrate, showing 44% and 
60% activity respectively, relative to dolichyl phosphate, 2. From this, it appeared 
that the dolichyl binding site was tolerant of polar groups at the co-position and 
simple heteroatom modifications of the lipid chain. 98 
2.2. Synthesis of novel dolichyl analogues. 
On the basis of these results, it was decided that our novel analogue for the natural 
dolichyl lipid would contain a combination of the structural features of the two active 
lipid substrates, 95 and 96. The bi-functionalised molecule, 99, retained two methyl 
branches close to the phosphate headgroup, an ct-saturated isoprene end unit while 
the chain length fell within predicted limits, Fig 2.4. The heteroatom modification of 
the lipid backbone would not only increase the solubility of the lipid substrate in 
water, but it also allowed for the possibility of extending the chain length of 
intermediate compounds, such as 106, Fig 2.5. The flexibility of this synthetic 
strategy gave the ability to alter the functionality at theco-position to allow both 
attachment of the lipid to solid support or derivatisation of substrate mimics for 
specific glycosyltransferases. Furthermore, the synthesis of a novel analogue of 
dolichol with a fluorescent label at the w-end of the lipid chain would be of some aid 
in characterising the interactions of Dol-P or its glucosylated derivatives with 
enzymes which utilise these substrates or proteins participating in sugar transport 
across the membrane. The fluorescently labelled lipid, 100, chosen as a novel 
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Fig 2.4: The two target lipids chosen as possible alternatives to dolichyl phosphate. 
2.2.1. Synthesis of 3,7-dimethyl-8-(12-N-phthalimidododecanoyloxy)octyl 
phosphate. 
The synthesis of lipid 99 began with benzyl protection of commercially available 
citronellol, 101, as shown in Fig 2.5. Citronellol, 101, was treated with sodium 
hydride in THF for one hour at room temperature to generate an alkoxy anion. 
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Addition of benzyl bromide followed by tetrabutyl ammonium iodide and stirring at 
40 °C for a period of four hours resulted in quantitative production of the benzyl 
NaH, THF 
101 
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protected alkene, 102.96 
Fig 2.5 Synthetic route to 3, 7-dimethyl-8-(]2-N-phthalirnidododecanoyloxy)octyl 
phosphate. 
The next step involved oxidation of the allylic group of 102 using catalytic selenium 
dioxide as the oxidising agent. Selenium dioxide displays a unique mode of 
interaction with olefins, involving an initial ene reaction followed by a [2,3] 
sigmatropic rearrangement. 9 The initial product is an allylic seleninic acid which 
undergoes allylic rearrangement to give an unstable compound that rapidly 
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R-Y — 11-'Y + Se(II) by-products 
Fig 2.6: Oxidation of an alkene to an allylic alcohol with Se02.2  
The utility of selenium dioxide as a selective allylic oxidant has been improved by 
the use of tert-butyl hydroperoxide, which as co-oxidant effectively prevents 
interference by reduced selenium species giving a cleaner oxidation.'°° tert-Butyl 
hydroperoxide re-oxides Se(II) species after the catalytic cycle, thereby preventing 
the formation of diols and epoxides and eliminating the need for disposal of large 
amounts of toxic selenium-containing products. 100 
The selenium-catalysed oxidation of acyclic olefin, 102, produced, in addition to the 
desired allylic alcohol, 103, an allylic aldehyde, 104. The aldehyde side-product, 
104, was isolated in 23% yield by flash column chromatography, while the allylic 
alcohol, 103, was recovered in 39% yield. In order to increase the amount of 103, 
sodium borohydride mediated reduction of the a,f3-unsaturated aldehyde, 104, was 
attempted in an ethanol-water solution.  96  This process did not proceed efficiently, 
giving a mixture of products which upon separation by flash-column-
chromatography afforded the desired allylic alcohol, 103, (28%) and the saturated 
alcohol (12%). 
The synthesis of the key intermediate ester, 106, was achieved in 87% yield by the 
addition of commercially available 12-bromododecanoic acid, 105, 4-
dimethylaminopyridine (DMAP) and dicyclohexylcarbodiimide (DCC) to a solution 
of the benzyl protected allylic alcohol, 103, in anhydrous diethyl ether.'°' The 
flexibility of the synthetic strategy would allow esterification of the allylic alcohol, 
103, with carboxylic acid substrates of different chain lengths. It is also possible at 
this point in the synthetic route to alter the functionality of the heteroatom substituent 
in the lipid chain. 
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Introduction of a nitrogen-containing group at the co-position commenced by heating 
the brominated lipid, 106, with potassium phthalimide, 107, at 80 °C in DMF.96 It 
was anticipated that the N-phthalimido lipid, 108, obtained in 84% yield from this 
step, would fulfil a two-fold purpose. Firstly, it would be tested to establish enzyme 
activity for this type of multi-functionalised lipid and, secondly, it would be used as a 
synthetic intermediate in the synthesis of the fluorescently labelled dolichyl 
phosphate derivative, 100, Fig 2.14 (section 2.2.2.). 
The final steps in the synthesis of the target lipid 99 required attachment of the 
phosphate headgroup to the a-saturated isoprene unit, Fig 2.5. It was hoped that 
unmasking of the benzyl protected alcohol and reduction of the double bond could be 
achieved in one-step by catalytic hydrogenation over finely divided 10% palladium 
on charcoal in 2:1 acetone: methanol. This reaction did not proceed as efficiently as 
anticipated with problems being encountered in the purification and isolation of the 
desired product. Partial hydrogenation was frequently encountered to give a product 
such as 111, Fig 2.7, where loss of the double bond and retention of the benzyl 








Fig 2.7 : Partial hydrogenation resulted in loss of the double bond but gave a lipid 
which still retained the benzyl protecting group. A number of unidentified side-
products were also produced in this reaction. 
These problems may have been due in part to the low temperatures in the lab at the 
time this work was carried out. The pale yellow oil obtained after the reaction was 
worked-up would rapidly turn to a white residue, which was difficult to purify, and 
low yields of all products were obtained. Only when the lab temperature increased 
did the efficiency and yield of this process improve to generate the saturated product, 
109, as a mixture of diastereomers at positions 3 and 7 in 66% yield. Previous work 
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has indicated that stereochemistry at position 3 has a negligible effect on activity. 98 
The phytanyl lipid used in previous experiments was also a diastereomeric mixture at 
positions 3 and 7 but it shows remarkably high activity (62%) compared to dolichyl 
phosphate.  98  It has thus been assumed for the scope of this project that the 
stereochemistry of the methyl groups on the lipid chain does not have a dramatic 
influence on the activity of the mannosyl transferase enzymes. 
Phosphorylation of the alcohol 109 was the next step to be undertaken. Previously, 
phosphorylation of a lipid alcohol was carried out under conditions developed by 
Perich and Johns where treatment with NN'-diisopropyl-di-tert-butyl 
phosphorarnidite and 1-H-tetrazole generated a phosphite.  102  Oxidation of the crude 
phosphite with meta-chloroperbenzoic acid (mCPBA) would then produce the 
protected di-tert-butyl phosphate. At the time that this procedure was to be 
conducted, l-H-tetrazole was not commercially available and so alternative methods 
were investigated. 
The synthesis of monoalkyl phosphates has been reported by a number of people 
using a wide variety of phosphorylating reagents, some of the most common being 
illustrated in Fig 2.8.38  
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Fig 2.8: Some common phosphorylating reagents used in the synthesis of monoalkyl 
phosphates. 38 
Diphenyiphosphochloridate, 112, has been shown to be much more stable and can be 
stored for several months.  38 However, the formation of diphenyiphosphates can be 
problematic and removal of the phenyl groups can be quite a challenge.  38 Another 
unstable phosphorylating reagent that has been used is 
dimorpholinephosphorobromidate, 113, which is readily prepared but unsuitable for 
storage.  38  The o-phenylenephosphorochloridate, 114, has been successfully utilised 
in the production of monoalkyl phosphates.  38  However, problems have been 
encountered in both the formation and deprotection of the resulting phosphotriesters, 
giving less than satisfactory yields. 38 
A similar method to that of Perich and Johns had been reported by Wong et al. 
utilising dibenzyl NN'-diethylphosphoramidite (DDP) in the preparation of dibenzyl 
glycosyl phosphites.103 Subsequent oxidation of the phosphite with hydrogen 
peroxide created the desired glycosyl phosphate.103 Glycosyl phosphites and 
phosphates of a number of sugars were prepared in this manner, including 2,3,4,6-
tetra-0-acetyl-D-glucose shown in Fig 2.9. 113 
OAc OAc OAc 
ACOS (BnO)2PNEt2 Ac 0 R,02, ThF Ac O\ 
Ac OH Iriazole AcO-.\.....OP(OBn)2 98% AcO__pSOB  OAc DCM,97% OAc OAc 
115 116 117 
OBn 
Fig 2.9: The use of DDP and 1,2,4-triazole in the synthesis of dibenzyl 2,3,4,6-tetra-
0-acetyl-D-glucopyranosyl phosphate. 103 
Treatment of 2,3,4,6-tetra-0-acetyl-D-glucose, 115, with DDP in the presence of 
1,2,4-triazole in anhydrous DCM under a nitrogen atmosphere resulted in the 
formation of dibenzyl 2,3,4,6-tetra-0-acetyl-D-glucopyranosyl phosphite, 116.'°  
Oxidation of 116 with 30% hydrogen peroxide at —78 °C in THF afforded the desired 
dibenzyl 2,3,4,6-tetra-0-acetyl-D-glucopyranosyl phosphate, 117, in 98% yield.  103  
A slightly modified version of this approach was used in an attempt to phosphorylate 
alcohol 109, whereby the previously used DDP was replaced with the more readily 
available compound NN'-diisopropyl-di-rert-butyl phosphoramidite. Treatment of 
compound 109 with 1,2,4-triazole and NN'-diisopropyl-di-tert-butyl 
phosphoramidite in anhydrous THF was followed by oxidation with a solution of 
mCPBA in anhydrous DCM, Fig 2.10. 
0 ('8u0)2PN'Pr2 
tdazole  THF Reaction failed 
0 mCPBA, DCM 
109 
Fig 2.10 : Atteinptedphosphorylation of the alcohol using 1,2,4-triazole. 
55 
Unfortunately, phosphorylation of the alcohol was not accomplished. Analysis of the 
crude reaction mixture did not provide any evidence of the desired product and the 
compound obtained was not identified. It would appear that the lower acidity of 
1,2,4-triazole (pKa lO, compared with tetrazole, pKa°5) makes it an unsuitable 
replacement for tetrazole in the synthesis of a lipid-phosphite from N,N'-diisopropyl-
di-tert-butyl phosphoramidite. 
A method of phosphorylation that had been successfully used in the synthesis of 
dibenzyl chitobiosyl phosphate was then considered. This process involved treatment 
of chitobiose heptaacetate, 71, with LDA at —78 °C in THF followed by reaction with 





Ac LDA, THF, -78°C 
XIXO~O Ac 
A. 
O[PO(0Bn)2]2 NHAc NHAc 
AcNH AcNH I 
OH 
72 0 OBn 71 
OBn 
Fig 2.11 : Phosphorylation of chitobiose heptaacetate using LDA and tetrabenzyl 
pyrophosphate. 82 
The main concern with this method was that the lipid chain would not withstand the 
reaction conditions. However, in the aforementioned reaction with chitobiose 
heptaacetate, the non-nucleophilic base, LDA, did not affect any of the acetate ester 
protecting groups so it was reasoned that the lipid should survive under such strongly 
basic conditions. A stirred solution of alcohol 109 in THF at —78 °C was duly treated 
with a 1.8M solution of LDA in 1:1:1 heptanelTHF/ethylbenzene followed by 
tetrabenzyl pyrophosphate, Fig 2.12. 
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Fig 2.12 : Attempted phosphorylation of the lipid using LDA and tetrabenzyl 
pyrophosphate. 
r,i 
The main compound recovered from the crude reaction mixture was thought to be the 
desired dibenzyl protected lipid phosphate, 118. NMR analysis of this compound 
supported product formation. When compared to the 'H NMR of 109, the 'H NMR 
for compound 118 showed additional peaks as follows: A multiplet integrating to ten 
protons at 5H  7.46-7.37 ppm which was assigned to the protons belonging to the two 
POCHii groups, and a broad multiplet integrating to six protons observed at 5,-, 
5.21-5.13 ppm which was assigned to the POth and two POJPh protons. The 
31P NMR of compound 118 showed the presence of one phosphorous in the molecule 
with a singlet recorded at 8p —13.3 ppm. However, mass spectral analysis proved 
inconclusive with no evidence of a parent ion or any lipid fragment being formed. A 
further test was conducted to detect the presence of a lipid phosphate. This involved 
running a TLC of the compound and developing the plate with a molybdenum blue 
reagent. A blue spot should develop in the presence of a lipid phosphate but in this 
case the test proved to be negative. Although the NMR data obtained for compound 
118 was consistent with the proposed structure, the lack of mass spectral and 
chromatographic data meant that there was no conclusive evidence for the formation 
of product 118 by this method. 
More problems were encountered when attempting to deprotect the dibenzyl 
phosphate of 118. Hydrogenation of lipid phosphate 118 over finely divided 10% 
palladium on charcoal as catalyst in anhydrous methanol gave a crude reaction 
mixture that proved difficult to purify, Fig 2.13. 
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Fig 2.13 : Attempted deprotection of the dibenzyl phosphate. 
Of the compounds obtained from this reaction no evidence was observed of any lipid 
phosphate by NMR, mass spectrometry or TLC analysis and although the 
compounds obtained could not be identified, they appeared to be fragments of the 
lipid chain. It would seem that the initial phosphorylation reaction with LDA and 
TBPP had been unsuccessful and that a mixture of lipid fragments and a phosphorus- 
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containing fragment co-eluted from the column during purification, giving what was 
thought to be the dibenzyl lipid phosphate. 
Fortunately, l-H-tetrazole became available as a 3% solution in acetonitrile, making 
it possible to phosphorylate lipid 109. The lipid phosphite was prepared from 109 by 
reaction with NN'-diisopropyl-di-tert-butyl phosphoramidite and 1-H-tetrazole, Fig 
2.5. Addition of a solution of mCPBA in DCM to the crude phosphite resulted in its 
successful oxidation to the desired di-tert-butyl lipid phosphate, 110, in an overall 
yield of 77%. 
Finally, it was possible to conduct the TFA mediated deprotection of the di-tert-butyl 
lipid phosphate generating the target novel dolichyl phosphate analogue, 99, in 94% 
yield, Fig 2.5. 
2.2.2. Synthesis of 3,7-dimethyl-8-[12-(4'-dimethylaminonaphthalene-l' - 
sulfonamido)dodecanoyloxy]octyl phosphate. 
The first lipid analogue, 99 (Fig 2.5), synthesised as a replacement for the natural 
dolichol lipid was also to be used in the synthesis of a fluorescently labelled 
derivative. It was expected that the N-phthalimido group could be removed to expose 
a reactive primary amine. This, in turn, could be attached to solid support to further 
develop the enzyme-catalysed solid phase synthesis of N-glycans or derivatised to 
produce substrate mimics for specific glycosyltransferases. 
Initially, a fluorescent label was to be attached to the amine for further study of the 




NPhth - GNH2 









Oft 123 0 
Fig 2.14 Proposed synthetic route to the fluorescent/v labelled-lipid, 123. 
A literature search was conducted to source methods for the removal of the N-
phthalimido group under conditions which would not prove detrimental to the 
remainder of the lipid chain, in particular the ester functional group. Several citations 
were identified which made use of hydrazine hydrate to convert the N-phthalarnide to 
a primary amine in substrates where an ester was also present)04' 105  In the first 
attempt, lipid 110 was dissolved in a mixture of anhydrous methanol and DCM and 
then treated with hydrazine hydrate. The reaction mixture was stirred for two hours 
at 60 °C in accordance with the experimental procedure of Muizer and Brand.  106 TLC 
analysis of the crude reaction mixture after work up showed a number of products, 
separation of which proved to be difficult. Mass spectral analysis of the crude 
reaction failed to show any evidence of product. Two compounds were obtained 
upon purification but neither was identified as the desired product, Fig 2.15. 
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Fig 2.15 : Attempted hydrolysis of the N-phthalimido group using hydrazine hydrate. 
Further reactions using hydrazine hydrate under different conditions such as varying 
the temperature, concentration of hydrazine and time of reaction all failed to produce 
the requisite amine, 119, as shown in Fig 2.14. It appeared that hydrazine hydrate 
was incompatible with the ester moiety in the lipid chain since each reaction 
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designed to deprotect the N-phthalimido group appeared to cause disintegration of 
the whole lipid. In order to attach a fluorescent probe to this lipid, a new synthetic 
route had to be devised. 
As can be seen from Fig 2.16 the new synthetic route began in the same way as in 
Fig 2.5 with benzyl protection of citronellol, 101, followed by Se02-catalysed 
oxidation to give the allylic alcohol, 103. Esterification of the alcohol with 12-
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Fig 2.16 : Synthetic route to 3,7-dirnethyl-8-[12-(4'-di,nethylaminonaphthalene-l'-
sulfonamido)dodecanoyloxy]octyl phosphate. 
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The new synthetic route deviates with the catalytic hydrogenation of lipid 106. 
Removal of the benzyl protecting group and reduction of the double bond was 
carried out at an earlier stage than in the previous synthesis to facilitate the use of the 
azide. Deprotection of the alcohol and reduction of the double bond was achieved by 
treating the newly formed ester, 106, with hydrogen gas in the presence of finely 
divided 10% palladium on charcoal to give lipid 120 in 78% yield, Fig 2.16. 
The alkyl azide, 121, was readily obtained from the alkyl bromide, 120, by 
nucleophilic substitution of the bromide upon treatment with three equivalents of 
sodium azide in anhydrous DMF.'°7 This efficient procedure afforded the alkyl azide, 
121, in 89% yield after purification. Since the reaction was carried out at room 
temperature and the product was isolated by column chromatography, it was possible 
to avoid the hazards associated with high temperature processes involving azides. 
Phosphorylation of the deprotected alcohol was the next step to be undertaken. Again 
this was carried out using the method of Perich and Johns and involved treating the 
alcohol, 121 with a solution of l-H-tetrazole and NN'-diisopropyl-di-tert-butyl 
phosphoramidite to give the phosphite.'  °2 Oxidation with mCPBA afforded the di-
tert-butyl lipid phosphate, 122, in 59% yield, Fig 2.16. 
In order to obtain the amine required for attaching the fluorescent probe, it was 
necessary to find some way of reducing the azide. A variety of reagents have been 
reported in the literature for the reduction of azides and the most commonly used 
include borohydrides,'°8 triphenylphosphine,'°9 propane dithiol,"° catalytic 
hydrogenation," hydriodic acid' 2 and FeCl3 with sodium iodide (NaI)."3 Catalytic 
hydrogenation was the first process used to attempt the reduction of the azide as the 
lipid was thought to be stable under such conditions. A stirred solution of lipid, 122%  
in a 2:1 mixture of acetone and methanol was treated with hydrogen gas over finely 
divided 10% palladium on charcoal, Fig 2.17. 
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Fig 2.17 : Attempted reduction of the azide using (1) catalytic hydrogenation, and (2) 
propane-], 3-dirhiol. 
TLC analysis of the crude reaction mixture showed that all of the starting material 
had been consumed and that a number of products had formed. Separation of these 
compounds followed by NMR and mass spectral analysis did not show any 
indication of the desired amine but evidence for lipid fragmentation was observed. 
The use of propane- 1 ,3-dithiol as a selective reagent for the efficient reduction of 
alkyl and aryl azides to amines has been reported.' ° Propane-1,3-dithiol mediated 
reduction of azido substrates containing a wide variety of functional groups such as 
esters, amides, alkenes and alkynes were found to proceed selectively and in 
excellent yield.TM° However, when lipid 122 was dissolved in anhydrous methanol 
and treated with a three-fold molar excess of both propane-1,3-dithiol and 
triethylamine, a rapid and clean azide reduction was not observed. After stirring 
under nitrogen at room temperature for 2 days, only unreacted starting materials were 
isolated, Fig 2.17. This reaction was also quite difficult to handle given the stench 
from the thiol. It was decided that an efficient and more practical procedure would be 
sought. The Staudinger reaction occurs between an organic azide, 125, and a trialkyl 
phosphite, 124, to produce a phosphazo compound which is then hydrolysed to yield 
the primary amine, 126, Fig 2.18." 
_____ 
-N2 H20 
R3P N3X R3P=N-N=N-X R3P=N-X R3P=O i XNH2 
124 125 phosphazide 126 
R = an alkyl or aryl substituent 
X = an organic fragment 
Fig 2.18 General representation of the Staudinger reaction. 114 
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A mixture of lipid 122 and triphenyiphosphine in THF containing water was stirred 
under nitrogen at room temperature for 24 hours and then concentrated in vacuo, Fig 
2.16. The crude reaction mixture was analysed by mass spectrometry and a clear 
product peak was observed. TLC of the crude substance indicated the presence of 
some side products. Great difficulty was experienced in trying to purify the amine 
and it was thought that the side products present would not interfere with attachment 
of the fluorescent probe. Consequently, the crude amine mixture was treated with 
one molar equivalent of both dansyl chloride and triethylamine, then stirred under an 
atmosphere of nitrogen for 16 hours, Fig 2.16. The lipid bearing a fluorescent probe, 
123, was isolated in 44% yield over this two-step reaction. 
Dansyl chloride was chosen as the precursor to the fluorescent component of the 
target lipid because this non-fluorescent naphthalene derivative reacts with amines to 
form fluorescent dansyl amides that exhibit large Stoke shifts, along with 
environmentally sensitive fluorescent quantum yields and emission spectra. 5  
Dansyl chloride has been used extensively to determine the N-terminal amino acid 
residue of proteins and to prepare fluorescent derivatives of drugs, amino acids, 
oligonucleotides and proteins for detection by numerous chromatographic 
methods.  115  
Once the fluorescent lipid 123 had been synthesised, the di-tert-butyl phosphate 
headgroup was deprotected in quantitative yield by treatment with TFA to afford the 
desired compound 100, Fig 2.16. 
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2.3. Fluorescence spectra of the dansyl-amide lipid. 
As previously mentioned, non-fluorescent dansyl chloride reacts with amines to form 
fluorescent dansyl amides that exhibit large Stoke shifts. The sequence of steps 
leading to fluorescence is illustrated in Fig 2.  19.94 
Fig 2.19 : Jablonski dia grain94 showing the sequence of steps leading to 
fluorescence. 
Absorption is a process whereby electromagnetic radiation interacts with matter to 
generate an electronically excited state, Fig 2. 19.94  The energy of this excited state 
may be lost in a variety of different ways. The most common is non-radiative decay, 
where the excess energy is transferred into the vibration and rotation of the 
surrounding molecules.  94  A radiative decay process is one in which a molecule 
discards its excitation energy as a photon of light.  94  Radiative decay occurs either in 
the form of fluorescence (where the spontaneously emitted radiation ceases 
immediately after the exciting radiation is extinguished) or phosphorescence (where 
the spontaneous emission may persist for long periods).94 
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For fluorescent studies involving the dansyl-sulfonamide substrate, 100, the lipid was 
dissolved in anhydrous methanol and steady-state fluorescent measurements were 
carried out on a Spex Fluoromax spectrofluorometer. 
The initial absorption took the molecule to an excited electronic state so that the 
absorption spectrum shown in Fig 2.20 was obtained with the emission 
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Fig 2.20 Absorption spectrum of the dansyl-amide lipid showing the excitation 
maximum at 347nm. 
The strong band obtained is a characteristic uv-absorption peak for the incorporated 
dansyl chromophores, with its excitation maximum at 347nm. 
In order for fluorescence to occur, the excited molecule is subjected to collisons with 
the surrounding molecules, and as it gives up energy it steps down the ladder of 
vibrational levels (non-radiative decay) to the lowest vibrational level of the excited 
electronic state, Fig 2. 19.94  If the surrounding molecules are unable to accept the 
larger energy difference needed to lower the molecule to the ground electronic state, 
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it may survive long enough to undergo spontaneous emission and emit the remaining 
excess energy as radiation giving a fluorescence spectrum, Fig 2.  19.94 
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Fig 2.21 : Emission spectrum of the dansyl-amide lipid. The lipid is strongly 
fluorescent and has an emission maximum at 516nm. 
Excitation at 347nm resulted in a broad emission band with its peak at 516nm. In the 
polyatomic lipid under investigation so many vibrational levels exist that bands 
merged and a continuous broadband spectrum was recorded under low resolution, 
Fig 2.21. 
In order to ensure that dansyl chloride, the starting material, was non-fluorescent, this 
too was investigated. Excitation of a solution of dansyl chloride in anhydrous 
methanol with radiation of wavelength 510nm produced the absorption spectrum 







250 300 350 400 450 500 
Wavelength (nm) Overlay X-Zoom SCROLL 
File #1 = BM510A 080512003 13:42 PM ResNone 
dansyl blank solution Scale All 
Fig 2.22 : Absorption spectrum of dansyl chloride. The excitation maximum is below 
300nm and does not inteifrre with the absorption (or overlap the area of absorption) 
of the dansyl-amide lipid. 
The excitation maximum occured well below 300nm in this instance and, as can be 
seen from Fig 2.22, no absorption was observed in the region of 350nrn, the 
wavelength corresponding to the strong absorption peak of the dansyl-sulfonamide 
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Fig 2.23 : Emission spectrum of dansyl chloride. The starting material is weakly 
fluorescent but this is insignificant  compared to the strength of fluorescence 
observed with the dansyl-amide lipid. 
A very weak emission was detected with maxima at 385 and 524nm. The 
insignificance of this fluorescence is compounded by Fig 2.24 in which all four 
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Fig 2.24 : All four spectra are shown together here, namely the absorption and 
emission spectra of dansyl chloride and the dansyl-amide lipid. 
On the left hand side of this diagram are the excitation spectra of both the lipid 100 
(large peak) and the dansyl chloride (flat line) and on the right hand side are the 
corresponding emission spectra. The excitation and emission spectra of dansyl 
chloride appear as a flat line close to zero when compared to the strength of 
absorption and emission observed for the fluorescently-labelled lipid. From this 
spectrum, it can be concluded that the strongly fluorescent lipid 100 had been 
successfully synthesised. 
2.4. Biological testing of dolichyl lipid analogues. 
The biological activity of the two lipid phosphates 99, (Fig 2.5), and 100, (Fig 2.16), 
were tested by assaying them with Do1-P-Man synthase for substrate specificity. As 
can be seen from Fig 2.25, Dol-P-Man synthase is the glycosyltransferase 
responsible for catalysing the stereoselective -mannosy1ation of dolichyl phosphate 
to yield the mannosyl dolichyl phosphate diester. 
o GDP-Man GOP OH OH 
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Fig 2.25: The transfer of mannose from GDP-Man to a lipid phosphate is catalysed 
by the enzyme Dol-P -Man synthase. 96 
Since Dol-P-Man synthase is thought to possess a putatively conserved dolichyl 
binding site, it was reasoned that if a lipid phosphate was to act as a substrate for this 
enzyme, it may also act as a substrate for other mannosyltransferases involved in N-
glycan biosynthesis. 
The biological testing was carried out by Dr. Ines Sprung, School of Chemistry, 
University of Edinburgh. The lipid phosphates 99 and 100 (100.0 AM) were 
incubated in parallel with phytanyl phosphate (100.0 AM), 98 (Table 2), with 
radiolabelled GDP-['4C]-Man (0.1 j.tCiJmL) and crude microsomal fractions (1.0-2.0 
mg) of Saccharomyces cerevisae in a pH 7.5 buffer solution (1.0 mL) comprising 
50.0 mlvi TrisHCl, 5.0 MM  MgCl2, 10.0 mM mercaptoethanol and 0.5% Triton X-
100 at 37°C for lh. The aqueous phase was removed after centrifugation. The 
organic phase was washed twice with water and incorporation of radioactivity into 
organic soluble material was measured by scintillation counting. After this 
procedure, minimal counts were retained in the pellet. Evidence for the activity of the 
enzyme was provided by expressing it with the same cell strains that had previously 
been used within the research group. 35 82 87 85 A comparison of the results from these 
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tests with material that is known to be active confirmed that the enzyme used to 
attach radiolabelled mannose to lipids 98, 99 and 100 was active. The results 
obtained are outlined in Table 2. 
Lipid Phosphate 
Incorporation relative 
to phytanyl phosphate 
0 I, 









Evidence for the transfer of radiolabelled mannose from GDP-['4C]-Man  to each 
lipid was provided by scintillation counting of an organic extract of the reaction. If 
the counts per minute of the organic extract were not above the background level 
(measured for the organic extract with no radioactive material) then no transfer of 
radiolabelled mannose to lipid had occurred. 
As can be seen, the soluble acceptor lipid 99 caused a significant increase in the 
radiation levels of the extractable lipids. It compared well to phytanyl phosphate as a 
substrate, being 77% as active as phytanyl phosphate, 98. Although the lipid bearing 
the fluorescent probe, 100, only exhibited a relative activity of 14%, it was 
nevertheless still clearly recognised and mannosylated by the enzyme. It would 
appear, from these results, that there is less tolerance by the enzyme for the bulky 
sulfonamide group at the a-position. 
71 
2.5. Attempted synthesis of 3,7,11-trimethyl-12-(12-N- 
phthalimidoclodecanoyloxy)dodecyl phosphate. 
In order to obtain further insight into the nature of the dolichyl binding site of the 
glycosyltransferase enzymes involved in N-glycan biosynthesis, it was decided to 
investigate a structural variation of the novel dolichol analogue 99. The new target 
lipid, 127, is illustrated in Fig 2.26. This lipid contains an extra saturated isoprene 
unit. In this way it would be possible to study the effect that increased chain length 









Fig 2.26 : Novel target lipid extended in length by one isoprene unit. 
To enhance the possibility that this substrate would be accepted by the 
glycosyltransferase enzymes under investigation, the new lipid 127 retained the 
structural features of lipid 99. This lipid had showed 77% activity relative to 
phytanyl phosphate, 98, in the biological assay. As can be seen in Fig 2.26, these 
structural features include the polar group at the co-position and the ester linkage in 
the lipid backbone, as well as the phthaloyl end unit. In order to devise a practical 




















Fig 2.27 : Retrosynthetic analysis of target lipid 45. 
Cleaving lipid 127 at the ester linkage generates synthetic equivalents 128 and 129. 
Compound 129 is readily synthesised from commercially available 12-
bromododecanoic acid, 105, using chemical procedures applied in the synthesis of 
lipids 99 and 100, Fig 2.5 and Fig 2.16. Literature precedent exists for the reduction 
of a diester into an allylic 16 and so it should be possible to obtain synthetic 
equivalent 128 from a substrate such as 130. Disconnection of lipid 130 between 
carbons 8 and 9 would give rise to commercially available diethyl ethylidene 
malonate, 132, and the easily synthesised citronellol derivative, 131. On the basis of 
this information, a synthetic route to the desired lipid was devised as shown in Fig 
2.28. 
The synthesis of lipid 127 began with the benzyl protection of commercially 
available citronellol, 101. As previously discussed, treating citronellol with sodium 
hydride in THF at room temperature for 1 hour, followed by heating to 40 °C in the 
presence of benzyl bromide and tetrabutyl ammonium iodide for a 4 hour period 
generated the benzyl protected alkene, 102, in quantitative yield. Oxidation of the 
73 
allylic end of 102 with catalytic selenium dioxide and aqueous tert-butyl 
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Fig 2.28 : Proposed route for the synthesis of 3,7,11-trimethyl-12-(12-N-
phthalimidododecanoyloxy)dodecany1 phosphate. 
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In order to prepare the citronellol derived lipid, 131, for the attachment of diethyl 
ethylidenemalonate, 132, the allylic alcohol had to be converted into a better leaving 
group. Conversion of the allylic alcohol into an allylic bromide was achieved in a 
two-step, one-pot process. A solution of the allylic alcohol, 103, in anhydrous DCM 
was cooled to —50 °C and treated with triethylamine. After stirring for 5 minutes 
under an atmosphere of nitrogen, a two-fold excess of methanesulfonyl chloride was 
added to the reaction mixture, which was then stirred at —50 °C for 90 minutesY6 
Treating the methanesulfonate ester thus formed with a solution of lithium bromide 
in anhydrous THF resulted in nucleophilic displacement of the labile sulfonate ester 
by the bromide anion to form lipid 131 in 85% yield, Fig 2.28.96 
Once the allylic bromide had been formed, it was anticipated that introduction of the 
new isoprene-like unit would be achieved by a simple nucleophilic displacement of 
the bromide by the diethyl ethylidene malonate anion. In order to find suitable 
conditions for such a process, test reactions were conducted using diethyl malonate, 





/LDA THF 6n 1 CO2Et 
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CO2 Et 139 
Sr LCO2E NaH DME 0C 
131 138 Reaction failed 
Reaction failed 
Fig 2.29 : Test reactions to find a suitable reagent for the coupling of the allylic 
bromide with diethyl malonate. 
The first procedure undertaken involved treating a solution of diethyl malonate, 138, 
in anhydrous TIIF with one molar equivalent of sodium ethoxide to generate the 
anion.' 7 Addition of the allylic bromide, 131, to this solution resulted in the 
successful preparation of diethyl 2-(8-benzyloxy-2,6-dimethyloct-2-en- l-yl) 
malonate, 139. However, when this method was applied to reaction with diethyl 
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ethylidene malonate, 132, only unreacted starting materials were recovered from the 
reaction mixture, Fig 2.30. 
BnO ' ' 
Br + 
131 





Unreacted starting materials 
Fig 2.30 Attempted coupling of the allylic bromide with diethyl ethylidene 
inalon ate. 
A second successful synthesis of diethyl 2-(8-benzyloxy-2,6-dimethyloct-2-en-1-yl) 
malonate, 139, was performed by treating a solution of diethylmalonate, 138, in 
anhydrous THF with one equivalent of 1.8 M solution of LDA in 1:1:1 
heptane/THF/ethylbenzene and stirring at 0 °C under an atmosphere of nitrogen for 1 
hour. Subsequent addition of a solution of the allylic bromide, 131, in anhydrous 
THF afforded the desired lipid, 139, in 95% yield, Fig 2.29. Unfortunately, when 
diethyl ethylidene malonate, 132, was treated with LDA and the allylic bromide, 131, 
under exactly the same conditions, none of the desired product was isolated. Some 
unreacted allylic bromide and another unidentified compound was recovered from 
the crude reaction mixture, Fig 2.30. 
A further two test reactions were conducted using diethyl malonate as a model 
compound in order to find a suitable procedure for the synthesis of diethyl 12-
benzyloxy-2-carbethoxy-6,10-dimethyldodec-2,6-dienoate, 130. The first of these 
involved treating a solution of diethyl malonate, 138, in anhydrous DME with 0.6 
molar equivalents of sodium hydride and stirring the reaction mixture at 0 °C under 
an atmosphere of nitrogen before adding a solution of the allylic bromide, 131, in 
anhydrous DME to the reaction mixture, Fig 2.29.118  When this procedure failed to 
generate any product, a similar method was employed in which n-butyl lithium was 
used as a base. Again, a cooled solution of diethyl malonate, 138, in anhydrous THF 
was treated with a 1.6 M solution of BuLi in hexanes and stirred under an 
atmosphere of nitrogen at 0 °C for 40 minutes.' 19 Addition of the allylic bromide, 
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131, failed once more to to give lipid 139, Fig 2.29. Neither of these last two bases 
was used in reaction with diethyl ethylidene malonate. 
At this point a decision was taken to consider alternative routes to the desired 
substrate, 130. One of the side products recovered from the selenium dioxide 
catalysed allylic oxidation of the benzyl protected alkene, 102, is an a,13-unsaturated 
aldehyde, 104, Fig 2.28. Rather than converting this to the allylic alcohol in an 
inefficient and low-yielding reduction, it was thought that this aldehyde may be used 
in the synthesis of lipid 130. Once again, several different test reactions were 
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Fig 2.31 : Test reactions to find a suitable reagent for the coupling of the allylic 
aldehyde with diethylmalonate. 
The first of these mixed carbonyl condensations was carried out in the presence of 
acetic acid and piperdine.120 A stirring solution of the allylic aldehyde, 104, in 
anhydrous DCM was treated with diethylmalonate, 138, acetic acid and piperidine, 
then stirred under an atmosphere of nitrogen at room temperature for 18 hours. This 
reaction failed to create even a small amount of the desired product, diethyl 10-
benzyloxy-2-carbethoxy-4,8-dimethyldec-2,4-dienoate, 140, as illustrated in Fig 
2.32. Even so a similar process was conducted using diethyl ethylidene malonate in 
place of diethyl malonate, Fig 2.32. 
77 
CO,Et CO,Et AcOH, DCM 
----------------- 
+ piperidine 
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Fig 2.32 Attempted coupling of the allylic aldehyde with diethyl ethylidenemalonate 
Unfortunately, however, when the aldehyde, 104, was treated with diethyl ethylidene 
malonate, 132, in the presence of acetic acid and piperidine, a brown oil was 
recovered which could not be purified. A number of other aldol condensation 
procedures between the aldehyde and diethyl malonate were attempted as illustrated 
in Fig 2.32 but none of the reactions shown effected condensation of the two 
substrates. 121, 122 It was reasoned that if such reaction conditions were unsuitable for 
diethyl malonate, then they were also unlikely to bring about a successful coupling of 
the allylic aldehyde with diethyl ethylidene malonate. 
A final attempt to introduce the isoprene-like unit into the lipid chain involved a 
palladium-catalysed cross coupling reaction. The procedure used was based on a 
method developed by Ito et al. for the asymmetric allylic alkylation of both cyclic 
and acyclic alkenyl substrates, Fig 2.33.  123  Treatment of 2-cyclohexenyl acetate, 142, 
with dimethyl malonate in the presence of a palladium complex in DCM using N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA) and potassium acetate as base, 
generated the desired diester in good yield (93%) and moderate enantiomeric excess 
(72% e.e.).'23  
MeO2C CO2Me 
0Ac allyl palladium chloride dirner 
6 chiral ligand, diethyl malonate BSTFA, KOAc 
142 
Fig 2.33 : The asymmetric allylic alkylation of 2-cyclohexenyl acetate with diethyl 
malonate in a palladium-catalysed cross coupling reaction. 123 
A modified version of this method was used to couple diethyl malonate, 138, and the 
protected citronellol derivative, 143, as a model for the latter reaction with diethyl 
ethylidene malonate. 
,L1 
The allylic alcohol, 103, was first acetylated in quantitative yield by treating it with 
acetic anhydride and pyridine in the presence of DMAP, Fig 2.34. 
]0H Ac2O, DMAP OAc BnO  
pyridine 
103 143 
allyl palladium chloride dimer 





Fig 2.34 : Attempted aikylation of an acetate protected citronellol derivative with 
diethyl malonate using a palladium-catalysed cross coupling reaction. 
Allylic alkylation of 143 commenced by stirring allyl palladium chloride dimer with 
triphenylphosphine in anhydrous DCM under an atmosphere of nitrogen for one hour 
at room temperature. A solution of the allylic acetate, 143, in anhydrous DCM was 
added to the palladium based reaction mixture which was then cooled to —20 °C and 
treated with diethyl malonate, BSTFA and catalytic potassium acetate. The reaction 
was maintained under an atmosphere of nitrogen at —20 °C for 18 hours. However, 
after work-up, only unreacted starting materials were obtained. None of the desired 
product, 139, was isolated from the reaction mixture. This procedure was not 
attempted using diethyl ethylidene malonate. 
Unfortunately, the synthesis of the elongated lipid was not completed due to lack of 
time and the inability to find reaction conditions suitable for the synthesis of 
intermediate lipid, 130. 
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2.6. Conclusion. 
Two novel analogues of the naturally occurring lipid, dolichyl phosphate, were 
synthesised. The first of these, lipid 99, was found to exhibit 77% activity relative to 
phytanyl phosphate, 98, in the biological assay with Dol-P-Man synthase. A new 
synthetic route had to be devised in order to attach a fluorescent probe to the (0-end 
of lipid 99 so that the dansyl amide lipid, 100, could be prepared. Although lipid 100 
showed only 14% activity relative to phytanyl phosphate in the biological assay with 
Dol-P-Man synthase, it was nevertheless clearly recognised and mannosylated by the 
enzyme. In addition, a fluorescence study of lipid 100 showed that this substrate is 
indeed strongly fluorescent. The environmentally sensitive fluorescent quantum 
yields and emission spectra that a dansyl amide provides will be useful for further 
study of the unknown mannosyltransferases active in the early pathway of N-glycan 
biosynthesis. Finally, work towards the synthesis of an analogue of lipid 99, namely 
lipid 127, which incorporates an extra isoprene unit, was conducted. 
We 
2.7. Future Work. 
Since this work was discontinued, literature precedent has been found for the 
condensation of diethyl ethylidene malonate, 132, with 3,5-
dibenzyloxybenzaldehyde, 144, in the presence of methanolic 
benzyltrimethylammonium hydroxide (Trition B) Fig 2.35.124 
O OBn Bn  
H 
+ LCO2EI 68% 
CO2EI Triton B 
Bn 
A
 Bn CO2EI 
144 a 132 145  
Fig 2.35 : The condensation of diethyl ethylidenemalonate with 3,5-dibenzyloxy 
benzaldehyde)24  
The half methyl ester, 145, was recovered in 68% yield. In future, this procedure 
may lead to the successful incorporation of diethyl ethylidene malonate into the lipid 
chain thereby giving the ability to create longer multifunctionalised lipids. 
In the event that suitable conditions cannot be found to attach diethyl ethylidene 
malonate to the allylic system, further work could be conducted using the lipid 
homologue diethyl 2-(8-benzyloxy-2,6-dimethyloct-2-en- 1-yl) malonate, 139. 
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3. Synthesis of lipid-linked carbohydrates and N-linked chitobiose. 
3.1. Introduction. 
As previously discussed in section 1.1, the oligosaccharide side-chains of 
glycoproteins are ubiquitous in nature and can play many roles in biological activity 
of the parent protein.3 (ilycoproteins are fundamental to many important biological 
processes including fertilisation, immune defence, viral replication, cell growth, cell-
cell adhesion, degradation of blood clots and inflammation.4 The glycoproteins found 
on cell-surface membranes play a role in intercellular recognition, acting as receptors 
for hormones, proteins and viruses.8 They are also able to regulate the transportation 
of proteins between cells and as such act as signal substances in cell metabolism.  64 
The biological activity of glycoproteins is largely due to the terminal sequences of 
the oligosaccharide portion, in other words the outer chains or antennae.  64  In the case 
of N-linked glycoproteins, these outer chain oligosaccharides are attached to the 
protein residue via a pentasaccharide core, 1, comprised of two N-acetylglucosamine 






Fig 3.1 : The pentasaccharide core common to all N-glycan species. 
In view of the biological importance of the oligosaccharide portion of glycoproteins, 
it is imperative that such species can be readily synthesised since biogenic material is 
frequently difficult to obtain. Modified antennae could provide information on the 
nature of the sites of attachment and thus on the mechanism of the biological 
interaction between the oligosaccharide side-chains and surrounding entities.  64 
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The synthesis of oligosaccharides has already been discussed in some detail (sections 
1.3 and 1.4) and from this it is evident that producing complex oligosaccharides is 
not always a simple task. Much research  125  has been conducted to find suitable 
chemical reactions and combinations of chemical and enzymatic techniques in order 
to establish facile methods of preparing oligosaccharides. Our work has focussed on 
the application of glycosyltransferase enzymes in the synthesis of N-linked 
glycoproteins. 35,82,85 
Many of the enzymes involved in the biosynthesis of N-linked glycoproteins have 
already been isolated and characterised. However, some of those enzymes involved 
in the early stages of N-glycan biosynthesis remain unidentified. The initial steps in 
























ALG2 or other enzyme r4xGDP 
Man 6 
/Man 3-1,4 GIcNAc -1,4 GIcNAc-PP-DoI 
a-1,2 a-1,2  Man Man Man 
Fig 3.2 : Steps to the synthesis of the dolichyl pyrophosphate-linked heptasaccharide, 
Man5GlcNAc2-PP-Dol. The linkage of each individual glycosyl residue and the 
known loci coding for the corresponding glycosyltransferases are indicated. 
As can be seen from Fig 3.2, the enzymes responsible for the addition of the last four 
mannose residues are not known. Studies have found that ALG2 mutant cells 
accumulate Man2G1cNAc2-PP-Dol suggesting that the a1g2 protein is a 
mannosyltransferase active in the early pathway of oligosaccharide assembly. 36 
However, no specific enzymatic activity for this protein has been demonstrated and 
additional mannosyltransferases required for the assembly of Man5GlcNAc2-PP-Do1 
remain to be identified. 
Work within our group has been aimed at establishing the structure and function of 
a1g2; in particular whether it plays a role in attaching one or more of the last four 
mannose units of the dolichyl pyrophosphate-linked heptasaccharide shown in Fig 
3.2. 
3.2. Synthesis of phytanyl-linked chitobiose. 
In order to investigate the role of a192 it is necessary to have readily available 
supplies of the lipid-linked trisaccharide acceptor substrate, Mani3  1-4G1cNAc3 1-
4GlcNAc-PP-Dol. It has previously been shown that the much shorter lipid, 
phytanol, can be successfully used as a substitute for the natural dolichol lipid.35 
Since phytanyl phosphate, 98, is readily available in gram quantities from phytol, 
146, by catalytic hydrogenation, it was decided to prepare a phytanyl-linked 
trisaccharide acceptor substrate. The synthesis of this substrate was achieved using a 
combination of chemical and enzymatic techniques and began with the preparation of 
the lipophilic membrane anchor, phytanyl phosphate, 98, as illustrated in Fig 3.3. 
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Fig 3.3: The synthesis ofphytanyl phosphate from commercially available phytol.35 
The synthesis of phytanyl phosphate, 98, began with the catalytic hydrogenation of 
commercially available phytol, 146 .35 A solution of phytol (3,7,11,15-
tetramethylhexadec-2-en- I -ol), 146, in anhydrous methanol was treated with 
hydrogen gas over finely divided 5% platinum on charcoal .35 The reduction of the 
double bond proceeded efficiently, generating the saturated lipid, 93, in 86% yield. 
Phosphorylation of the saturated alcohol, 93, was achieved using conditions 
developed by Perich and Johns, where treatment of the alcohol with N,N'-di-tert-
butyl diisopropylphosphoramidite and 1-H-tetrazole resulted in the formation of a 
phosphite.  102  The phosphite was not isolated and immediate oxidation of the crude 
reaction mixture with a solution of mCPBA in anhydrous DCM resulted in 65% yield 
of the desired lipid, di-tert-butyl phytanyl phosphate, 147. Finally, TFA mediated 
147 
deprotection of the di-tert-butyl lipid phosphate 147 was conducted to generate 
phytanyl phosphate, 98, in 83% yield. This deprotected lipid phosphate was to be 
coupled to chitobiose phosphate, 73, to create a lipid-linked disaccharide. The 
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Fig 3.4 Synthesis of phytanyl-linked chitobiose. 82 
The selective anomeric deacetylation of commercially available chitobiose 
octaacetate, 70, was the first step in the synthetic route to the lipid-linked 
disaccharide, 7582  This was achieved by treating a solution of chitobiose octaacetate, 
70, in anhydrous DMF with a 2M solution of dimethylamine in DMF.  82  The resulting 
hemiacetal disaccharide 71 was obtained in quantitative yield, a marked 
improvement on previously reported syntheses of this compound, where selective 1-
0-deacetylation of chitobiose octaacetate had been achieved in only 82% yield when 
using hydrazine acetate. 35 
The chitobiose heptaacetate 71 was then treated with a 1.8 M solution of lithium 
diisopropylamide (LDA) in 1:1:1 heptane/THF/ethylbenzene at —78°C with the 
subsequent in situ addition of tetrabenzyl pyrophosphate.  82  This reaction afforded 
selectively the cx-glycosyl phosphate dibenzyl ester, 72, in 66% yield, Fig 3.4. 
Hydrogenolysis of the benzyl groups was achieved in the presence of 10% palladium 
on charcoal under an atmosphere of hydrogen gas to give the heptaacetyl chitobiosyl 
phosphate, 73, in 96% yield.82 
Conversion of phosphate 73 to its triethyl ammonium salt was followed by treatment 
with NN'-carbonyldiimidazole in DMF to form an intermediate imidazole-carbonyl 
phosphate anhydride.  82  The addition of methanol to quench any excess N,N'-
carbonyldiimidazole was followed by the addition of phytanyl phosphate to afford 
the phytanyl pyrophosphoryl chitobioside, 74, in 73% yield.  82  Saponification of the 
protected pyrophosphate derivative, 74, using sodium methoxide gave the acceptor 
substrate, 75, in 37% yield. 12 
In order to further confirm the identity of 74 and 75 the analytical data for these 
compounds was compared to that published in the literature.  82  When this synthesis 
was first carried out the identity of the lipid-linked trisaccharide was confirmed by 
cleaving the trisaccharide from phytanyl pyrophosphate and comparing the NMR of 
the Manf 1-4G1cNAc 1-4GlcNAc thus generated, to that of a sample of -mannosy1-
linked trisaccharide isolated from natural sources. 82 
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3.3. Synthesis of the phytanyl-linked trisaccharide, ManJ31-4G1cNAcJ1-
4GlcNAc. 
The preparation of the immobilised -mannosyltransferase enzyme needed for the 
synthesis of the lipid-linked trisaccharide was conducted by Dr Ines Sprung, School 
of Chemistry, University of Edinburgh. A culture of E. coli cells harbouring the 
plasmid pLR36 yielded 3-mannosyltransferase activity in cleared-cell lysates. 
Purification and immobilisation of the f3-mannosyltransferase was achieved by 
passing the cleared-cell lysate through a nickel (II) charged affinity column followed 
by washing to remove any impurities.  92  The resulting functionally pure biocatalyst 























Fig 3.5 : The formation of a phytanyl-linked trisaccharide using an immobilised 
/3-mannosyltransferase.82  
Pellets of recombinant E. Coli were stored at —80°C. After rapid thawing to promote 
lysis, and the addition of DNasel and Triton X-100, the cleared-cell lysate (25.0 mL) 
was applied to a column containing His-Bind resin (10.0 mL).82 To ensure maximum 
immobilisation of the J3-mannosyltransferase, the cleared-cell lysate was passed 
through the column twice and subsequently washed with binding buffer (100.0 mL) 
and mannosyltransferase buffer (30.0 mL).82 Evidence for the activity of the enzyme 
was provided by expressing it with the same cell strains that had previously been 
used within the research group. 82 87 85 A comparison of the results from these tests 
with material that is known to be active confirmed that the enzyme used in the 
conversion of 75 to 76 was active. The mannosyltransferase activity was assayed at 
37°C by incubation of 50% (vlv) enzyme-charged resin in mannosyltransferase 
buffer (20.0 mL) with final concentrations of 160.0 pM 75 and 200.0 p.M GDP-[2- 
3H]mannose (0.8 p.Ci/mL).82 The reaction was shaken at 100 rpm at 37°C for 30 mm 
foliwed by the addition of alkaline phosphatase (8 U); shaking was continued for a 
further lb. The phytanyl-linked trisaccharide, 76, was separated from the resin by 
vacuum filtration. Dr Sprung also completed this enzyme catalysed reaction. 
Evidence for the formation of the lipid-linked trisaccharide, 76, was provided by 
cleaving a sample of the trisaccharide from phytanyl pyrophosphate with aqueous 
HCl. A comparision of the NMR of the Man1-4GlcNAcf31-4G1cNAc thus 
generated, to that of a sample of f3-mannosyl-linked trisaccharide isolated from 
natural sources confirmed that the lipid-linked trisaccharide, 76, had been formed.82 
The lipid-linked trisaccharide is to be used to investigate the nature of ALG2 and any 
other enzymes involved in the addition of four mannose residues to form the lipid-
linked heptasaccharide as illustrated in Fig 3.2. 
3.4. Synthesis of phytanyl-linked glucosamine. 
Although the synthesis of the phytanyl pyrophosphoryl chitobioside 75 outlined 
above is generally quite efficient, it has a major drawback in the high cost of the 
chitobiose octaacetate, 70, starting material. A price of £200 per gram of starting 
material inhibits the large-scale production of the lipid-linked disaccharide needed to 
synthesise the lipid-linked trisaccharide for studies involving ALG2. Chemical 
syntheses of disaccharide 70 have been reported)26' 127  However, they suffer from 
problems of selective protection and stereo- and regioselectivity discussed previously 
in relation to the chemical synthesis of oligosaccharides. 
Alternatively, chitobiose octaacetate, 70, can be obtained by controlled 













Fig 3.6 : The synthesis of chitobiose octaacetate by the controlled fragmentation of 
chitin. 38 
Several methods have been reported for the controlled fragmentation of chitin, 148, 
including fluorohydrolysis,128 enzymatic degradation129 and acidic hydrolysis.38  
Although the use of hydrogen fluoride and the enzymatic method offer reasonably 
good yields of disaccharide 70, neither technique is suitable for large-scale 
preparation work. Controlled acidic hydrolysis of chitin has also been found to be a 
complex, unreliable and low-yielding procedure. 38 
In view of the difficulties associated with obtaining chitobiose octaacetate, we 
decided to devise a cheaper, more robust synthetic route to the lipid-linked 
disaccharide, which would involve a combination of chemical and enzymatic 
methodologies. It was hoped that a chemically synthesised phytanyl-linked 
go 
monosaccharide could be modified by an enzyme-catalysed reaction, thereby giving 
the desired phytanyl pyrophosphoryl chitobioside. The proposed synthetic route to 
the lipid-linked monosaccharide is outlined in Fig 3.7. 
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Fig 3.7 : Proposed synthetic route to phytanyl -linked glucosamine using tri-O-acetyl-
D-glucal as starting material. 
The synthesis of the lipid-linked monosaccharide began with the azidonitration of 
3,4,6-tri-O-acetyl-D-glucal, 149, a relatively cheap starting material costing £33 per 
25 grams. Reaction of 3,4,6-tri-O-acetyl-D-glucal, 149, with excess ceric ammonium 
nitrate (CAN) and sodium azide in anhydrous acetonitrile under an atmosphere of 
nitrogen at —15°C was conducted according to the procedure developed by Lemieux 
and Radcliffe.  130  It was necessary to use an excess of both CAN and sodium azide 
since some of these reagents are lost in the ceric oxidation of azide to nitrogen gas.' 30 
The desired 2-azido- 1-nitrate addition product, 150, was isolated in a disappointing 
yield of 13%. The low yield of product recovered from this reaction may be 
attributed to the formation of a number of side-products that were difficult to 
separate, Fig 3.8.' °  
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Fig 3.8 : Azidonitration of tri-O-acetyl-D-giucal and some of the by-products of the 
process. 
Denitration of the azido-nitrate sugar, 150, was the next step to be attempted. This 
process was first carried out by treating a cooled solution of 2-azido-3,4,6-tri-0-
acetyl-2-deoxy-D-glucopyranosyl nitrate, 150, in anhydrous acetonitrile at 0°C with 
one molar equivalent of benezenethiol and Htinigs base (diisopropylamine, DIPEA) 
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Fig 3.9: Conversion of the anomneric nitro group to an alcohol using Hünigs base. 
This reaction was unreliable and did not proceed efficiently. It proved difficult to 
obtain consistent results with this method and yields ranged from 63% to 0% for 
product, 151. 
An alternative, more robust process for generating the desired species 151 was 
found. This method involved treating a solution of the azido-nitrate sugar, 150, in 
dioxane, with a solution of sodium nitrite in water. After stirring at 80°C for 3 hours 
under an atmosphere of nitrogen the desired sugar, 151, was recovered in 63% yield, 
Fig 3•7•132 
The monosaccharide, 151, was then treated with a 1.8M solution of LDA in 1:1:1 
heptane/THF/ethylbenzene at —78°C with the subsequent in situ addition of 
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Fig 3.10 : Attempted phosphorylation of 2-azido-3,4,6-tri-O-acetyl-2-deoxy-D-
glucopyranose. 
This reaction, however, failed to generate any of the desired glycosyl phosphate 
dibenzyl ester, 158, and the compounds recovered from the crude reaction mixture 
could not be identified. 
The phosphorylation method of Perich and Johns was also attempted in the hope that 
the di-tert-butyl glycosyl phosphate, 152, could be prepared, Fig 3.7. 
A solution of the sugar, 151, in anhydrous THF was treated with NN'-di-tert-butyl 
diisopropylphosphoramidite and 1-H-tetrazole with the subsequent in situ addition of 
mCPBA.102 This method also failed to produce any of the phosphorylated sugar, with 
only unreacted starting materials isolated. 
In view of the low yields of the first two steps of the synthetic route outlined in Fig 
3.7 and the difficulty experienced in attempts to synthesise the sugar phosphate, an 
alternative method to generate the lipid-linked monosaccharide was considered. A 
synthesis of 163 from N-acetyl-u-glucosamine, 159, was proposed and this is 
outlined in Fig 3.11. 
93 
OA c OH 
AC 





AcNH AcNH 50% 
159 160 OAc 161 OH 
LDA, THF, -78°C 
75% I tetrabenzyl 
pyrophosphate 
OAc OAc 
Ac H2, Pd/C AcO ' 
AcNI-1 
11 OCM,MeOH AeNHj p 
154 OOH 
100% 162 OIOBn 
OH CBn 
1. EI3N,MeOH 
91% 2. CDI DM F. MeOH 




1554  o 
OH OH 
Ii. Et3N, MeOH, 0CM 
100% 2. NaOMe, MeOH, 0CM 
3. EI3N, MeOH, 0CM 
OH 




Fig 3.11 : The synthesis of Pj-phytanyl-P2-2-acetarnido-3,4, 6-tn- O-acetyl-2-deoxy-
cx-D-glucopyranosyl pyrophosphate. 
The synthesis of the lipid-linked monosaccharide, 163, began with the per-
acetylation of commercially available N-acetyl-D-glucosamine, 159. The sugar was 
stirred in a mixture of acetic anhydride and pyridine under an atmosphere of nitrogen 
at room temperature for 16 hours and the desired 2-acetamido- 1,3 ,4,6-tetra-O-acetyl-
2-deoxy-a-D-glucopyranose, 160, was isolated in quantitative yield.133 Selective 1-0-
deacetylation of the per-acetylated glucosamine, 160, was achieved by treating a 
solution of the sugar with an excess of ammonium carbonate.134 The anomeric 
deprotection proceeded smoothly affording a moderate, 50%, yield of the 
monosaccharide, 161, Fig 3.11. Although the NMR data obtained for 161 was 
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consistent with the predicted structure it was noted that the melting point obtained for 
this compound did not agree with that reported in the literature. 
The method developed by Wong et al. to generate glycosyl phosphites and 
phosphates of a number of sugars using dibenzyl NN'-diethylphosphoramidite and 
triazole followed by oxidation with hydrogen peroxide was discussed in section 
2.2.1.103 This procedure was used to synthesise the di-tert-butyl sugar phosphate, 
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Fig 3.12: The synthesis of the di-tert-butyl glycosyl phosphate, 153. 
A solution of the hemiacetal, 161, in anhydrous DCM was treated with 1,2,4-triazole 
and NN'-di-tert-butyl diethyiphosphorarnidite and stirred under an atmosphere of 
nitrogen. The solution was cooled to —78°C and treated with 30% hydrogen peroxide 
solution.  103  This resulted in 78% yield of the desired di-tert-butyl glycosyl 
phosphate, 153, Fig 3.12. 
The final stage in the preparation of the monosaccharide for coupling to the lipid was 
deprotection of the di-tert-butyl glycosyl phosphate, 153. Initially a solution of the 
glycosyl phosphate, 153, in anhydrous DCM was treated with TFA for 10 minutes in 
35 order to remove the di-tert-butyl protecting groups, Fig 
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Fig 3.13 : Attempted deprotection of the di-tert-butyl phosphate using TFA. 
Unfortunately, this reaction failed to produce the desired glycosyl phosphate, 154. A 
number of products were formed but purification of the crude reaction mixture and 
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subsequent analysis did not result in identification of any of these side-products. 
Despite treating a solution of sugar 153 in anhydrous DCM with a variety of acids 
such as acetic acid, citric acid and TFA, at differing concentrations and for different 
reaction times, it proved impossible to successfully deprotect the di-tert-butyl 
glycosyl phosphate. 
Consequently, an alternative phosphorylation procedure was investigated. The 2-
acetamido-3 ,4,6-tri-O-acetyl-2-deoxy-ix-D-glucopyranose, 161, was dissolved in 
anhydrous THF and treated with a 1.8 M solution of LDA in 1:1:1 
heptane/THF/ethylbenzene at —78°C with the subsequent in situ addition of 
tetrabenzyl pyrophosphate.  82  This reaction afforded selectively the a-glycosyl 
phosphate dibenzyl ester, 162, in 75% yield, Fig 3.11. Hydrogenolysis of the benzyl 
groups was achieved in the presence of 10% palladium on charcoal under an 
atmosphere of hydrogen gas to give the deprotected glycosyl phosphate, 154, in 
quantitative yield, Fig 3.1  1.82  Conversion of phosphate, 154, to its triethyl ammonium 
salt was followed by treatment with NN'-carbonyldiimidazole in DMF to form an 
intermediate imidazole-carbonyl phosphate anhydride.  82  The addition of methanol to 
quench any excess NN'-carbonyldiimidazole was followed by the addition of 
phytanyl phosphate, 98, to afford the phytanyl pyrophosphoryl monosaccharide, 155, 
in 91% yield .82 Saponification of the protected pyrophosphate derivative using 
sodium methoxide gave the acceptor substrate, 163, in quantitative yield. 82 
3.5. Enzyme-catalysed synthesis of phytanyl-linked chitobiose. 
The final stage of this project was to use the phytanyl-linked glucosamine acceptor 
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Fig 3.14 : Enzyme-catalysed conversion of the lipid-linked monosaccharide into 
phytanyl-linked chitobiose. 
The lipid-linked monosaccharide, 163, was incubated with radiolabelled UDP-['4C]-
GlcNAc (0.1 p.CiJmL) and crude microsomal fractions (1.0-2.0 mg) of 
Saccharomyces cerevisae in a pH 7.5 buffer solution (1.0 mL) comprising 50.0 mM 
TrisHCl, 5.0 mM MgCl2, 10.0 mM mercaptoethanol and 0.5% Triton X-100 at 37°C 
for lh. The aqueous phase was removed after centrifugation. The organic phase was 
washed twice with water and incorporation of radioactivity into organic soluble 
material was measured by scintillation counting. Evidence for the activity of the 
enzyme was provided by expressing it with the same cell strains that had previously 
been used within the research group.82 87 85 A comparison of the results from these 
tests with material that is known to be active confirmed that the enzyme used in the 
conversion of 163 to 75 was active. 
Dr Ines Sprung attempted this enzyme-catalysed reaction but unfortunately none of 
the desired phytanyl pyrophosphoryl chitobioside, 75, was obtained; only unreacted 
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starting materials were recovered from the reaction mixture. From this, it would 
appear that the phytanyl-linked monosaccharide, 163, is not a suitable acceptor 
substrate for the first glycosyltransferase (N-acetylglucosaminyltransferase) in the 
biosynthetic pathway to N-linked glycoproteins. 
W. 
3.6. Conclusion. 
The synthesis of phytanyl-linked chitobiose, 75 (Fig 3.4), from commercially 
available chitobiose octaacetate, 70 (Fig 3.4), was successfully achieved, using 
methods that were previously developed in the group. 35, 82 Enzymatic transformation 
of this substrate was performed to generate a phytanyl-linked trisaccharide, 76 (Fig 
3.5), which will be used in future studies involving ALG2. 
A new method for preparing phytanyl-linked glucosamine, 163 (Fig 3.11) has also 
been developed. The aim of devising a cheap, practical and robust chemical synthesis 
of a lipid-linked monosaccharide has been fulfilled. The yield obtained for each step 
in this synthetic route was excellent, with the exception of the anomeric 
deacetylation of peracetylated glucosamine. The low yield of this reaction is 
counteracted by the ease with which large quantities of 1-0-deacetylated 
glucosamine can be prepared. Although the attempted enzyme-catalysed 
transformation of phytanyl-linked glucosamine, 163, to phytanyl-linked chitobiose 
failed (Fig 3.14), it shows that the phytanyl-linked monosaccharide is not a suitable 
acceptor substrate for the first glycosyltransferase (N-acetylglucosaminyltransferase) 
in the biosynthetic pathway to N-linked glycoproteins. 
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3.7. Synthesis of orthogonally-protected chitobiose. 
The ultimate focus of our research was to find simple, practical methods for the 
synthesis of N-linked glycoproteins. Currently, it is possible to synthesise phytanyl-
linked chitobiose, 75, and subsequent enzymatic transformation of this acceptor 
substrate allows for the preparation of a phytanyl-linked trisaccharide, 76, as 
illustrated in Fig 3.15.82 
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Fig 3.15 : Synthesis of an N-linked trisaccharide, Man/31-4G1cNAc/31-4GlcNAc. 
Acid hydrolysis of the lipid-linked trisaccharide, 76, results in the isolation of the J-
mannosyl-linked trisaccharide, Man1-4GlcNAcf31-4GlcNAc, 77, Fig 3.15.82 
However, direct attachment of this trisaccharide to a peptide, via an asparagine 
residue, is not an easy task. Thus, this research aimed to synthesise an N-linked 
chitobiose glycoprotein, 165, and then, using enzyme technology, transform it into an 
N-linked trisaccharide, 164, Fig 3.15. Work in the group has focussed on finding the 
-mannosy1transferase needed to catalyse the process. The purpose of my work in 
this project was to chemically synthesise an orthogonally protected chitobiose 
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derivative and to attach a fluorescently-labelled asparagine residue. This substrate 
would then be used in the search for a mannosyltransferase to complete the synthesis 
of an N-linked trisaccharide glycoprotein. 
In order to devise a practical synthetic route to the fluorescently labelled asparagine-






































Fig 3.16 : Retrosynthetic analysis of the target compound generates commercially 
available dansyl chloride, 169, aspartic acid, 168 and orthogonally protected 
monosaccharides, 171 and 172. 
The target compound, 166, can be cleaved at two sites, as illustrated in Fig 3.16, to 
generate accessible synthetic equivalents 167, 168 and 169. These synthetic 
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equivalents include commercially available dansyl chloride, 169, and aspartic acid, 
168, which can be coupled together to produce the fluorescent amino acid residue. 
The third synthetic equivalent created in this retrosynthetic analysis is an 
orthogonally protected chitobiose derivative bearing an amine residue at the 
anomeric position, 167. Functional group conversions and disconnection of the p1-4 
linkage of the disaccharide generates two readily available, orthogonally protected 
monosaccharides, 171 and 172. 
On the basis of this information, a synthetic route to the chitobiose derivative 175 
was devised as shown in Fig 3.17. By choosing a suitable protection strategy, it 
would be possible to selectively react different areas of the chitobiose derivative so 
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Fig 3.17 Proposed synthesis of orthogonally protected chitobiose. 
Work commenced with the synthesis of 3,6-0-dibenzyl-D-glucal, 173, using a 
method developed by Danishefsky et aL, Fig 3.17.  135  A solution of tri-O-acetyl-n-
glucal, 149, in anhydrous methanol was treated with sodium methoxide and stirred 
under an atmosphere of nitrogen for three hours. The crude reaction mixture was 
purified to generate quantitative yield of the totally deprotected glucal. The resulting 
D-glucal was dissolved in anhydrous toluene and heated at reflux with bis-tributyltin 
oxide using a Dean-Stark apparatus for twenty hours. The reaction mixture was 
cooled to allow the addition of benzyl bromide (BnBr) and tetrabutylammonium 
bromide (TBABr) and then heated at reflux for a further sixteen hours to afford a 
102 
dark brown residue containing a number of products. Despite repeated attempts to 
isolate the desired 3,6-0-dibenzyl-D-glucal, 173, from the crude reaction mixture, it 
proved to be impossible to remove tin side-products from the fraction containing the 
desired compound. 
Consequently, it was not possible to synthesise 174 by the route shown in Fig 3.17 so 
that it could be used as an acceptor in the assembly of the disaccharide bearing 
orthogonally protected 2-amino functional groups. However, work had already 
commenced on the synthesis of a donor component for the coupling reaction as 
shown in Fig 3.18. It was decided that both the donor and acceptor monosaccharides 
required for the coupling reaction would be prepared sequentially by extending the 
route to the donor molecule, since it would be less time consuming and more 
efficient to synthesise both the donor and acceptor components using just one 
synthetic route. 
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The new target disaccharide, 184, would bear an N-phthalimido protecting group at 
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Fig 3.18 : Synthesis of orthogonally protected chitobiose derivative. 
The synthesis of disaccharide 184 began with the one-pot, three-step acetylation and 
N-phthalimido protection of commercially available glucosamine hydrochloride, 176. 
A solution of glucosamine hydrochloride, 176, in anhydrous methanol was treated 
with sodium methoxide and stirred under an atmosphere of nitrogen. Addition of 
phthalic anhydride and triethylamine generated a sticky white solid, which upon 
reaction with acetic anhydride and pyridine afforded the desired sugar, 177, in 48% 
yield.  13' Although this reaction does not produce high yields, it can be performed on 
a large scale and so significant amounts of 177 can be prepared. 
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The next step required replacement of the anomeric acetate group with the more 
versatile thiophenyl functionality. Activation of 177 with the Lewis acid, tin 
tetrachloride, with subsequent in situ addition of benzenethiol resulted in 74% yield 
of 2-phthalimido-2-deoxy-3 ,4,6-tri-O-acetyl- 1-thiophenyl-l3-o-glucopyranoside, 
178)' 
The orthogonal protection strategy was further implemented by tethering the hydroxy 
groups at positions 4 and 6 in a benzylidene acetal. Saponification of 178 with 
sodium methoxide in anhydrous methanol resulted in the deprotection of the acetyl 
groups at positions 3, 4 and 6. Subsequent treatment of a solution of the trihydroxy 
sugar in anhydrous DMF with benzaldehyde dimethyl acetal and catalytic toluene 
sulfonic acid afforded the 4,6-0-benzylidene acetal, 179, in 80% yield. '31 Although 
the 1H and '3C NMR data for 179 were consistent with the quoted literature, it was 
noteworthy that the [a]D  value obtained did not agree with published results. The 
next step required protection of the free hydroxy group at position 3. Attempts were 
made to attach a benzyl group at this site by treating a solution of 179 in anhydrous 
DMF at 0°C with sodium hydride followed by the addition of benzyl bromide, Fig 
3. 19.136 
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Fig 3.19 : Attempted benzylation of the unprotected hydroxy group at position 3. 
This reaction failed to generate any product on a number of occasions and when the 
benzyl protected sugar, 185, was eventually isolated, it was in only a 19% yield. In 
order to improve the consistency and increase the yield of product an acetyl 
protecting group was employed. To a solution of 179 in anhydrous DCM was added 
acetic anhydride and pyridine. This process successfully generated an almost 
quantitative yield of the 3-0-acetyl protected sugar, 180, Fig 3.18. 
Reductive ring-opening of the 4,6-0-benzylidene acetal was next carried out as 
depicted in Fig 3.18. A triethylsilane (TES)-trifluoroacetic acid (TFA) system was 
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chosen for this reaction because of its reported selective and high-yielding 
conversions of 4,6-0-benzylidene-protected carbohydrates to the corresponding 6-0-
benzyl-4-hydroxy derivatives.  137  A solution of the 4,6-0-benzylidene acetal, 180, in 
anhydrous DCM was cooled to 0°C and treated with TES and TFA to generate the 
desired product 181 in 76% yield, Fig 3.18. 
The 2-phthalimido-2-deoxy-3-O-acetyl-6-benzyl- 1-thiopheny1..3-n-glucopyranoside, 
181, thus generated was divided into two portions. One aliquot was used as the 
acceptor in the coupling reaction to create protected chitobiose. The remaining sugar 
was transformed into the donor component for the coupling reaction. 
The free 4-hydroxy position of 181 now required protection and again an acetyl 
group was chosen for this task. A solution of 181 in anhydrous DCM was treated 
with acetic anhydride and pyridine. The 4-0-acetyl protected monosaccharide, 182, 
was recovered in quantitative yield. 
In order to reduce the number of steps in the synthetic route to the disaccharide an 
attempt was made to use thioglycoside, 182, as the glycosyl donor, Fig 3.20. 138 
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Fig 3.20: The coupling of donor 182 and acceptor 181 in the presence of NIS and 
trfluoroinethane sulfonic acid. 
Coupling of 182 and 181 in the presence of N-iodosuccinimide (NIS) and 
trifluoromethane sulfonic acid in DCM at —20°C failed to produce the disaccharide, 
184, and the species recovered from the crude reaction mixture could not be 
identified. Further activation of the donor molecule was deemed necessary in order to 
achieve a successful coupling reaction. 
Consequently, the thioglycoside, 182, was converted to a glycosyl fluoride using a 
method reported by Nicolaou et al.  139 A solution of the thioglycoside, 182, in 
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anhydrous DCM was cooled to —15°C whereupon diethylaminosulfur trifluoride 
(DAST) and N-bromosuccinimide (NBS) were added to the reaction mixture. This 
reaction resulted in an 82% yield of the glycosyl fluoride, 183, Fig 3.18. 
The coupling of glucosamine derivative, 181, with glycosyl fluoride, 183, was 
carried out under Mukaiyama-Suzuki'4° conditions. The disaccharide 184 was 
formed in 91% yield by treating a solution of silver triflate, zirconocene dichloride, 
2,6-collidine and 3A molecular sieves in anhydrous DCM with a solution of both 
donor and acceptor sugars in anhydrous DCM.  141 Evidence for the formation of a 
glycosidic linkage was observed in the 1H NMR of the disaccharide where a doublet 
at 8H 5.39 had a spin coupling constant of 8.4 Hz. All other analytical data obtained 
for 184 were satisfactory with the exception of the elemental analysis. Although the 
expected %C for this compound was 64.91%, elemental analysis found only 61.78% 
C. Both %H and %N obtained for this compound were in agreement with the 
expected values. 
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Once the orthogonally protected chitobiose derivative had been synthesised it was to 
be attached to a fluorescently-labelled aspartic acid derivative and then deprotected 
as shown in Fig 3.21. 
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Fig 3.21 : Propsed synthesis offluorescently-labelled asparagine-linked chitobiose. 
The first stage in this process involved introduction of a nitrogen group at the 
anomeric position. A solution of the disaccharide, 184, in anhydrous DCM 
containing 4A molecular sieves was cooled to —40°C before adding trimethylsilyl 
azide, NIS and catalytic triflic acid, Fig 3.21.138  This reaction failed to generate the 
desired product and only unreacted starting material was recovered from the reaction 
mixture. Unfortunately, due to time constraints, it was not possible to attach the 
anomeric azide and then complete the synthesis of the fluorescently-labelled 
asparagine-linked chitobiose derivative depicted in Fig 3.21. 
3.8. Conclusion. 
The synthesis of an orthogonally protected chitobiose derivative, 184 (Fig 3.18), has 
been achieved. This work has formed the basis for the synthesis of a fluorescently-
labelled asparagine-linked chitobiose substrate, 166 (Fig 3.21), that will be used to 
find a 3-mannosy1transferase capable of directly mannosylating N-linked chitobiose. 
3.9. Future Work. 
The synthesis of an asparagine-linked chitobiose residue will allow research into the 
availability of an enzyme that could be used in the synthesis of an asparagine-linked 
trisaccharide. 
An alternative means of introducing an azide at the anomenc position is described in 
the literature whereby thioglycoside 184, Fig 3.21, would be treated with 
trimethylsilyl azide and the Lewis acid, tin tetrachloride, in DCM.'42 Having 
performed their function as activating and 3-directing groups, the phthalamide 
moieties could be removed by treatment with hydrazine, leading to a diamine which 
could be directly acetylated to afford the diacetamide, 187, Fig 3.21)' Reduction of 
the azide to an anomeric amine could be achieved by hydrogenolysis using 10% 
palladium on charcoal as catalyst under an atmosphere of hydrogen gas. Subsequent 
treatment of the amine with N-ethylmorpholine in THF and an aspartic acid residue 
bearing a dansyl probe should generate the N-linked disaccharide, 188, Fig 3.21.142 
Finally, removal of all the chitobiose protecting groups will generate the target 
compound, 166, Fig 3.21. 
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4. Experimental. 
4.1. General Experimental. 
4.1.1. Instrumentation. 
'H and '3C NMR spectra were recorded on Bruker AC250, WH360 or Varian 
Gemini 200 instruments. Both 'H and '3C NMR spectra were referenced to residual 
protic solvents i.e. CDC13  (6H  7.3, s; 5c 77.0, 1), (CD3)2S0 (8H 2.5, q; 8C 39.7, m) and 
CD30D (H  4.8, s, 3.4, q; 8c 49.0, m). Chemical shifts (6H, 6c) are recorded in parts 
per million (ppm) and coupling constants (J) are measured in Hertz (Hz) and quoted 
to the nearest 0.5 Hz. 
Infrared spectroscopy was recorded on a Perkin Elmer Paragon 1000 FT-JR 
spectrophotometer with the frequencies (v) measured in wavenumbers (cm). 
Infrared spectra were recorded as thin films on sodium chloride plates. 
Melting points were obtained on a Gallenkamp melting point apparatus and are 
quoted in degrees Celsius (°C) and uncorrected. 
Optical rotations were performed in dichioromethane on an Optical Activity PolAAr 
2 AA series automatic polarimeter. 
Elemental analysis (CHN) was performed using a Perkin Elmer 2400 CHN 
Elemental Analyser. 
Fast atom bombardment (FAB) mass spectrometry was performed in positive ion 
mode using a Kratos MS50TC instrument from a nitrobenzyl alcohol or THIOG 
matrix. Values are quoted in daltons. 
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4.1.2. Chromatography. 
Analytical thin layer chromatography (TLC) was carried out on Merck aluminium 
backed plates coated with silica gel 60 F254, 0.25mm. The components were detected 
using ultra-violet light (254 nm), or visualised with ammonium molybdate and 
anisaldehyde dips. 
Column chromatography was carried out using either the appropriate sized parallel-
sided column filled with silica gel 60H (Merck, particle size 0.04-0.063 mm, 230-
400 mesh) or a FLASH 121 chromatography module with pre-packed cartridge 
system (biotage company). 
4.1.3. Solvents and Reagents. 
All solvents and reagents were standard laboratory grade and used as supplied unless 
otherwise stated. Tetrahydrofuran (THF) was pre-dried over sodium wire and 
distilled from sodium benzophenone ketal while dichloromethane (DCM) was 
distilled from calcium hydride. All other solvents were purchased as anhydrous 
grade. 
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4.2. Synthesis of lipid analogues of dolichyl phosphate. 
8-Benzyloxy-2,6-dimetbyloct-2-ene, 102.96 
NaH,THF 
Bn ' BnBr, TBABr 
101 40°C, 100% 102 
A stirred solution of citronellol, 101, (20.0 g, 100.0 mmol) in anhydrous THF (80.0 
mL) was treated with a 60% dispersion of sodium hydride in mineral oil (5.5 g, 200.0 
mmol) and the grey suspension was stirred under N2 at room temperature for lh. 
Benzyl bromide (15.2 mL, 100.0 mmol) and tetrabutylammonium iodide (1.3 g, 3.4 
mmol) were added to the reaction mixture which was then stirred at 40°C for 4h 
under N2. The reaction, containing a thick white precipitate, was cooled to room 
temperature and treated with water (100.0 mL), causing the white solid to dissolve. 
The solution was extracted with ethyl acetate (3 x 100.0 mL) and the combined 
organic layers were washed with brine (100.0 mL) and dried over anhydrous MgSO4. 
Filtration, followed by concentration in vacuo yielded a dark yellow oil. This was 
purified by column chromatography on silica using petroleum ether:ethyl acetate, 
9:1, as the eluent to afford the product, 102, (31.5 g, 100%) as a pale yellow oil. 
R1 (petroleum ether:ethyl acetate, 6:4) 0.65; HRMS (FAB) 247.2065 ([M+H], 
C1711270 requires 247.2062); LRMS (FAB) 247 (C17H270), 107 (C7H70), 91 (C7H7); 
(CDC13, 250MHz) 7.64-7.51 (5H, m, AM), 5.35 (1H, tm, J 7.1 Hz, 
CH=C(CH3)2), 4.76 (21-1, s, PhCH20), 3.77 (21-1, td, J 7.0, 2.4 Hz, BnOCH2), 2.27-
2.22 (2H, br in, CH2), 1.94 and 1.86 (2 x 3H, 2 x s, 2 x C113), 1.76-1.35 (511, br m, 
CH, 2 x CH2), 1.15 (3H, d, J 6.4 Hz, CH()); 5C (CDC13, 63MHz) 138.6 and 
131.0 (qC), 128.2 (2 x ArCH), 127.5 (2 x ArCH), 127.3 and 124.7 (CH), 72.8 and 
68.6 (PhCH2ocH2), 37.1 and 36.6 (CH2), 29.4 (H(CH3)), 25.6 (CH3), 25,3 (CH2), 







102 39% 103 
A stirred solution of 8-benzyloxy-2,6-dimethyloct-2-ene, 102, (12.4 g, 50.4 mmol) in 
DCM (120.0 mL) was treated with tert-butyl hydroperoxide (23.4 mL, 100.0 mmol), 
selenium dioxide (167.7 mg, 1.5 mmol) and water (2.0 mL). The reaction mixture 
was stirred for 16h under N2 at room temperature. The pale pink solution was cooled 
to' 0°C in an ice bath and carefully treated with a saturated solution of sodium 
metabisulfite (150.0 mL). A peroxide test at this point proved negative and so the 
resulting white solution was concentrated in vacuo. The concentrate was extracted 
with ethyl acetate (3 x 100.0 mL), the organic layers combined, washed with brine 
(100.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield 
a dark yellow oil. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 9:1, as the eluent to afford the product, 103, (5.2 g, 
39%) as a pale yellow oil. 
R1 (petroleum ether:ethyl acetate, 8:2) 0.14; HRMS (FAB) 263.2012 ([M+H], 
C17H2702 requires 263.2011); LRMS (FAB) 263 (C17H2702), 261 (C17112502), 245 
(C17H240), 91 (C7H7); 6H  (CDCI3, 250MHz) 7.57-7.46 (5H, m, AM), 5.59 (lH, tm, J 
7.2 Hz, CH=C(CH3)2), 4.71 (2H, s, PhCH20), 4.27 (2H, s, CH20H), 3.71 (211, td, J 
6.2, 2.3 Hz, BnOCH2), 2.25-2.22 (2H, br m, CH2), 2.09 (114, br s, CH20H), 1.86 (3H, 
s, CH3), 1.71-1.33 (5H, br m, CH, 2 x CH2), 1.11 (31-1, d, J 6.5 Hz, CH(j)); & 
(CDCI3, 63MHz) 138.4 and 134.4 (qC), 128.2 (2 x ArCH), 127.4 (2 x ArCH), 127.3 
and 126.2 (CH), 72.7, 68.4, 68.2, 36.6 and 36.4 (CH2), 29.3 (H(CH3)), 24.8 (CH2), 





BflO L1( H 
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102 23% 104 0 
A stirred solution of 8-benzyloxy-2,6-dimethyloct-2-ene, 102, (12.4 g, 50.4 mmol) in 
DCM (120.0 mL) was treated with tert-butyl hydroperoxide (23.4 mL, 100.0 mol), 
selenium dioxide (167.7 mg, 1.5 mmol) and water (2.0 mL). The reaction mixture 
was stirred for 16h under N2 at room temperature. The pale pink solution was cooled 
to 0°C in an ice bath and carefully treated with a saturated solution of sodium 
metabisulfite (150.0 mL). A peroxide test at this point proved negative and so the 
resulting white solution was concentrated in vacuo. The concentrate was extracted 
with ethyl acetate (3 x 100.0 mL), the organic layers combined, washed with brine 
(100.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield 
a dark yellow oil. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 9:1, as the eluent to afford the product, 104, (3.0 g, 
23%) as a pale yellow oil. 
Rf (petroleum ether:ethyl acetate, 8:2) 0.36; HRMS (FAB) 261.1857 ([M+H], 
C17H02 requires 261.1855); LRMS (FAB) 261 (C17H2502), 107 (C7H70), 91 
(C7117), 8H  (CDCI3, 250MHz) 9.37 (111, s, CHO), 7.39-7.25 (5H, m, ArH), 6.45 (1H, 
td, J 7.4, 1.3 Hz, CH=C(CH3)2), 4.49 (2H, s, PhCH20), 3.50 (2H, td, J 6.9, 2.2 Hz, 
BnOCH2), 1.73 (3H, s, CH3), 1.67-1.20 (7H, br m, CH, 3 x CH2), 0.92 (3H, d, J 6.5 
Hz, CH(C)); c  (CDC13, 63Mhz) 195.1 (CHO), 154.8 (H=C(CH3)), 138.5 and 
130.9 (qC), 128.1 (2 x ArCH), 127.4 (2 x ArCH), 127.3 (ArCH), 72.8, 68.3, 37.0 and 







A stirred solution of 8-benzyloxy-2,6-dimethyl-2-octenal, 104, (2.31 g, 8.9 mmol) in 
a 4:1 mixture of MeOH:DCM (15.0 mL) was treated with a solution of sodium 
borohydride (0.4 g, 10.0 mmol) in water (10.0 mL). The reaction was stirred under 
an atmosphere of N2 at room temperature for 16h. The solution was concentrated in 
vacuo and the resulting residue dissolved in diethyl ether (10.0 mL). The organic 
layer was separated, washed with 0.1 M aq I-IC! (15.0 mL), water (15.0 mL), dried 
over anhydrous MgSO4, filtered and concentrated in vacuo to yield a yellow oil. This 
was purified by column chromatography on silica using petroleum ether:ethyl 
acetate, 9:1, as the eluent to afford the product, 103, (0.65 g, 28%) as a clear oil. 
Data as for 103 above. 







A stirred solution of 8-benzyloxy-2,6-dimethyloct-2-en-1-ol, 103, (11.0 g, 41.9 
mmol) in anhydrous Et20 (140.0 mL) was treated with 12-bromododecanoic acid 
(11.7 g, 41.9 mmol), DMAP (0.5 g, 4.2 mmol) and DCC (9.5 g, 46.1 mmol). A white 
precipitate rapidly developed and this mixture was stirred for 16h under N2 at room 
temperature. The reaction mixture was filtered and the filtrate was concentrated in 
vacuo to yield a yellow oil. This was purified by column chromatography on silica 
using petroleum ether:ethyl acetate, 9:1, as the eluent to afford the product, 106, 
(19.0 g, 87%) as a clear oil. 
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Rf (petroleum ether:ethyl acetate, 9:1) 0.39; RRMS (FAB) 523.2781, 525.2706 
([M+H], C29H4303Br requires 523.2787, 525.2708); LRMS (FAB) 523 
(C29H4803Br), 279 (C12H2202Br), 245 (C12H22Br), 154 (C10H180), 91 (C7H7); SH 
(CDC13, 250MHz) 7.65-7.54 (5H, m, ArH), 5.72 (1H, tm, J 7.2 Hz, CH=C(CH3)), 
4.79 (2H, s, PhCH20), 4.74 (2H, s, CH20C=O), 3.79 (2H, td, J 6.8, 2.2 Hz, 
BnOCH2), 3.69 (2H, t, J 6.9 Hz, CH2Br), 2.61 (2H, t, J 7.5 Hz, OCOCH2), 2.40-
2.28 (2H, br m, CH2), 2.27-2.19 (2H, m, CH2), 1.91 (3H, s, CH3), 1.78-1.52 (21H, br 
m, CH, 10 x CH2), 1.18 (3H, d, J 6.5 Hz, CH(C1-j)); 6c  (CDCI3, 63MHz) 173.7 
(CO), 138.5 and 130.8 (qC), 129.8 (CH), 128.2 (2 x ArCH), 127.5 (2 x ArCH), 127.4 
(CH), 72.8, 69.9, 68.5, 37.1, 36.5, 36.4, 34.3, 33.9, 32.7 and 29.5 (CH2), 29.3 
(CH(CH3)), 29.2, 29.1, 29.0, 28.6, 28.0, 25.1 and 24.9 (CH2), 19.4 and 13.8 (CR3); 
Vmax (film)/cm' 2986 (CH), 1725 (OC=O), 1454 (Ph), 1167 (CH2Br), 1097 
(BnOCH2). 
8-Benzyloxy-2,6-dimethyloct-2-en-1-yi 12-N-phthalimidododecanoate, 108. 





106 84% 108 
A stirred solution of 8-benzyloxy-2,6-dimethyloct-2-en-1-yl 12-bromododecanoate, 
106, (3.8 g, 7.3 mmol) in anhydrous DMF (50.0 mL) was treated with potassium 
phthalamide (2.7 g, 14.6 mmol). The reaction mixture was heated to 80 °C and 
stirred for 16h at this temperature under N2. The orange solution was diluted with 
ethyl acetate (30.0 mL) and washed with water (3 x 30.0 mL). The combined 
aqueous layers were back extracted with ethyl acetate (20.0 mL). The organic layers 
were combined, washed with brine (50.0 mL), dried over anhydrous MgSO4, filtered 
and concentrated in vacua to yield an orange oil. This was purified by column 
chromatography on silica using petroleum ether:ethyl acetate, 9:1, as the eluent to 
afford the product, 108, (3.6 g, 84%) as a clear oil. 
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R1 (petroleum ether:ethyl acetate, 9:1) 0.17; HRMS (FAB) 590.3849 ([M+H], 
C37H5205N requires 590.3846); LRMS (FAB) 590 (C37H5205N), 346 (C20H2804N), 
91 (C7H7); 8j-1 (CDCI3, 250MHz) 8.15-7.93 (41-1, m, AM, NPhth), 7.62-7.53 (514, m, 
ArH), 5.69 (1H, tm, J 7.2 Hz, CH=C(CH3)), 4.77 (2H, s, PhCH20), 4.71 (2H, s, 
CH20C=O), 3.93 (211, t, J 7.3 Hz, CH2NPhth), 3.76 (2H, td, .1 6.7, 2.4 Hz, BnOCH2), 
2.56 (211, t, J 7.6 Hz, OC=OCH2), 2.38-2.26 (2H, br m, CH2), 2.18-2.06 (2H, rn, 
CH2), 1.97-1.83 (2H, m, CH2), 1.91 (31-1, s, CH3), 1.71-1.39 (19H, br m, CH, 9 x 
CR2), 1.15 (3H, d, J 6.5 Hz, CH(CIj)); 8c (CDC13, 63MHz) 177.8 and 173.7 (qC), 
168.4 (2 x qC), 138.5 (qC), 133.7 (2 x CH), 132.0 (2 x qC), 129.8 (CH), 128.2 (2 x 
CH), 127.5 (2 x CH), 127.3 (CH), 123.0 (2 x CH), 72.8, 69.9, 68.5, 37.9, 36.5, 34.3, 
33,9 and 32.7 (CH2), 29.5 (CH(CH3)), 29.3, 29.0, 28.6, 28.5, 28.0, 26.7, 25.1, 24.9 
and 24.6 (CH2), 19.4 and 13.8 (CH3); Vinax (fi1m)/crn 2986 (CH), 1712 (0C=O), 
1618 and 1551 (N-C=O). 
8-Hydroxy-2,6-dimethyloctyl 12-N-phthalimidododecanoate, 109. 
ace OH 
108 66% 109 
A stirred solution 8-benzyloxy-2,6-dimethyloct-2-en-1-yl 12-N- 
phthalimidododecanoate, 108, (340.0 mg, 0.5 mmol) in 2:1 acetone: methanol (22.0 
mL) was treated with finely divided 10% palladium on charcoal (265.0 mg) as 
catalyst and placed under an atmosphere of N2. The system was evacuated and 
flushed with hydrogen. This process was repeated twice and the reaction mixture was 
then allowed to stir under an atmosphere of hydrogen for 16h. The solution was 
filtered through a pad of celite, which was washed well with acetone (3 x 20.0 mL). 
The combined filtrate and washings were concentrated in vacuo to give a yellow oil. 
This was purified by column chromatography on silica using petroleum ether:ethyl 
acetate, 9:1, as the eluent to afford the product, 109, (0.2 g, 66%) as a white solid. 
Rç (petroleum ether:ethyl acetate, 1:1) 0.40; Mp 57.0-59.0 °C; HRMS (FAB) 
502.3536 ([M+HV, C30H4805N requires 502.3533); LRMS (FAB) 524 
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(C30H4705NNa), 502 (C30H4805N), 346 (C20H2804N), 328 (C20H2503N); 8H (CDC131  
250MHz) 8.04-7.81 (4H, m, ArH, NPhth), 5.09 (1H, br s, OH), 4.05 (1H, m, CH), 
3.72 (2H, t, J 7.3 Hz, CH2NPhth), 2.48-2.37 (2H, m, OC=OCH2), 1.80-1.70 (8H, br 
m, 4 x CH2), 1.50-1.32 (2311, br s, CH, 11 x Cl2), 1.06 (6H, d, J 6.4 Hz, 2 x 
CH(j3)); 8c (CDCI3, 63MHz) 173.9 (CO), 168.3 (2 x qC), 133.7 (2 x ArCH), 132.0 
(2 x qC), 123.0 (2 x ArCH), 69.0, 61.0 and 39.8 (CH2), 37.9 (2 x CH2), 37.2, 34.9, 
34.3 and 33.4 (CH2), 32.4 (çH(CH3)), 29.4, 29.2, 29.1 and 29.0 (CH2), 28.5 
(CH(CH3)), 26.7 (2 x CH2), 24.9 and 24.0 (CH2), 19.5 and 16.8 (CH3); Vmax 
(film)/cm' 3444 (OH), 2986, 2932 (CH), 1712 (OC=O), .1616 and 1551 (N-C=O). 
Di-tert-butyl 3,7-dimethyl-8-(12-N-phthalimidododecanoyloxy)octyl phosphate, 
110. 
('BuO),PN1Pr2 o 0 
---- iazoIe ----- --- NPhth 
, ThF 
10 mCPBA DCM 8u0' 
109 OBu 110 
A stirred solution of 8-hydroxy-2,6-dimethyloctyl 12-N-phthalimidododecanoate, 
109, (0.5 g, 0.9 mmol) in anhydrous THF (10.0 mL) was treated with N,N'-di-tert-
butyl diisopropylphosphoramidite (0.6 mL, 2.0 mmol) and 1,2,4-triazole (0.2 g, 2.9 
mmol). The reaction mixture was stirred at room temperature under an atmosphere of 
N2 for 3h. The reaction mixture was cooled to 0°C in an ice bath and treated with a 
solution of mCPBA (0,6 g, 3.2 mmol) in anhydrous DCM (5.0 mL). The reaction 
mixture was gradually allowed to warm to room temperature and stirred under N2 for 
lh. The reaction mixture was treated with a saturated solution of sodium sulfite (15.0 
mL) and stirred for 30 min under N2. The solution was extracted with ethyl acetate (3 
x 20.0 mL), the organic layers combined, washed with a saturated solution of 
NaHCO3 (2 x 20.0 mL) and brine (20.0 mL), dried over anhydrous MgSO4, filtered 
and concentrated in vacuo to yield a yellow oil. The crude mixture was separated by 
column chromatography on silica using petroleum ether:ethyl acetate, 6:4, as the 
eluent but no product was isolated. 





Bn Nth 10 
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118 
A stirred solution of of 8-hydroxy-2,6-dimethyloctyl 12-N-phthalimidododecanoate, 
109, (1.1 g, 2.1 mmol) in anhydrous THF (20.0 mL) was cooled to -78°C and treated 
with a 1.8 M solution of LDA in 1:1:1 heptane/THF/ethylbenzene (1.7 mL, 2.9 
mmol). The reaction mixture was stirred under N2 for 45 min whereupon a solution 
of tetrabenzyl pyrophosphate (1.6 g, 2.9 mmol) in anhydrous THF (10.0 mL) was 
added. The solution was stirred at -78°C for 4h under N2 after which time it was 
gradually allowed to warm to room temperature. The reaction was concentrated in 
vacuo to yield a yellow residue. This was purified by column chromatography on 
silica using petroleum ether:ethyl acetate, 7:3, as the eluent to afford the product, 
118, (0.8 g, 49%) as a white solid. 
H (CDC13, 250MHz) 7.99-7.80 (4H, m, AM, NPhth), 7.46-7.37 (1014, in, AM), 
5.21-5.13 (6H, br m, PO, 2 x POjPh), 4.08-4.02 (211, m, CH2), 3.91 (214, t, J 
7.6 Hz, CH2NPhth), 2.48 (2H, t, J 7.1 Hz, OC=OCH2), 1.95-1.88 (8H, m, 4 x CH2), 
1.57-1.49 (20H, br m, 2 x CH, 9 x CH2), 1.14 (6H, d, J 6.5 Hz, 2 x CH(CI-)); 5p 
(CDC13, 101MHz) —13.3 (s, P=O). 
Di-tert-butyl 3,7-dimethyl-8-(12-N-phthalimidododecanoyloxy)octyi phosphate, 
110. 
0 ('Pr)2NP(OBu)2 0 
NPhth 
tetrazo. THE 11 
NPhth 
mCPBA, 0°C Bu0 ID 
109 DCM,77% OBu 110 
A stirred solution of 8-hydroxy-2,6-dimethyloctyl 12-N-phthalimidododecanoate, 
109, (1.0 g, 2.1 mmol) in anhydrous THF (20.0 mL) was treated with N,N'-di-tert-
butyl diisopropylphosphoramidite (1.9 mL, 6.0 mmol) and a 3% solution of 1-H-
tetrazole in acetonitrile (19.6 mL, 6.6 mmol). A white precipitate developed and the 
resulting mixture was stirred at room temperature for 3h. The reaction mixture was 
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cooled to 0°C in an ice bath and treated with a solution of mCPBA (1.7 g, 7.5 mmol) 
in anhydrous DCM (25.0 mL). The reaction mixture was gradually allowed to warm 
to room temperature and stirred under N2 for lh. The clear, pale blue reaction 
mixture was treated with a saturated solution of sodium sulfite (40.0 mL) and stirred 
for 30 min under N2. The solution was extracted with ethyl acetate (3 x 50.0 mL), the 
organic layers combined, washed with a saturated solution of NaHCO3 (2 x 60.0 mL) 
and brine (60.0 mL), dried over anhydrous MgSO4, filtered and concentrated in 
vacuo to yield a yellow oil. This was purified by column chromatography on silica 
using petroleum ether:ethyl acetate, 8:2, as the eluent to afford the product, 110, (1.1 
g, 77%) as a white solid. 
Rf (petroleum ether:ethyl acetate, 7:3) 0.12; Mp 65.0-67.0 °C; HRMS (FAB) 
694.4442 ([M+H], C38H6508NP requires 694.4448); LRMS (FAB) 716 
(C38H6408NPNa), 694 (C38116508NP), 582 (C30H4908NP), 346 (C20H2804N); 6H 
(CDC13, 250MHz) 8.13-7.99 (4H, m, ArH, NPhth), 4.23-4.12 (411, complex m, 
POd 2, CH2), 4.10-4.08 (211, m, CH2), 3.95 (2H, t, J 7.4 Hz, CH2NPhth), 2.56 (2H, 
t, J 7.6 Hz, OC=OCH2), 2.05-1.88 (6H, m, 3 x CH2), 1.74 (18H, s, 2 x C(ç)3), 
1.51-1.46 (20H, br m, 2 x CH, 9 x CH2), 1.17 (6H, d, J 6.5 Hz, 2 x CH(9I-1)); 5c  
(CDC13, 63MHz) 173.9 (CO), 168.3 (2 x qC), 133.7 (ArCH), 132.6 (2 x qC), 129.9, 
127.9 and 123.3 (ArCH), 82.8 and 82.0 (OC(CH3)3), 69.1, 65.1, 46.5 and 37.9 (Cl2), 
36.9 (2 x CH2), 34.2 and 33.4 (CH2), 32.4 (CH(CH3)), 30.2 (2 x C(CI-)3), 29.7 (2 x 
Cl2), 29.3 (H(CH3)), 29.0 (2 x CFI2), 28.4, 26.7, 24.9, 23.9 and 22.2 (H2), 19.1 
and 16.8 (CH3); 6p  (CDCI3, 101MHz) —6.5 (s, P=O); Vm (film)km' 2986 (CH), 
1713 (OC=O), 1168 (P=O) and 984 (P-0-C). 
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A solution of di-tert-butyl 3 ,7-dimethyl-8-( 12-N-phthalimidododecanoyloxy)octyl 
phosphate, 110, (109.8 mg, 0.2 mmol) in TFA (5.0 mL, 65.2 rnmol) was stirred 
under N2 at room temperature for 10 mm. The reaction mixture was then 
concentrated in vacuo and the resulting residue was azeotroped with anhydrous 
toluene (2 x 15.0 mL) to afford the product, 99, (86.0 mg, 94%) as a white solid. 
Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.19; HRMS (FAB) 
582.3198 ([M+H], C30H4908NP requires 582.3196); LRMS (FAB) 626 
(C3oH4808NPNa2), 604 (C3oH4708NPNa), 582 (C30H4908NP), 328 (C20H2603N); 
(CDC13, 250MHz) 7.94-7.77 (4H, m, ArH, NPhth), 7.09 (2H, br s, P(OH)2), 4.07-
3.82 (4H, complex m, POCH2, CH2), 3.76 (2H, t, J 7.3 Hz, CH2NPhth), 2.37 (214, t, J 
7.5 Hz, OC=OCH2), 1.78-1.65 (6H, m, 3 x CH2), 1.45-1.25 (22H, br m, 2 x CH, 10  
CH2), 0.98-0.88 (614, br m, 2 x CH(C1-)); öc (CDC13, 63MHz) 173.9 (CO), 168.3 (2 
x qC), 133.7 (2 x ArCH), 132.0 (2 x qC), 123.0 (2 x ArCH), 69.1 and 64.9 (CH2), 
37.9 (2 x CH2), 37.3 (CH2), 34.2 (2 x Cl2), 33.5 (CH2), 32.4 (çH(CH3)), 29.3 (2 x 
CH2), 29.1 (cH(CH3)), 28.5 (2 x CH2), 26.7 (2 x CH2), 24.9 (2 x CH2), 23.9 (CH2), 
19.1 and 16.9 (CH3); op (CDC13, 250MHz) 0.0 (s, P=O); Vmax (film)Icm' 2929, 2856 
(CH), 1711 (OC=O), 1172 (P=O) and 907 (P-0-C). 
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A stirred solution of di-tert-butyl 3,7-dimethyl-8-(12-N- 
phthalimidododecanoyloxy)octyl phosphate, 110, (200.0 mg, 0.3 mmol) in a 2:1 
mixture of anhydrous MeOH and DCM (6.0 mL) was treated with hydrazine hydrate 
(0.2 mL, 2.8 mmol). The reaction mixture was stirred at 60°C for 2h under an 
atmosphere of N2. The solution was cooled to room temperature and concentrated in 
vacuo to yield a white solid. The crude mixture was separated by column 
chromatography on silica using petroleum ether:ethyl acetate, 1:1, as the eluent but 
no product was isolated. 
The reaction was repeated using the same quantites of each material as given above, 
but without heating to 60°C for 2h. Instead the solution was stirred under an 
atmosphere of N2 for 16h and then worked up as before. Again no product was 
recovered from the process. 





10 acetone, MeOH H 10 
106 78% 120 
A stirred solution of 8-benzyloxy-2,6-dimethyloct-2-en-1-yl 12-bromododecanoate, 
106, (23 g, 4.3 mmol) in 2:1 acetone: methanol (30.0 mL) was treated with finely 
divided 10% palladium on charcoal (350.0 mg) as catalyst and placed under an 
atmosphere of N2. The system was evacuated and flushed with hydrogen. This 
process was repeated twice and the reaction mixture was then allowed to stir under 
an atmosphere of hydrogen for 16h. The solution was filtered through a pad of celite, 
which was washed well with acetone (3 x 30.0 mL). The combined filtrate and 
washings were concentrated in vacuo to give a yellow oil. This was purified by 
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column chromatography on silica using petroleum ether:ethyl acetate, 9:1, as the 
eluent to afford the product, 120, (1.5 g, 78%) as a white solid. 
Rf (petroleum ether:ethyl acetate, 8:2) 0.18; Mp 43.0-45.0 °C; HRMS (FAB) 
457.2289, 459.2201 ([M+Na], C22H4303BrNa requires 457.2294, 459.2204); CHN 
found %C 60.5 1, %H 9.97; (required %C 60.69, %H 9.89); LRMS (FAB) 457 
(C22H4303BrNa), 245 (C12H22Br), 154 (C10H180); 8H (CDC13, 250MHz) 6.08 (lH, br 
s, 011), 3.86-3.80 (21-1, m, HOCH2), 3.56 (2H, t, J 6.9 Hz, CH2Br), 2.49 (211, t, J 7.5 
Hz, OC=OCH2), 2.06-1.94 (211, m, CH2), 1.83-1.65 (414, m, 2 x CH2), 1.59-1.39 
(20H, br in, 2 x CH, 9 x CH2), 1.34-1.23 (411, m, 2 x CH2), 1.01 (6H, d, J 6.5 Hz, 2 x 
CH(CI-j)); 8C (CDC13, 63MHz) 179.4 (CO), 61.1 and 39.7 (CH2), 39.1 (2 x CH2), 
37.2 (2 x CH2), 33.9 and 32.7 (CH2), 29.3 (CH(CH3)), 29.2 (2 x CH2), 29.1 (2 x 
CH2), 28.9, 28.6 and 28.0 (CH2), 27.8 (H(CH3)), 24.5 and 22.6 (CH2), 22.5 and 
19.5 (CH3); Vnm (film)/cm 3400 (OH), 2986 (CH), 1709 (OC=O), 1167 (CH2Br). 





A stirred solution of 8-hydroxy-2,6-dimethyloctyl 12-bromododecanoate, 120, (3.7 g, 
8.4 mmol) in anhydrous DMF (50.0 mL) was treated with sodium azide (1.6 g, 25.3 
mmol). The reaction mixture was stirred at room temperature under N2 for 16h. 
Water (25.0 mL) was added and the reaction mixture was extracted with DCM (3 x 
50.0 mL). The organic layers were combined, washed with brine (70.0 mL), dried 
over anhydrous MgSO4, filtered and concentrated in vacuo to yield a pale yellow oil. 
This was purified by column chromatography on silica using petroleum ether:ethyl 
acetate, 9:1, as the eluent to afford the product, 121, (3.0 g, 89%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 8:2) 0.22; HRMS (FAB) 398.3380 ([M+H], 
C221103N3 requires 398.3383); LRMS (FAB) 398 (C22H4403N3), 370 (C22H03N), 
123 
154 (C1011180); oH (CDC13, 250MHz) 4.18-4.00 (2H, m, CH2), 3.88-3.84 (2H, m, 
CH2), 3.45 (2H, t, J 6.9 Hz, CH2N3), 2.51 (2H, t, J 7.5 Hz, OC=OCH2), 2.01-1.90 
(2H, m, CH2), 1.85-1.73 (6H, in, 3 x CH2), 1.63-1.37 (20H, br m, 2 x CH, 9 x C112), 
1.09 (611, d, J 6.6 Hz, 2 x CH(Ij)); 0c  (CDC13, 63MHz) 173.9 (CO), 69.0, 60.9, 
51.3, 39.8, 39.7, 37.1, 34.5, 33.8 and 33.5 (CH2), 32.4 (CH(CH3)), 29.3 and 29.1 
(CH2), 28.9 (H(CF13)), 28.7, 26.6, 24.9, 24.6, 23.9 and 19.5 (CH2), 18.5 and 16.8 
(CH3); Vmax (film)Icni1 3400 (OH), 2986 (CH), 1725 (OC=O). 





121 59% 122 
A stirred solution of 8-hydroxy-2,6-dimethyloctyl 12-azidododecanoate, 121, (2.0 g, 
5.1 mmol) in anhydrous THF (20.0 mL) was treated with N,N'-di-tert-butyl 
diisopropylphosphoramidite (4.9 mL, 15.4 mmol) and a 3% solution of 1-H-tetrazole 
in acetonitrile (48.6 mL, 16.4 mmol). A white precipitate developed and the resulting 
solution was stirred at room temperature for 3h. The reaction mixture was cooled to 
0°C and treated with a solution of mCPBA (4.1 g, 18.5 mmol) in anhydrous DCM 
(25.0 mL). The reaction mixture was gradually allowed to warm to room temperature 
and stirred under N2 for lh. The clear, pale blue reaction mixture was treated with a 
saturated solution of sodium sulfite (40.0 mL) and stirred for 30min under N2. The 
solution was extracted with ethyl acetate (3 x 50.0 mL), the organic layers were 
combined, washed with a saturated solution of NaHCO3 (2 x 60.0 mL) and brine 
(60.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield 
a yellow oil. This was purified by column chromatography on silica using petroleum 
ether:ethyl acetate, 9:1, as the eluent to afford the product, (1.8 g, 59%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 9:1) 0.09; HRMS (FAB) 590.4298 ([M+H], 
C30H6106N3P requires 590.4298); LRMS (FAB) 590 (C30H5106N3P), 562 
(C30H5105NP), 365 (C18H3805P); 0H  (CDC13, 250MHz) 4.31-4.15 (2H, in, CH2), 4.07 
124 
(2H, dd, J 10.7, 6.9 Hz, POCH2), 3.49 (2H, t, J 6.9 Hz, CH2N3), 2.55 (211, t, J 75 Hz, 
OC=OCH2), 2.03-1.94 (2H, m, CH2), 1.85-1.79 (6H, in, 3 x CH2), 1.75 (18H, s, 2 x 
C(If)3), 1.61-1.47 (20H, brm, 10  CH2), 1.14 (6H, d, J4.8 Hz, 2 x CH(th)); 8C  
(CDC13, 63MHz) 173.9 (CO), 81.8 and 81.7 (OC(CH3)3), 69.0 and 64.9 (CH2), 51.3 
(2 x CH2), 36.9 (2 x CH2), 34.3 (2 x CH2), 33.5 (CH2), 32.4 (H(CH3)), 29.7 (CH2), 
29.3 (2 x C(CH3)3), 29.1 (H(CH3)), 29.0 (2 x CH2), 28.7 (CH2), 26.6 (2 x CH2), 
24.9 and 23.9 (CH2), 19.2 and 16.7 (CH3); 8P  (CDCI3, 101MHz) —7.8 (s, P=O); v ax  
(film)/cm' 1725 (OC=O), 1175 (P=O), 997 (POC). 
Di-tert-butyl 3,7-dimethyl-8-(12-aminododecanoyloxy)octyl phosphate, 119. 
MeOH, acetone OBu 122 OBu 119 
A stirred solution of di-tert-butyl 3 ,7-dimethyl-8-( 12-azidododecanoyloxy)octyl 
phosphate, 122, (1.0 g, 1.7 mmol) in 2:1 acetone: methanol (15.0 mL) was treated 
with finely divided 10% palladium on charcoal (302.0 mg) as catalyst and placed 
under an atmosphere of N2. The system was evacuated and flushed with hydrogen. 
This process was repeated twice and the reaction mixture was then allowed to stir 
under an atmosphere of hydrogen for 16h. The solution was filtered through a pad of 
celite, which was washed well with acetone (3 x 20.0 mL). The combined filtrate and 
washings were concentrated in vacuo to give a yellow oil. The crude mixture was 
separated by column chromatography on silica using petroleum ether:ethyl acetate, 
1:1, as the eluent but no product was isolated. 
Di-tert-butyl 3,7-dimethyl-8-(12-aminododecanoyloxy)octyl phosphate, 119. 
- thame OBu 122 MeOH OBu 119 
A stirred solution of di-tert-butyl 3,7-dimethyl-8-(12-azidododecanoyloxy)octyl 
phosphate, 122, (0.5 g, 0.9 mmol) in anhydrous MeOH (5.0 mL) was treated with 
propane-1,3-dithiol (0.3 mL, 2.5 mmol) and triethylamine (0.4 mL, 2.5mmo1). The 
reaction mixture was stirred under an atmosphere of N2 for 48h and then 
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concentrated in vacua. TLC analysis of the crude reaction mixture showed that only 
starting materials were present. This was confirmed by mass spectral analysis. 
R (petroleum ether:ethyl acetate, 9:1) 0.09; LRIvIS (FAB) 590 (C30H6106N3P), 562 
(C30H6106NP), 365 (C18H3805P). 
J)i-tert-butyl 3,7-dimethyl-8- [12-(4' -dimethylaminonaphthalene-1' - 








Ph3P, H20, THF 








A stirred solution of di-tert-butyl 3,7-dimethyl-8-(12-azidododecanoyloxy)octyl 
phosphate, 122, (0.6 g, 1.0 mmol) in THF (10.0 mL) and H20 (0.1 mL) was treated 
with triphenylphosphine (1.2 g, 4.6 mmol) and stirred for 16h at room temperature 
under N2. The reaction mixture was concentrated in vacua to yield a white solid. A 
portion of the white solid (0.3 g, 0.5 mmol) was dissolved in anhydrous DCM (4.0 
mL) and treated with triethylamine (65.0 j.tL, 0.5 mmol) and dansyl chloride (130.0 
mg, 0.5 mmol). The resulting bright orange reaction mixture was stirred under N2 at 
room temperature for 16h. The solution was diluted with H20 (5.0 mL) and the 
organic layer separated. The aqueous layer was extracted with DCM (3 x 5.0 mL). 
The organic layers were combined, washed with brine (10.0 mL), dried over 
anhydrous MgSO4, filtered and concentrated in vacua to yield a brown oil. This was 
purified by column chromatography on silica using petroleum ether:ethyl acetate, 
8:2, as the eluent to afford the product, 123, (0.2 g, 44%) as a clear oil. 
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Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.77; HRMS (FAB) 
796.4874 ([M], C42H7308N2PS requires 796.4865); LRMS (FAB) 797 
(C42H7408N2PS), 590 (C34115804N2S), 450 (C24H3804N2S); 6H  (CDCI3, 250MHz) 
8.81 (1H, m, ArH), 8.48 (2H, m, 2 x ArH), 7.79 (11-1, m, ArH), 7.67 (1H, m, ArH), 
7.44 (11-1, d, J 6.9 Hz, ArH), 5.10-5.06 (1H, m, NH), 4.29-4.15 (211, m, CH2), 4.12 
(214, dd, J 10.5, 6.8 Hz, POCH2), 3.67 (21-1, m, CH2NH), 3.14 (611, s, N(CH3)2), 2.55 
(2H, td, J7.5 Hz, OC=OCH2), 2.04-1.95 (21-1, m, CH2), 1.90-1.81 (4H, m, 2 x CH2), 
1.73 (18H, s, 2 x C(F)3), 1.61-1.38 (22H, br m, 2 x CH, 10 x C112), 1.16 (61-1, d, J 
5.1 Hz, 2 x CH(fH 5c (CDCI3, 63MHz) 173.9 (CO), 165.9, 151.8, 136.6 and 
134.6 (ArC), 132.0, 131.8, 128.5, 128.3, 128.1 and 127.2 (ArCH), 81.8 and 81.7 
(OC(CH3)3), 68.9 and 64.9 (CH2), 45.3 (N(CH3)2), 43.2 and 40.1 (CH2), 36.9 (2 x 
CH2), 34.2 and 33.4 (CH2), 32.4 and 29.7 (H(CH3)), 29.3 (2 x CR2), 29.2 (2 x 
CH2), 29.1 (2 x C(çH3)3),  28.8, 26.8, 26.3, 24.9 and 23.9 (CH2), 19.1 and 16.7 
(CH3); 8p (CDCI3, 250MHz) —6.5 (s, P=O); v (film)/cm' 1712 (000), 1363 (N-
S(=0)2), 1223 (P=O), 1091 (C-N), 997 (POC). 
3,7-dimethyl-8-[ 12-(4' -dimethyiaminonaphthalene-1 t..  
snlfonamido)dodecanoyloxy]octyl phosphate, 100. 








A solution of di-tert-butyl 3 ,7-dimethyl-8-[ 12-(4'-dimethylaminonaphthalene- 1'- 
sulfonamido)dodecanoyloxy]octyl phosphate, 123, (35.0 mg, 0.1 mmol) in TFA (1.4 
mL, 18.1 mmol) was stirred under N2 at room temperature for 10mm. The reaction 
mixture was then concentrated in vacuo and the resulting residue was azeotroped 
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with anhydrous toluene (2 x 10.0 mL) to afford the product, 100, (30.0 mg, 100%) as 
a white solid. 
Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.41; HRMS (FAB) 
685.3666 ([M+H], C34H5808N2PS requires 685.3655); LRMS (FAB) 707 
(C34H5708N2PSNa), 685 (C34H5808N2PS), 449 (C24H3704N2S), 250 (C12H1402N2S); 
0H (CDC13, 250MHz) 8.73 (1H, d, J 8.5 Hz, ArH), 8.50 (1H, d, J 8.7 Hz, ArH), 8.42 
(111, dd, J 7.3, 1.2 Hz, ArH), 7.98 (1H, m, ArH), 7.75 (1H, dd, J 8.8, 1.3 Hz, ArH), 
7.40 (1H, d, J7.1 Hz, ArH), 4.19-3.99 (6H, br in, POCH2, 2 x OH, CH2), 3.63-3.57 
(214, m, CH2NH), 3.06 (6H, s, N(CH3)2), 2.51 (214, t, J 7.1 Hz, OC=OCH2), 2.02-
1.92 (2H, br m, CH2), 1.85-1.75 (61-1, br m, 3 x CH2), 1.64-1.48 (14H, br s, 2 x CH, 6 
x CH2), 1.53-1.41 (6H, br m, 3 x CH2), 1.13-1.06 (6H, d, J 6.6 Hz, 2 x CH(j)); 0c 
(CDC13, 63MHz) 174.3 (CO), 163.3, 151.6, 134.6 and 134.3 (ArC), 131.1, 130.0, 
129.6, 129.2, 127.9 and 127.0 (ArCH), 69.0 and 63.8 (Cl2), 45.1 (N(CF)2), 42.8 
(CH2), 39.9(2 x CH2), 37.1 and 34.1 (CH2), 33.3 (2 x Cl2), 32.3 (CH(CH3)), 29.1 (2 
x CH2), 28.9 (CH2), 28.8 (H(CH3)), 28.7, 26.7, 26.2, 24.7 and 23.8 (CH2), 18.8 and 
16.5 (CH3); op (CDC13, 101MHz) 6.3 (s, P=O); Vmax (fi1m)/cm 1711 (OC=O), 1364 
(N-S(=0)2), 1223 (P=O), 1092 (C-N). 
8-Benzyloxy-1-bromo-2,6-dimethyloct-2-ene, 131.96 
MeS02CI, Et3N 
OH DCM, -50°C Br 
LiBr, TI-IF, -20°C  BnC" Jl"~
103 85% 131 
A stirred solution of 8-benzyloxy-2,6-dimethyloct-2-en-1-01, 103, (1.0 g, 3.8 mmol) 
in anhydrous DCM (15.0 mL) was cooled to —50°C and treated with triethylamine 
(0.8 g, 7.6 mmol). The reaction mixture was stirred for 5 minutes under an 
atmosphere of nitrogen before the addition of methanesulfonyl chloride (0.7 g, 6.5 
mmol). A white precipitate developed and this mixture was stirred for 1.5h under N2 
at —50°C. The reaction mixture was warmed to —20°C and a solution of lithium 
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bromide (1.2 g, 13.3 mmol) in anhydrous THF (7.0 mL) was added to the flask. After 
stirring at —20°C for 2h under an atmosphere of nitrogen, the reaction mixture was 
poured into ice-water (30.0 mL). The solution was extracted with DCM (3 x 50.0 
mL), the organic layers combined, washed with brine (30.0 mL) and water (30.0 
mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield a 
yellow oil. This was purified by column chromatography on silica using petroleum 
ether:ethyl acetate, 9:1, as the eluent to afford the product, 131, (1.1 g, 85%) as a 
white solid. 
Rf (petroleum ether:ethyl acetate, 9:1) 0.68; HRMS (FAB) 323.1018, 325.0992 
([M}, C17H24OBr requires 323.1011, 325.0991); LRMS (FAB) 325 (C17H24OBr), 
107 (C71170), 91 (C7117); 5H  (CDC13, 250MHz) 7.35-7.25 (5H, m, ArH), 5.61 (1H, 
tm, J 7.0 Hz, CH=C(CH3)), 4.49 (2H, s, PhCH20), 3.96 (2H, s, CH2Br), 3.53 (2H, td, 
J6,5, 1.3 Hz, BnOCH2), 2.04(311,s, CH3), 1.83-1.62 (4H, brm, 2 x CH2), 1.58-1.20 
(3H, br m, CH2, CH), 0.89 (3H, d, J 6.3 Hz, CH(çj)); 6c  (CDC13, 63MHz) 138.5 
(qC), 131.6 (CH), 131.3 (qC), 131.0 (CH), 128.2 (2 x ArCH), 127.5 (2 x ArCH), 
72.8, 68.4, 41.8, 36.5 and 36.1 (CH2), 29.4 (CH(CH3)), 25.6 (CH2), 19.3 and 14.5 
(CH3). 
Diethyl 2-(8-benzyloxy-2,6-dimethyloct-2-en-1-yl) malonate, 139. 
CO2 ,Et Et CO 
Sn 
Br 
CO2E1 90% Bn 
+ NaOEt, THE 
O ' CO2Et 
131 138 139 
A stirred solution of diethyl malonate, 138, (150.0 mg, 318.5 jimol) in anhydrous 
THF (5.0 mL) was treated with sodium ethoxide (21.7 mg, 318.5 jimol). The reaction 
mixture was stirred for 1 h under an atmosphere of N2 at room temperature before the 
addition of 8-benzyloxy-1-bromo-2,6-dimethyloct-2-ene, 131, (103.6 mg, 318.5 
p.mol). The reaction mixture was stirred under an atmosphere of N2 for 16h. The 
solution was diluted with water (5.0 mL) and extracted with ethyl acetate (3 x 10.0 
mL), the organic layers were combined, washed with brine (15.0 mL), dried over 
anhydrous MgSO4, filtered and concentrated in vacuo to yield a yellow oil. This was 
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purified by column chromatography on silica using petroleum ether:ethyl acetate, 
9:1, as the eluent to afford the product, 139, (115.9 mg, 90%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 9:1) 0.30; HRMS (FAB) 405.2640 ([M+H], 
C24H3705 requires 405.2640); LRMS (FAB) 405 (C24H3705), 313 (C17H3005), 91 
(C7117); 8H  (CDC13, 250MHz) 7.39-7.28 (5H, m, ArH), 5.15 (1H. t, J 6.9 Hz, 
CH=C(CH3)), 4.48 (211, s, PhCH20), 4.36 (1H, t, J 7.6 Hz, CH(CO2Et)2), 4.20-4.04 
(4H, m, 2 x CO9CH9CH3), 3.47 (211, td, J 7.2, 2.3 Hz, BnOCH2), 2.55 (2H, d, J 8.2 
Hz, CH2), 2.02-1.91 (3H, br m, CH2, CH), 1.52 (3H, s, CM3), 1.26-1.14 (7H, br m, 
CH3, 2 x CH2), 0.89-0.85 (6H, m, 2 x CH2 jj); 5c (CDC13, 63MHz) 172.2 and 
169.7 (C=O), 139.1 (qC), 131.6 (CM), 130.6 (qC), 128.8 (2 x ArCH), 128.0 (2 x 
ArCH), 127.9 (CH), 73.3, 69.1 and 61.3 (CH2), 43.6 (CH(CO2Et)2), 38.9, 37.4 and 
37.1 (CH2), 30.0 (H(CH3)), 25.9 and 25.8 (CH2), 19.9, 17.2, 14.5 and 14.4 (CH3); 
Vmax (film)/cm 2920 (CH), 1715 (OCO) and 1450 (Ph). 




LDA, THF, 0°C 
O2Et 
CO,Et 95% Bn 
- 
131 138 139 
A stirred solution of diethyl malonate, 138, (24.6 mg, 153.7 .tmol) in anhydrous THF 
(1.0 mL) was cooled to 0°C and treated with a 1.8 M solution of LDA in 1:1:1 
heptane/THF/ethylbenzene (80.0 p.L, 153.7 j.tmol). The reaction mixture was stirred 
for 45 minutes under an atmosphere of N2 at 0°C before the addition of 8-benzyloxy-
1-bromo-2,6-dimethyloct-2-ene, 131, (50.0 mg, 153.7 llmol). The reaction mixture 
was warmed to room temperature and stirred under an atmosphere of N2 for 16h. The 
solution was diluted with water (5.0 mL) and extracted with ethyl acetate (3 x 10.0 
mL), the organic layers were combined, washed with brine (15.0 mL), dried over 
anhydrous MgSO4, filtered and concentrated in vacuo to yield a yellow oil. This was 
purified by column chromatography on silica using petroleum ether:ethyl acetate, 
9:1, as the eluent to afford the product, 139, (59.1 mg, 95%) as a clear oil. Analytical 
data as above. 
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131 132 130 
A stirred solution of diethyl ethylidene malonate, 132, (172.0 mg, 922.5 lImo!) in 
anhydrous THF (5.0 mL) was treated with sodium ethoxide (62.7 mg, 922.5 Jmol). 
The reaction mixture was stirred for lh under an atmosphere of N2 at room 
temperature before the addition of 8-benzyloxy-l-bromo-2,6-dimethyloct-2-ene, 131, 
(200.6 mg, 614.7 J.Imol). The reaction mixture was stirred under an atmosphere of N2 
for 16h. The solution was diluted with water (5.0 mL) and extracted. with ethyl 
acetate (3 x 10.0 mL), the organic layers were combined, washed with brine (15.0 
mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield a 
yellow oil. The crude mixture was separated by column chromatography on silica 
using petroleum ether:ethyl acetate, 9:1, as the eluent but no product was isolated. 
Diethyl 12-benzyloxy-2-carbethoxy-6,10-dimethyldodec-2,6-dienoate, 130. 
CO2EI 
Bn 11 + . CO2Et BnO J 1 CO2Et 
131 132 130 
A stirred solution of diethyl ethylidene malonate, 132, (57.0 mg, 307.0 jtmol) in 
anhydrous THF (5.0 rnL) was was cooled to 0°C and treated with a 1.8 M solution of 
LDA in 1:1:1 heptane/THF/ethylbenzene (154.0 IlL, 307.0 jimol). The reaction 
mixture was stirred for 45 minutes under an atmosphere of N2 at 0°C before the 
addition of 8-benzyloxy-1-bromo-2,6-dimethyloct-2-ene, 131, (100.0 mg, 307.0 
lImo!). The reaction mixture was stirred under an atmosphere of N2 for 16h. The 
solution was diluted with water (5.0 mL) and extracted with ethyl acetate (3 x 10.0 
mL), the organic layers were combined, washed with brine (15.0 mL), dried over 
anhydrous MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The 
crude mixture was separated by column chromatography on silica using petroleum 
ether:ethyl acetate, 9:1, as the eluent but no product was isolated. 
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Diethyl 2-(8-benzyloxy-2,6-dimethyfoct-2-en-1-yl) malonate, 139. 
CO2Et 
Br + I NaH, DME, 0°C JJJ 
BnO CO2E- ---------------- BnO CO2Et 
131 138 139 
A stirred solution of diethyl malonate, 138, (49.2 mg, 307.0 .imo1) in anhydrous 
DME (3.0 mL) was cooled to 0°C and treated with a 60% dispersion of sodium 
hydride in mineral oil (4.7 mg, 184.0 p.mol). The reaction mixture was stirred at 0°C 
for 30 min under an atmosphere of N2 before the addition of 8-benzyloxy-1-bromo-
2,6-dimethyloct-2-ene; 131, (100.0 mg, 307.0 Jimol). The reaction mixture was 
gradually allowed to warm to room temperature and stirred under an atmosphere of 
N2 for 16h. The solution was diluted with water (5.0 mL) and extracted with ethyl 
acetate (3 x 10.0 mL), the organic layers were combined, washed with brine (15.0 
mL), dried over anhydrous MgSO4, filtered and concentrated in vacua to yield a 
yellow oil. The crude mixture was separated by column chromatography on silica 
using petroleum ether:ethyl acetate, 9:1, as the eluent but no product was isolated. 







131 138 139 
A stirred solution of diethyl malonate, 138, (24.6 mg, 154.0 p.mol) in anhydrous THF 
(3.0 mL) was cooled to 0°C and treated with a 1.6 M solution of BuLi in hexanes 
(50.0 IlL, 76.0 p.mol). The reaction mixture was stirred at 0°C for 30 min under an 
atmosphere of N2 before the addition of 8-benzyloxy-1-bromo-2,6-dimethyloct-2-
ene, 131, (50.0 mg, 154.0 pmol). The reaction mixture was gradually allowed to 
warm to room temperature and stirred under an atmosphere of N2 for 16h. The 
solution was diluted with water (5.0 mL) and extracted with ethyl acetate (3 x 10.0 
mL), the organic layers were combined, washed with brine (15.0 mL), dried over 
anhydrous MgSO4, filtered and concentrated in vacua to yield a yellow oil. The 
crude mixture was separated by column chromatography on silica using petroleum 
ether:ethyl acetate, 9:1, as the eluent but no product was isolated. 
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Diethyl 10-benzyloxy-2-carbethoxy-4,8-dimethyldec-2,4-dienoate, 140. 
CO2Et CO,Et 
CO2Et I COEt 
Bn 
 H + I AcOH, DCM 
104 138 140 
A stirred solution of 8-benzyloxy-2,6-dimethyl-2-octenal, 104, (200.0 mg, 768.0 
imol) and diethyl malonate, 138, (135.3 mg, 844.8 tmol) in anhydrous DCM (5.0 
mL) was treated with a solution of acetic acid (8.2 mg, 153.6 p.mol) and piperidine 
(13.0 mg, 153.6 j.tmol) in anhydrous DCM (3.0 mL). The reaction was stirred under 
an atmosphere of N2 at room temperature for 16h. The solution was concentrated in 
vacuo, the resulting residue dissolved in diethyl ether (10.0 mL) and washed with 
water (2 x 10,0mL). The organic layer was separated and washed with a saturated 
solution of NaHCO3 (2 x 10.0niL) and brine (10.0mL), dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude mixture 
was separated by column chromatography on silica using petroleum ether:ethyl 
acetate, 8:2, as the eluent but no product was isolated. 
Diethyl 12-benzyloxy-2-carbethoxy-6,10-dimethyldodec-2,4,6-trienoate, 141. 
CO2Et AcOH, DCM I CO2Et 
Bfl L1( H + CO2Et piperi thne -- Bn ' CO2Et 
1040 132 141 
A stirred solution of 8-benzyloxy-2,6-dimethyl-2-octenal, 104, (100.0 mg, 384.0 
jimol) and diethyl ethylidene malonate, 132, (78.7 mg, 422.0 1.tmol) in anhydrous 
DCM (5.0 mL) was treated with a solution of acetic acid (8.2 mg, 153.6 Jtmol) and 
piperidine (13.0 mg, 153.6 pmol) in anhydrous DCM (3.0 mL). The reaction was 
stirred under an atmosphere of N2 at room temperature for 16h. The solution was 
concentrated in vacuo, the resulting residue dissolved in diethyl ether (10.0 mL) and 
washed with water (2 x 10.0 mL). The organic layer was separated and washed with 
a saturated solution of NaHCO3 (2 x 10.0mL) and brine (10.0 mL), dried over 
anhydrous MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The 
crude mixture was separated by column chromatography on silica using petroleum 
ether:ethyl acetate, 8:2, as the eluent but no product was isolated. 
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104 138 140 
A stirred solution of diethyl malonate, 138, (67.6 mg, 422.0 tmol) in anhydrous THF 
(3.0 mL) was cooled to 0°C and treated with a 60% dispersion of sodium hydride in 
mineral oil (10.1 mg, 422.0 l.Lmol). The reaction mixture was stirred at 0°C for 45 
min under an atmosphere of N2 before the addition of a solution of 8-benzyloxy-2,6-
dimethyl-2-octenal, 104, (100.0 mg, 384.0 limo!) in anhydrous THF (3.0 mL). The 
reaction mixture was gradually allowed to warm to room temperature and stirred 
under an atmosphere of N2 for 16h. The solution was diluted with water (5.0 mL) and 
extracted with ethyl acetate (3 x 10.0 mL), the organic layers were combined, 
washed with brine (15.0 mL), dried over anhydrous MgSO4, filtered and 
concentrated in vacuo to yield a yellow oil. The crude mixture was separated by 
column chromatography on silica using petroleum ether:ethyl acetate, 9:1, as the 
eluent but no product was isolated. 
Diethyl 10-benzyloxy-2-carbethoxy-4,8-dimethyldec-2,4-dienoate, 140. 
CO ,Et 2 t
+ CO2Et pipedine 
Bn11 Benzoic acid 
CO2E1 
0 toluene 104 138 140 
A stirred solution of 8-benzyloxy-2,6-dimethyl-2-octenal, 104, (100.0 mg, 384.0 
limol) and diethyl malonate, 138, (29.0 p.L, 188.0 limo!)  in anhydrous toluene (5.0 
mL) was treated with a solution of benzoic acid (0.9 mg, 7.7 limol)  and piperidine 
(11.0 RL, 11.5 limol)  in anhydrous toluene (1.0 mL). The reaction was heated at 
reflux under an atmosphere of N2 in a Dean-Stark apparatus for 16h. The solution 
was allowed to cool to room temperature and diluted with toluene. The organic layer 
was washed with water (2 x 10.0 mL), a saturated solution of NaHCO3 (2 x 10.0 mL) 
and brine (10.0 mL), dried over anhydrous MgSO4, filtered and concentrated in 
vacua to yield a brown oil. The crude mixture was separated by column 
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chromatography on silica using petroleum ether:ethyl acetate, 8:2, as the eluent but 
no product was isolated. 
Diethyl 10-benzyloxy-2-carbethoxy-4,8-dimethyldec-2,4-dienoate, 140. 
CO,Et CO2E1 
H + I AcOH 




A stirred solution of 8-benzyloxy-2,6-dimethyl-2-octenal, 104, (100.0 mg, 384.0 
p.mol) and diethyl malonate, 138, (52.4 jiL, 345.0 p.mol) in anhydrous toluene (5.0 
mL) was treated with a solution of acetic acid (4.2 IlL, 69.0 jimol) and morpholine 
(1.2 [tL, 13.8 Ilmol) in anhydrous toluene (1.0 mL). The reaction was heated at reflux 
under an atmosphere of N2 in a Dean-Stark apparatus for 16h. The solution was 
allowed to cool to room temperature and diluted with toluene. The organic layer was 
washed with water (2 x 10.0 mL), a saturated solution of NaHCO3 (2 x 10.0 mL) and 
brine (10.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
yield a dark yellow oil. The crude mixture was separated by column chromatography 
on silica using petroleum ether:ethyl acetate, 9:1, as the eluent but no product was 
isolated. 
Diethyl 2-(8-benzyloxy-2,6-dimethyloct-2-en-1-yl) malonate, 139. 
CO 
BnO 1 
allyl palladium chloride dimer BnO'
O2El 
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Ph3P, diethyl malonate 
BSTFA, KOAc 139 
A solution of allyl palladium chloride dimer (0.8 mg, 2.17 Ilmol)  and 
triphenyiphosphine (1.4 mg, 5.43 Ilmol) in anhydrous DCM (2.0 mL) was stirred at 
room temperature under an atmosphere of N2 for lh. A solution of 8-benzyloxy-2,6-
dimethyloct-2-en-1-yl acetate (66.1 mg, 217.0 j.unol) in anhydrous DCM (2.0 mL) 
was added and the reaction mixture was cooled to -20°C before the addition of 
diethyl malonate, 138, (98.9 IlL,  652.0  Ilmol),  BSTFA (173.2 IlL,  652.0  Ilmol)  and 
potassium acetate (0.2 mg, 2.17 j.tmol). The reaction was stirred at -20°C for 10h and 
then quenched by the addition of a saturated solution of ammonium chloride (6.0 
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mL). The organic layer was separated, washed with water (2 x 10.0 mL), a saturated 
solution of NaHCO3 (2 x 10.0 mL) and brine (10.0 mL), dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to yield a dark yellow oil. The crude 
mixture was separated by column chromatography on silica using petroleum 
ether:ethyl acetate, 9:1, as the eluent but no product was isolated. 
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4.3. Synthesis of lipid-linked monosaccharide and disaccharide. 
3,7,11,15-Tetramethylhexadecan-1-ol (Phytanol), 93•35 
OH 
146 
H2, PVC  




A stirred solution of 3,7,11,15-tetramethylhexadec-2-en-1-ol, 146, (2.0 g, 6.7 mmol) 
in anhydrous methanol (20.0 mL) was treated with finely divided 5% platinum on 
charcoal (288.0 mg) as catalyst and placed under an atmosphere of N2. The system 
was evacuated and flushed with hydrogen. This process was repeated twice and the 
reaction mixture was then allowed to stir under an atmosphere of hydrogen for 3.5h. 
The solution was filtered through a pad of celite, which was washed well with 
methanol (3 x 20.0mL). The combined filtrate and washings were concentrated in 
vacuo to give a pale yellow oil. This was purified by column chromatography on 
silica using petroleum ether:ethyl acetate, 6:4, as the eluent to afford the product, 93, 
(1.7 g, 86%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.47; HRIVIS (FAB) 297.3153 ([M], C20H410 
requires 297.3157); LRMS (FAB) 297 (C2011410); 8H (CDC13, 250MHz) 3.96-3.83 
(2H, in, Cfl2OH), 1.86-1.67 (4H, m, 2 x CH2), 1.63-1.24 (21H, m, S x CH2, 4 x CH, 
OH), 1.11-1.03 (15H, m, 5 x CH3); 8C (CDCI3, 63MHz) 61.4 (CH20H), 40.2 and 
40.1 (CH2), 39.5 (2 x CH2), 37.6, 37.5 and 37.4 (CH2), 32.9 (2 x CH), 29.7 and 28.1 
(CH), 24.9, 24.6 and 24.5 (CH2), 22.9 (2 x CH3), 22.8, 19.9 and 19.8 (CH3); Vm 
(film)/cm 3615 (OH), 2927, 2869 (CH). 
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Di-tert-butyl 3,7,11,15-Tetramethyihexadecyl phosphate (Di-tert-butyl phytanyl 





mCPBA, DCM, 65% 
0 
II 
P o1 OBu 
147 OBu 
A stirred solution of 3,7,11,15-tetramethylhexadecan-1-ol, 93, (1.6 g, 5.4 mmol) in 
anhydrous THF (20.0 mL) was treated with NN'-di-tert-butyl 
diisopropylphosphoramidite (3.8 mL, 12.1 mmol) and 1-H-tetrazole (1.2 g, 17.2 
mmol). A white precipitate developed and the resulting solution was stirred at room 
temperature for 3h. The reaction mixture was cooled to 0°C in an ice bath and treated 
with a solution of mCPBA (3.3 g, 19.3 mmol) in anhydrous DCM (20.0 mL). The 
reaction mixture was gradually allowed to warm to room temperature and stirred 
under N2 for lh. The clear, pale blue reaction mixture was treated with a saturated 
solution of sodium sulfite (30.0 mL) and stirred for 30min under N2. The solution 
was diluted with DCM (30.0 mL), the aqueous layer separated and extracted with 
DCM (2 x 15.0mL). The organic extracts were combined, washed with a saturated 
solution of NaHCO3 (2 x 30.0mL) and brine (30.0mL), dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to yield a yellow oil. This was purified by 
column chromatography on silica using petroleum ether:ethyl acetate, 8:2, as the 
eluent to afford the product, 147, (1.7 g, 65%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 8:2) 0.30; HRMS (FAB) 491.4226 ([M+H], 
C28H6001P requires 491.4229); LRMS (FAB) 491 (C28H6004P), 435 (C24H5204P), 
379 (CoHOP); 5H (CDC13, 250MHz) 4.11-4.02 (214, m, CH20P), 1.85-1.65 (4H, 
in, 2 x CH2), 1.55 (18H, s, 2 x C(CI-j)3), 1.36-1.27 (20H, br m, 4 x CH, 8 x CH2), 
0.99-0.90 (15H, m, 5 x CH3); & (CDC13, 63MHz) 81.8 and 81.7 (Q(CH3)3), 65. 1, 
65.0, 60.3 and 39.2 (CH2), 37.2 (2 x CH2), 37.1 (CH2), 32.6 (CH), 29.8 (2 x CH), 
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29.1 (CH), 27.8, 24.6, 24.3 and 24.2 (CH2), 22.6 (3 x CH3), 22.5, 21.8 and 20.9 
(CH3), 19.6 (3 x CH3), 19.3 and 14.1 (CH3); 5p (CDC13,  101MHz) —8.4 (s, P=O); Vm 
(film)/cm-1 2983, 2956, 2928 (CH), 1172 (P=O), 1039 (P-0-C). 
3,7,11,15-Tetramethyihexadecyl phosphate (Phytanyl phosphate), 35 
LJJ 







A stirred solution of di-tert-butyl 3,7,11,15-tetramethyihexadecyl phosphate, 147, 
(0.7 g, 1.4 mmol) in anhydrous DCM (5.0 mL) was treated with TFA (2.1 mL, 27.7 
mmol) and stirred under N2 for 30 mm. The reaction mixture was concentrated in 
vacuo to yield a colourless oil. This residue was dissolved in a 2:1 mixture of 
anhydrous DCM : MeOH (9.0 mL) and treated with triethylamine (3.0 mL, 27.7 
mmol). The reaction mixture was stirred for 10 min under N2 then concentrated in 
vacuo and azeotroped with anhydrous toluene (3 x 30.0 mL) to afford the product, 
98, (0.4 g, 83%) as a colourless oil. 
Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.76; HRMS (FAB) 
401.2800 ([M+Na}, C20H4304PNa requires 401.2797); LRMS (FAB) 410 
(C201-14304PNa); 8H (CDC13, 250MHz) 3.94-3.82 (2H, m, CH20P), 1.61-1.39 (4H, m, 
2 x CH2), 1.31-0.97 (20H, br m, 4 x CH, 8 x CH2), 0.81-0.75 (15H, m, 5 x CH3); SC 
(CDC13, 63MHz) 63.8 (CH20P), 45.4 (2 x CH2), 39.2 (2 x C112), 37.4 and 37.3 
(CH2), 37.2 (2 x CH2), 32.7 (2 x CH), 29.3 and 27.8 (CH), 24.7 and 24.4 (CH2), 22.5, 
19.5, 19.3, 19.2 and 18.9 (CH3); 5p (CDC13, 101MHz) 3.0 (s, P=O); Vmax (film)/cm-1  
2986, 2956, 2928 (CH), 1152 (P=O), 1013 (P-OH). 
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2-Acetamido-3,4,6-tri-O-acetyi-2-deoxy-3-n-gJucopyranosyl-(1-4)-2-acetamido-
3,6-di-O-acetyl-2-deoxy-a-D-glucopyranose (chitobiose heptaacetate), 70.82 
OAc OAc 
OAc OAc 
Me2NH, DMF, 0°C 






70 71 OH 
A stirred solution of chitobiose octaacetate, 70, (1.0 g, 1.5 mmol) in anhydrous DMF 
(10.0 mL) was cooled to 0°C under Ar and treated with a 2 M solution of 
dimethylamine (10.0 mL, 20.0 mmol) in THE The reaction mixture was stirred at 
0°C for lh under Ar and then allowed to gradually warm to room temperature. A 
second aliquot of the 2 M dimethylamine solution (10.0 mL, 20.0 mmol) was added 
and the reaction was stirred at room temperature under Ar for 16h. The reaction 
mixture was concentrated in vacuo to yield a yellow solid which was crystallised 
from DCM and petroleum ether to give the product, 71, (0.9 g, 99%) as a white solid. 
Rf (DCM:MeOH, 9:1) 0.27; Mp 240.1-242.5 °C (Lit 245.0-247.0 0082); [a]0 —23.40 
(c 1.0, CHCI3) (Lit [(X]0 —30.00 (c 1.0, CHC13)82); HRMS (FAB) 635.2299 ([M+H], 
C26H39016N2 requires 635.2299); 5H  (CDC13, 250MHz) 5.54 (1H, dd, J3',2'  10.3 Hz, 
J3.,4. 9.5 Hz, H3'), 5.18 (1H, d, J12 3.6 Hz, Hi'), 5.10 (1H, dd, J3,2 10.1 Hz, J3,4 9.0 
Hz, H3), 4.59 (11-1, d, J1,2 8.3 Hz, Hi), 4.48 (1H, dd, JH6a-H6b  12.6 Hz, JH6bH5  4.1 Hz, 
1-16b), 4.43 (iH, dd, JH6a'.H6b'  12.2 Hz, JH6a'HS'  3.8 Hz, 146a'), 4.35-4.28 (1H, m, H5), 
4.26 (1H, dd, J116b-H6a  12.6 Hz, JH6a-H5  3.2 Hz, H6a), 4.19 (111, dd, J2',I'  3.6 Hz, J2',3' 
10.3 Hz, H2'), 4.07 (1H, dd, J4,3 9.0 Hz, J4,5 9.9 Hz, H4), 4.05-3.99 (1H, m, H5'), 
3.96 (111, dd, J2,1 8.3 Hz, J2,3 10.1 Hz, H2), 3.74 (1H, dd, JH6a'H6b'  12.2 Hz, JH6b'-H5' 
9.4 Hz, H6b'), 3.70-3.64 (1H, m, H4'), 2.15-1.93 (21H, m, 7 x COCH3); 8C (CDC13, 
63MHz) 172.5, 172.4, 171.9, 171.7, 171.6, 171.1 and 169.6 (CO), 101.9, 91.4, 76.3, 
72.1, 71.6, 71.0, 68.2 and 68.0(CH), 63.0 and 61.7 (CH2), 53.8 and 51.9 (CH), 23.9 
(CH3), 22.8 (2 x CH3), 20.9 (3 x CH3), 20.7 (CH3); Vmax (film)/cm' 3374 (OH), 2986 
(CH), 1742 (OC=O), 1674 (N-C=O) and 1092 (C-0-C). 
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2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-f3-D-glucopyranosyl-(1-4)-2-acetamjdo.. 





















A stirred solution of 2-acetamido-3 ,4,6-tri-O-acetyl-2-deoxy--D-glucopyranosy1-( 1-
4)-2-acetamido-3 ,6-di-O-acetyl-2-deoxy-ct-D-glucopyranose, 71, (349.5 mg, 0.6 
mmol) in anhydrous THF (5.0 mL) was cooled to -78°C and treated with a 1.8 M 
solution of LDA in 1:1:1 heptane/THF/ethylbenzene (0.4 mL, 0.8 mmol). The 
reaction mixture was stirred under Ar for 45 min whereupon a solution of tetrabenzyl 
pyrophosphate (0.4 g, 0.8 mmol) in anhydrous THF (5.0 mL) was added. The 
solution was stirred at -78°C for 4h under Ar after which time it was gradually 
allowed to warm to room temperature. The reaction was concentrated in vacuo to 
yield a white residue. This was purified by column chromatography on silica using 
DCM:MeOH, 24:1, as the eluent to afford the product, 72, (322.8 mg, 66%) as a 
white solid. 
Rf (DCM:MeOH, 9:1) 0.59; Mp 146.2-148.7 °C (Lit 139.0-141.0 0C38); [(]D —11.0°  
(c 1.4, CRC13) (Lit [aID -15.0 ° (c 1.1, CHC13)82); HRMS (FAB) 895.2906 ([M+H], 
C40H52019N2P requires 895.2902); CHN found %C 53.59, %H 5.68, %N 3.09 
(required %C 53.69, %H 5.7 1, %N 3.13); 81, (CDC13, 250MHz) 7.32-7.24 (10H, m, 
ArH), 5.83 (114, dd, J3',4' 9.6 Hz, 9.3 Hz, H3'), 5.51 (114, dd, JHI'P 5.9 Hz, J1',2. 
3.4 Hz, Hi'), 5.07 (111, dd, J2,3 10.3 Hz, J3,4 9.0 Hz, 113), 4.99-4.87 (5H, m, 114, 2 x 
POCH2), 4.44 (1H, d, J1,2 8.3 Hz, Hi), 4.27 (1H, dd, J146a-H6b  12.7 Hz, JH6bH5  4.3 Hz, 
H6b), 4.18 (1H, dd, JH6a'H6b' 12.1 Hz, JH6a'-H5'  2.9 Hz, H6a'), 4.11 (1H, dd, J2,,i , 3.4 
Hz, J2',3' 9.3 Hz, H2'), 3.94 (1H, dd, JH6a145b  12.7 Hz, JH6a-H5 2.2 Hz, 146a), 3.83-3.79 
(1H, m, H5'), 3.73 (1H, dd, J2,1 8.3 Hz, J2,3 10.3 Hz, 1-12), 3.62 (1H, d, J4',5' 9.8 Hz, 
J3.. 9.6 Hz, H4'), 3.54-3.50 (1H, in, 1-15), 3.49-3.45 (1H, m, H6b'), 1.96-1.86 (15H, 
in, 5 x COCH3), 1.82 and 1.58 (2 x 311, 2 x s, 2 x COCH3); & (CDC13, 63MHz) 
170.9, 170.8, 170.6, 170.4 (CO), 170.2 (2 x CO), 169.2 (CO), 135.1 and 135.0 (ArC), 
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128.8 (2 x ArCH), 128.7 (2 x ArCH), 128.6 (2 x ArCH), 128.0 (2 x ArCH), 127.9 (2 
x ArCH), 101.1, 95.9, 75.5, 72.3, 71.8, 70.5 and 70.0 (CH), 69.9 and 69.8 (CH2), 
67.8 (CH), 61.5 and 61.1 (CH2), 54.7 and 51.7 (CH), 23.1, 22.6, 20.8 (CH3), 20.6 (2 
x Cl3), 20.5 (2 x CH3); 8p (CDC13, 101MHz) 0.0 (s, P=O); Vmax (film)/cm' 2986 
(CH), 1744 (OC=O), 1604 (N-CO) and 1156 (P-0-C). 
2-Acetamido-3,4,6-tri-O-acety1-2-deoxy-J-D-g1ucopyranosyJ-(1-4)-2-acetamido-





2:1 MeOH:DCM Ac 
AcNH AcNH 
AC AcNH II 96% ArNH 11 
72 ° 'OBn 73 
OBn OH 
A stirred solution of 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy--D-glucopyranosyl-( 1-
4)-2-acetamido-3 ,6-di-O-acetyl-2-deoxy-ct-n-glucopyranosyl phosphate dibenzyl 
ester, 72, (469.0 mg, 0.5 mmol) in a 2:1 mixture of anhydrous MeOH:DCM (15.0 
mL) was treated with finely divided 10% palladium on charcoal (168.0 mg) as 
catalyst and placed under an atmosphere of N2. The system was evacuated and 
flushed with hydrogen. This process was repeated twice and the reaction mixture was 
then allowed to stir under an atmosphere of hydrogen for 3.5h. The solution was 
filtered through a pad of celite, which was washed well with MeOH (3 x 20.0 mL). 
The combined filtrate and washings were concentrated in vacuo to give a pale yellow 
solid. This was azeotroped with anhydrous toluene (3 x 15.0 mL) and dried under 
high vacuum to afford the product, 73, (369.8 mg, 96%) as a white solid. 
Rf (DCM:MeOH, 9:1) 0.29; Mp 184.5-186.7 °C; [a]D  22.4° (c 1.0, CHC13); HRMS 
(FAB) 737.1781 ([M+Na], C26H39019N2PNa requires 737.1783); 5H  (CDC13, 
250MHz) 5.39 (2H, br s, P(OH)2), 5.15 (1H, dd, J3,2 9.8 Hz, J3,4 9.3 Hz, 113), 5.05 
(1H, dd, J3',2' 10.5 Hz, J3',' 9.3 Hz, H3'), 4.96 (111, dd, JHI',p  10.8 Hz, J1',2'  3.8 Hz, 
Hi'), 4.90 (111, dd, J3,4 9.3 Hz, J4,5 9.7 Hz, H4),4.55-4.50 (1H, m, H6b'), 4.44 (1H, 
d, .11,2 8.4 Hz, Hi), 4.30 (1H, dd, JH6a-H6b  12.3 Hz, JH6bH5  3.8 Hz, H6b), 4.26 (1H, dd, 
J3',4' 9.3 Hz, J4 ,5 9.9 Hz, 114'), 4.17-4.10 (1H, br m, 116a'), 4.01 (1H, dd, .12',3'  10.5 
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Hz, J2 ,1 3.8 Hz, H2'), 3.91 (1H, dd, JH6a-H6b  12.3 Hz, JH6aH5  2.1 Hz, H6a), 3.83 (1H, 
dd, J2,3 9.8 Hz, J2,1 8.4 Hz, H2), 3.54-3.50 (1H, m, 115), 3.39-3.26 (1H, m, H5'), 2.02, 
1.97, 1.94, 1.93, 1.92, 1.90 and 1.80 (7 x 311, 7 x s, 7 x COd 3); 6c  (CDCI3, 63MHz) 
177.5, 177.1, 176.6, 176.4 and 176.2 (CO), 175.3 (2 x CO), 106.1, 80.8, 77.9, 77.6, 
76.9, 76.2, 75.1 and 73.8 (CH), 67.2 (CH2), 60.2 and 57.1 (CH), 51.6 (CH2), 27.9 (2 
x Cl3), 27.7 (2 x CH3), 25.8 (3 x CH3); 8P  (CDC13, 101MHz) 0.0 (s, P=O); Vm 











73 ° OH 
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3. Phytanyt phosphate, DCM 
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A stirred solution of 2-acetamido-3 ,4,6-tri-O-acety1-2-deoxy-f-D-g1ucopyranosy1-( 1-
4)-2-acetamido-3 ,6-di-O-acetyl-2-deoxy-a-n-glucopyranosyl phosphate, 73, (150.0 
mg, 0.2 mmol) in anhydrous methanol (4.0 mL) was treated with triethylamine (0.8 
mL, 0.6 mmol). The reaction mixture was stirred under N2 at room temperature for 5 
mm, then concentrated and evaporated with anhydrous toluene (3 x 3.0 mL). The 
resulting pale yellow residue was dissolved in anhydrous DMF (3.0 mL) and treated 
with a solution of NN'-carbonyldiimidazole (188.0 mg, 1.2 mmol) in anhydrous 
DMF (3.0 mL). The reaction mixture was stirred under N2 at room temperature for 
4.5h. Anhydrous methanol (80.0 [LL) was added to the reaction, which was stirred 
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under N2 at room temperature for 30 mm. The reaction mixture was then treated with 
a solution of phytanyl phosphate, 98, (142.0 mg, 0.3 mmol) in anhydrous DCM (2.0 
mL) and the reaction mixture was stirred under N2 at room temperature for 3.5 days 
after which time the solution was concentrated in vacuo to yield a yellow residue. 
This was purified by column chromatography on silica using DCM:MeOH:H20, 
8:2:0.4, as eluent to afford the product, 74, (165.8 mg, 73%) as a white solid. 
R1 (DCM:MeOH:H20:2M aq NH4}TC03, 6.5:3.5:0.4:0.4) 0.53; HRMS (FAB) 
1097.4560 ([M+Na], C46H80022N2P2Na requires 1097.4576); 5H  (CDC13, 250MHz) 
5.61-5.53 (111, in, CH), 5.39-5.30 (2H, in, 2 x CH), 5.27-5.19 (1H, in, CH), 4.97-4.89 
(1H, m, CH), 4.70-4.50 (111, in, CH), 4.34-4.20 (211, in, 2 x CH), 3.99-3.82 (4H, in, 
POCH2, 2 x CH), 3.75-3.60 (2H, m, 2 x CH), 3.58-3.50 (2H, m, 2 x CH), 1.96-1.77 
(21H, br in, 7 x COd 3), 1.44-1.38 (611, m, 3 x CH2), 1.18-1.00 (18H, m, 4 x CH, 7 
x CH2) and 0.79-0.70 (15H, in, 5 x CH3); 8p (CDC13, 101MHz) -8.1 (s, PO) and - 
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A stirred solution of Pj-phytanyl-P2- [2-acetamido-3 ,4,6-tri-O-acetyl-2-deoxy--D-
glucopyranosyl-( 1-4)-2-acetamido-3 ,6-di-O-acetyl-2-deoxy-a-n-glucopyranosyl}- 
pyrophosphate, 74, (47.0 mg, 43.7 .tmol) in anhydrous DCM (2.0 mL) and 
anhydrous methanol (1.0 mL) was cooled to 0°C and treated with triethylamine (0.6 
mL). The reaction was stirred under N2 for 5 min and then concentrated in vacuo. 
The resulting residue was azeotroped with anhydrous toluene (3 x 3.0 mL) and then 
re-dissolved in anhydrous DCM (2.0 mL) and anhydrous methanol (1.0 mL). The 
reaction was cooled to 0°C, treated with 0.5 M sodium methoxide solution (0.4 mL, 
0.2 mmol) and stirred under N2 for 15 mm. The reaction mixture was passed through 
a H Dowex AG50W-X8 ion exchange resin, which was then washed with 
anhydrous methanol (7 x 1.0 mL). The combined filtrate and washings were 
concentrated in vacuo and azeotroped with anhydrous toluene (3 x 3.0 mL). The 
resulting residue was dissolved in anhydrous DCM (2.0 mL) and anhydrous 
methanol (1.0 mL) and cooled to 0°C, treated with triethylamine (0.6 mL) and stirred 
under N2 for 5 mm. The solution was concentrated in vacuo and azeotroped with 
anhydrous toluene (3 x 3.0 mL) to afford the product, 75, (14.1 mg, 37%) as a white 
solid. 
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Rf (DCM:MeOH:1120:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.27; HRMS (FAB) 
887.4049 ([M+Naf, C36H70017N2P2Na requires 887.4048); 6H  (CDC13, trace MeOD, 
250MHz) 11.61-11.55 (214, in, 2 x CH), 11.47-11.38 (2H, in, 2 x CH), 8.11-8.06 
(2H, m, 2 x CH), 7.95-7.57 (911, br m, 5 x OH, 4 x CH), 7.27-7.22 (2H, m, 2 x CH), 
5.99-5.82 (2H, m, 2 x CH), 5.63-5.52 (2H, in, Cl2), 5.46-5.30 (211, m, CH2), 5.22-
5.06 (18H, br in, 4 x CH, 7 x CH2), 5.04-4.89 (4H, m, 2 x CH2), 4.81-4.68 (15H, m, 5 
x CH3), 3.95 (6H, s, 2 x COCH3); 5p (CDC13, 250MHz) -8.4 (s, P=O) and —11.8 (s, 
P=O); Vmax (film)/cm 3279 (OH), 2986, 2961, 2927 and 2855 (CH), 1653 (N-C=O), 
1096 (P-0-C) and 1014 (P-O-P). 





MeCN, -1 5'C ONO, 
13% N3 
149 150 
A stirred solution of tri-O-acetyl-D-glucal, 149, (2.0 g, 7.4 mmol) in anhydrous 
acetonitrile (50.0 mL) was cooled to —15°C and treated with ceric ammonium nitrate 
(14.7 g, 26.8 mmol) and sodium azide (0.7 g, 11.0 mmol). The reaction mixture was 
stirred at —15°C for 6h and then at room temperature for 16h under an atmosphere of 
N2. The reaction mixture was poured onto ice-water (30.0 mL) and the resulting 
solution was extracted with diethyl ether (3 x 30.0 mL). The organic extracts were 
combined, washed with brine (50.0 mL), dried over anhydrous MgSO4, filtered and 
concentrated in vacuo to give a yellow syrup. This was purified by column 
chromatography on silica using petroleum ether:ethyl acetate, 6:4, as the eluent to 
afford the product, 150, (3.5 g, 13%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.65; HRMS (FAB) 377.0944 ([M+H], 
C12H17010N4 requires 377.0945); LRMS (FAB) 377 (C121117010N4), 314 
(C12H1607N3), 273 (C10H1506N3); 6H  (CDC13, 250MHz) 6.23 (1H, d, J1,2 1.9 Hz, 
111cc), 5.63 (111, ci, f 1,2 8.8 Hz, H1f3), 5.42 (1H, dd, J4,3 9.9 Hz, J4,5 9.7 Hz, H40), 
5.34 (114, dd, JH6aH6b  13.3 Hz, JH6a.H5  2.8 Hz, Map), 5.28 (1H, dd, JH6b-H6a  13.3 Hz, 
146 
.JFl6b-H5 3.9 Hz, H6b13), 5.18 (1H, dd, J3,2 9.9 Hz, J3,4 9.9 Hz, H3), 5.15 (1H, dd, J4,3  
9.7 Hz, J4,5 9.4 Hz, H4ct), 5.07 (1H, dd, J3,2 9.9 Hz, J3,4 9.7 Hz, H3ct), 4.37 (1H, dd, 
"H6b-H6. 13.4 Hz, .JH6b-H5 4.2 Hz, H6ba), 4.29 (1H, dd, JH6a-H6b  13.4 Hz, JH6a-H5  2.1 Hz, 
Mau), 4.26-4.20 (2H, in, 2 x H5), 3.91-3.87 (1H, m, H2a), 3.71 (1H, dd, J12 8.8 Hz, 
J2,3 9.9 Hz, H2), 2.14, 2.11, 2.09, 2.07, 2.06 and 2.05 (6 x 3H, 6 x s, 6 x COCH3); 
c (CDC13, 63MHz) 170.9, 170.8, 170.2, 170.1, 169.9 and 169.7 (CO), 98.1, 97.5, 
96.7, 95.5, 73.3, 71.6, 70.8, 67.9 and 65.2 (CH), 61.8 and 61.6 (CH2), 59.2 (CH), 
21.4, 21.1, 21.0, 20.9, 20.8 and 20.7 (CH3). 
2-Azido-3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranose, 151.132 
OAc OAc 
AcO ONO dxane, 80°C 
NaNO,, H20 AcO ° 
Ac Ac 
N, 63% N, 
150 151 OH 
A stirred solution of 2-azido-3,4,6-tri-O-acetyl-2-deoxy-D-glucopyranosyl nitrate, 
150, (0.6 g, 1.6 mmol) in dioxane (10.0 mL) was treated with a solution of sodium 
nitrite (0.33 g, 4.8 mmol) in water (3.0 mL). The reaction mixture was stirred at 80°C 
for 6h and then poured onto ice-water (20.0 mL). The resulting solution was 
extracted with diethyl ether (3 x 15.0 mL). The organic extracts were combined, 
washed with a saturated solution of NaHCO3 (20.0 mL) and brine (20.0 mL), dried 
over anhydrous MgSO4, filtered and concentrated in vacuo to give a yellow oil. This 
was purified by column chromatography on silica using petroleum ether:ethyl 
acetate, 6:4, as the eluent to afford the product, 151, (0.3 g, 63%) as a clear oil. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.27; HRMS (FAB) 332.1104 ([M-i-H], 
C12H1808N3 requires 332.1094); LRMS (FAB) 354 (C12Hi708N3Na), 332 
(C12H1808N3), 306 (C12H1908N), 43 (C2H30); 5H  (CDC13, 250M1-[z) 5.51 (1H, dd, 
J3,2 10.0 Hz, J34 9.3 Hz, H3), 5.42 (1H, d, J1,2 3.7 Hz, Hi), 5.37-5.30 (1H, m, H4), 
5.24 (1H, br s, OH), 4.27 (1H, dd, J2,1 3.7 Hz, J2,3 10.0 Hz, H2), 4.18 (1H, dd, JH6 
H6a 12.7 Hz, JH6b-H5  4.1Hz, H6b), 4.04 (1H, dd, JH6a-Mb  12.7 Hz, JH6aH5  1.8 Hz, H6a), 
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3.92-3.87 (1H, m, H5), 2.09, 2.06 and 2.02 (3 x 311, 3 x s, 3 x COCH3); öc (CDC13, 
63MHz) 170.9, 170.0 and 169.6 (CO), 91.9, 71.7, 70.3, 68.3 and 62.2 (CH), 61.7 
(CH2), 20.9, 20.6 and 20.4 (CH3). 










'NOBI 151 OH 158  
OBn 
A stirred solution of 2-azido-3 ,4,6-tri-O-acetyl-2-deoxy-a-o-glucopyranose, 151, 
(40.3 mg, 121.0 j.tmol) in anhydrous THF (5.0 mL) was cooled to -78°C and treated 
with a 1.8 M solution of LDA in 1:1:1 heptane/THF/ethylbenzene (85.6 .tL, 169.0 
prnol). The reaction mixture was stirred under Ar at -78°C for 45 min after which 
time a solution of tetrabenzylpyrophosphate (90.5 mg, 169.0 Jimol) in anhydrous 
THF (2.0 mL) was added. The solution was stirred at -78°C under Ar for a further 4h 
and then concentrated in vacuo to give a brown solid. The crude mixture was 
separated by column chromatography on silica using 4% MeOH in DCM as eluent 
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152 151 OH 
OBu 
A stirred solution of 2-azido-3,4,6-tri-O-acetyl-2-deoxy-cc-D-glucopyranose, 151, 
(79.0 mg, 240.0 j.tmol) in anhydrous DCM (5.0 mL) was treated with 1-H-tetrazole 
(0.1 g, 107.0 Rmol) and NN'-di-tert-butyl diethyiphosphoramidite (169.3 j.iL, 540.0 
J.tmol). A white precipitate developed and the resulting solution was stirred at room 
temperature for 3h. The reaction mixture was cooled to 0°C in an ice bath and treated 
with a solution of mCPBA (0.2 g, 860.0 j.tmol) in anhydrous DCM (5.0 mL). The 
reaction mixture was gradually allowed to warm to room temperature and stirred 
under N2 for lh. The clear, pale blue reaction mixture was treated with a saturated 
solution of sodium sulfite (15.0 mL) and stirred for 30 min under N2. The solution 
was diluted with DCM (15.0 mL), the aqueous layer separated and extracted with 
DCM (2 x 15.0 mL). The organic extracts were combined, washed with a saturated 
solution of NaHCO3 (2 x 30.0 mL) and brine (30.0 mL), dried over anhydrous 
MgSO4, filtered and concentrated in vacuo to yield a yellow oil. The crude mixture 
was separated by column chromatography on silica using petroleum ether:ethyl 
acetate, 8:2, as the eluent but no product was isolated. 
2-Acetamido-1,3,4,6-tetra-0-acetyl-2-deoxy-ct-D-glucopyranose, 160.103 
AC 




OH 100%  ~
Ac AcNH 
159 160 OAc 
A stirred solution of N-acetyl-D-glucosamine, 159, (25.0 g, 0.1 mol) in acetic 
anhydride (107.0 mL) was treated with pyridine (56.0 mL) and the reaction mixture 
was stirred under Ar at room temperature for 16h. The pale yellow solution was 
concentrated in vacua to yield a clear syrup. This was azeotroped with toluene (3 x 
40.0 mL) and dried under high vacuum to give the product, 160, (44.2 g, 100%) as a 
white foam. 
R1(6% MeOH in DCM) 0.36; Mp 127.0-129.3 °C (Lit. 136.0-137.0 °C133) [aID 85.40 
(c 1.2, C11C13); FIRMS (FAB) 390.1405 ([M+H], C16H24010N requires 390.1400); 
LRMS (FAB) 412 (C16H230joNNa), 390 (C16H24010N), 330 (C14H2008N), 43 
(C2H30); CHN found %C 49.33, %H 5.76, %N 3.34 (required %C 49.36, %H 5.91, 
%N 3.59); 5H  (CDC13, 250MHz) 6.29 (1H, d, J1,2 3.6 Hz, Hi), 5.80 (1H, br d, J 9.1 
Hz, NH), 5.37-5.32 (2H, in, H3, H4), 4.62-4.60 (1H, in, H2), 4.38 (1H, dd, JH6bU6a 
12.4 Hz, JH6b-H5  4.0 Hz, H6b), 4.20 (1H, d, .Jl-i6a-H5 2.3 Hz, H6a), 4.17-4.08 (1H, m, 
H5), 2.32, 2.21, 2.18, 2.16 and 2.06 (5 x 3H, 5 x s, 5 x COCH3); 3c  (CDC13, 63MHz) 
172.1, 171.2, 170.4, 169.5 and 169.1 (CO), 91.1, 71.7, 70.1 and 67.8 (CH), 61.6 
149 
51.4 (CH), 23.5, 21.4, 21.1, 20.9 and 20.7 (CH3); Vmax (film)/cm' 2987 (CH), 
1752 (OC=O), 1687 (N-C=O) and 1604 (NH). 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranose, 161.103 
OAc OAC 
ACO q (NH4)2CO3  o. AcO Q 
MeOH, THE ACO 
 
AcNH 50% AcNH 
160 OAc 161 OH 
A stirred solution of 2-acetamido- 1,3 ,4,6-tetra-O-acetyl-2-deoxy-a-D-glucopyranose, 
160, (22.3 g, 57.3 mmol) in 2:1 anhydrous methanol:THF (180.0 mL) was treated 
with ammonium carbonate (22.6 g, 300.0 mmol). The reaction mixture was stirred 
under Ar at room temperature for 16h. The white solution was then concentrated in 
vacuo and the resulting yellow oil dissolved in DCM (50.0 mL). This solution was 
washed with water (3 x 40.0 mL) and brine (40.0 rnL), dried over anhydrous MgSO4 
and concentrated in vacuo to yield the product, 161, (10.1 g, 50%) as a white foam. 
Rf (6% MeOH in DCM) 0.25; Mp 52.2-53.9 °C (Lit. 84.0-85.0 0C143);  [aID 51.20 (c 
1.3, CHC13) (Lit. [aID 52.2 ° (c 1.0, CHC13)143); HRMS (FAB) 348.1294 ([M+H], 
C14H2209N requires 348.1295); LRMS (FAB) 370 (Ci4H2109NNa), 348 
(C14H2209N), 330 (C14H2008N), 43 (C2H30); 5H (CDC13, 250MHz) 6.11 (114, br d, J 
9.4 Hz, NH), 5.39 (111, dd, J3,4 9.5 Hz, /2,3  10.0 Hz, 143), 5.35-5.30 (114, m, CH), 
5.21 (1H, dd, J,5 9.5 Hz, J4,3 9.5 Hz, 144), 4.75 (1H, br s, OH), 4.38 (1H, dd, JH6a-H6b 
12.8 Hz, JH6aH5  2.4 Hz, 146a), 4.30 (1H, dd, J32 10.0 Hz, J2,1 3.9 Hz, H2), 4.27-4.23 
(1H, m, CH), 4.21 (1H, dd, JH6b-H5  3.7 Hz, JH6b'H6a  12.8 Hz, H6b), 2.19, 2.12, 2.10 
and 2.05 (4 x 3H, 4 x s, 4 x COCH3); 6c (CDC13, 63MHz) 171.9, 171.5, 171.0 and 
169.9 (CO), 91.9, 71.4, 68.6 and 67.9 (CH), 62.5 (CH2), 52.7 (CH), 23.6 and 21.2 






AcO Et2NP(O8u) O 
Ac()
,_ c 
Ac triazole, DCM Ac 0  
ANH H,02, THF,-78C AcNH 
161 OH 78% 153 OBu 
A stirred solution of 2-acetamido-3 ,4,6-tri- O-acetyl-2-deoxy-a-D-glucopyranose, 
161, (1.8 g, 5.2 mmol) in anhydrous DCM (20.0 mL) was treated with 1,2,4-triazole 
(1.4 g, 20.0. mmol) and NN'-di-tert-butyl diethylphosphoramidite (4.3 mL, 20.0 
mmol). The reaction mixture was stirred under an atmosphere of N2 for 3h after 
which time it was cooled to —78°C so that a 30% solution of hydrogen peroxide (13.0 
mL) could be added in a dropwise manner. The reaction mixture was warmed to 
room temperature and stirred for a further 2h under N2. The reaction mixture was 
diluted with ice-cold diethyl ether (40.0 mL) and then carefully treated with a cold 
saturated solution of sodium thiosulphate (50.0 mL). The organic layer was 
separated, washed with a saturated solution of NaHCO3 (2 x 40.0 mL) and brine 
(40.0 mL), dried over anhydrous MgSO4, filtered, then concentrated in vacuo to give 
a clear oil. This was purified by column chromatography on silica using 4% MeOH 
in DCM as the eluent to afford the product, 153, (2.17 g, 78%) as a white foam. 
Rf (DCM:MeOH, 9:1) 0.31; HRMS (FAB) 540.2223 ([M+H], CH39012NP 
requires 540.2220); LRMS (FAB) 562 (C22H38012NPNa), 540 (C22H39012NP), 330 
(C14H2008N); 8H  (CDC13, 250MHz) 6.02 (1H, br d, J 9.2 Hz, NH), 5.54 (1H, dd, JHIP 
6.7 Hz, J1,2 3.3 Hz, Hi), 5.23 (1H, dd, J3,2 9.5 Hz, J3,4 9.2 Hz, H3), 5.14 (1H, dd, J43  
9.2 Hz, J4,5 9.3 Hz, H4), 4.41-4.30 (1H, m, H2), 4.19 (1H, dd, JH6b.H5  3.6 Hz, Ji-i61,-H6a 
12.2 Hz, H6b), 4.04 (1H, dd, JH6a-H6b  12.2 Hz, JH6a.H5  2.1 Hz, H6a), 3.75-3.68 (1H, 
m, H5), 1.47, 1.44, 1.43 and 1.42 (4 x 3H, 4 x s, 4 x COCH3), 1.38 (18H, s, 2 x 
C(CH3)3); 8c (CDC13, 63MHz) 171.4, 170.9, 170.2 and 169.4 (CO), 96.5 (CH), 84.5 
and 84.3 (C(CH3)3), 73.0, 70.7 and 68.3 (CH), 62.2 (CR2), 54.2 (CH), 30.1 (3 x 
CH3), 29.9 (3 x CH3), 23.4 (CH3), 20.8 (2 x CH3), 13.6 (CH3); 5p (CDC13, 101MHz) 
—12.6 (s, P=O). 
151 
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A stirred solution of di-tert-butyl-2-acetamido-3 ,4,6-tri-O-acetyl-2-deoxy-cx-D-
glucopyranosyl phosphate, 153, (0.5 g, 0.9 mmol) in anhydrous DCM (2.0 mL) was 
treated with TFA (0.7 mL, 9.3 mmol) and stirred under N2 for 10 mm. The reaction 
mixture was concentrated in vacuo to yield a yellow oil. TLC and mass spectral 
analysis of the crude reaction mixture failed to produce any evidence of the desired 
product. 
The reaction was repeated several times under different conditions as follows: 
Compound 153 (0.5 g, 0.9 mmol) in anhydrous DCM (1.0 mL) was treated with 
citric acid (80.0 mg, 0.4 mmol) and stirred under N2. The reaction mixture was 
analysed by TLC at 30 min intervals but after 16h no product formation was 
observed; 
Compound 153 (0.5 g, 0.9 mmol) in anhydrous DCM (1.0 mL) was treated with 
acetic acid (70.0 j.tL, 0.9 mmol) and stirred under N2. The reaction mixture was 
analysed by TLC at 30 min intervals but after 16h no product formation was 
observed; 
Compound 153 (0.5 g, 0.9 mmol) in anhydrous DCM (1.0 mL) was treated with 
TFA (7.0 mL, 9.0 mmol) and stirred under N2. The reaction mixture was 
analysed by TLC at 30 min intervals but after 16h no product formation was 
observed. 
152 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-n-giucopyranosyl phosphate dibenzyl 
ester, 162.144 
OAc OAc 
LDA, THE, -78°C Ac 
tetrabenzyl A -0 
NH 0 AcNH pyrophosphate A 
161 OH 162 OBn 
A stirred solution of 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-(X-o-glucopyranose, 
161, (0.3 g, 0.7 mmol) in anhydrous THF (10.0 mL) was cooled to —78°C and 
treated with a 1.8 M solution of LDA in 1:1:1 heptane/THF/ethylbenzene (0.6 mL, 
1.0 mmol). The reaction mixture was stirred under Ar at —78°C for 45 min after 
which time a solution of tetrabenzylpyrophosphate (0.5 g, 1.0 mmol) in anhydrous 
THF (5.0 mL) was added. The solution was stirred at —78°C under Ar for a further 4h 
and then concentrated in vacuo to give a yellow solid. This was dissolved in DCM 
(2.0 mL) and purified by column chromatography on silica using 4% MeOH in DCM 
as eluent to afford the product, 162, (0.3 g, 75%) as a white foam. 
Rf (DCM:MeOH, 9:1) 0.62; Mp 62.1-63.9 °C; [ct]D 29.9° (c 1.3, CHC13) (Lit. [(XID 
29.00 (c 1.0, CHC13)144); HRMS (FAB) 608.1894 ([M+H], C28H35012NP requires 
608.1897); LRMS (FAB) 608 (C28H35012NP), 300 (C14112008N), 91 (C7H7), 43 
(C2H30); 5H (CDC13, 250MHz) 7.57-7.45 (10H, m, AM), 5.61 (1H, br d, J 9.2 Hz, 
NH), 5.55 (1H, dd, JHI.P  6.0 Hz, J1,2 3.2 Hz, Hi), 5.05 (114, dd, J4,5 10.9 Hz, J4,3 9.9 
Hz, 114), 5.00-4.94 (5H, complex m, 2xPOCH2, H2), 4.324.22 (111, m, H3), 4.03 
(1H, dd, JH6b-H5  3.8 Hz, JH6bH6a 12.4 Hz, 116b), 3.93-3.85 (114, m, H5), 3.80 (114, dd, 
JH6a-H6b 12.4 Hz, JH6aH5 2.2 Hz, H6a), 1.93, 1.92, 1.90 and 1.59 (4 x 3H, 4 x s, 4 x 
COCH3); öc (CDC13, 63MHz) 171.0, 170.4, 170.0 and 168.9 (CO), 135.2 and 135.1 
(ArC), 128.8 (4 x ArCH), 128.7 (2 x ArCH), 128.0 (2 x ArCH), 127.9 (2 x ArCH), 
96.1 and 69.9 (CH), 69.8(2 x CH2), 69.5 and 67.1 (CH), 61,1 (CH2), 51.6 (CH), 22.6 
and 20.5 (CH3), 20.4 (2 x CH3); 5p (CDC13, 101MHz) 0.0 (s, P=O); (film)km-1  
2982 (CH), 1747 (OC=O), 1684 (N-C=O), 1139 (P=O) and 1231 (P-O-Bn). 
153 
2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-cz-D-glucopyranosyi phosphate, 154. 
OAC 
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A stirred solution of 2-acetaniido-3 ,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranosyl 
phosphate dibenzyl ester, 162, (330.0 mg, 0.5 mmol) in 2:1 anhydrous 
DCM:methanol (15.0 mL) was treated with finely divided 10% palladium on 
charcoal (133.0 mg) as catalyst and placed under an atmosphere of N2. The system 
was evacuated and flushed with hydrogen. This process was repeated twice and the 
reaction mixture was then allowed to stir under an atmosphere of hydrogen for 16h. 
The solution was filtered through a pad of celite, which was washed well with DCM 
(15.0 mL) and methanol (2 x 20.0 mL). The combined filtrate and washings were 
concentrated in vacuo to give a colourless residue. This was dried under high 
vacuum to afford the product, 154, (0.2 g, 100%) as a white foam. 
Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.19; Mp dec 109.5-111.7 
°C; [aID 71.2° (c 1.1, CHC13); FIRMS (FAB) 450.0783 ([M+Naf, C14H22012NPNa 
requires 450.0778); LRMS (FAB) 450 (C14H22012NPNa), 330 (C14H2008N), 289 
(C12111907N), 43 (C1130); CHN found %C 39.12, %H 5.55, %N 2.95 (required %C 
39.34, %H 5.19, %N 3.28); 6H  (CDC13, 250MHz) 7.52 (211, br s, P(OH)2), 5.69 (1H, 
br s, NH), 5.25-5.22 (1H, m, CH), 5.16-5.07 (1 H, m, CH), 4.54-4.23 (5H, br m, 5 x 
CH), 2.04-1.97 (12H, m, 4 x COCH3); 5c (CDC13, 63MHz) 174.1, 171.1, 170.9 and 
169.3 (CO), 94.1 69.8, 68.9 and 67.7 (CH), 61.4 (Cl2), 52.3 (CH), 21.9 (2 x CH3), 
20.6 and 20.4 (CH3); 5p (CDC13, 101MHz) —7.9 (s, P=O); Va (film)/cm' 2986 
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A stirred solution of 2-acetamido-3 ,4,6-tri-O-acetyl-2-deoxy-a-o-glucopyranosyl 
phosphate, 154, (230.9 mg, 0.5 mmol) in anhydrous methanol (6.0 mL) and DCM 
(0.2 mL) was treated with triethylamine (1.5 mL). The reaction mixture was stirred 
under N2 at room temperature for 5 mm. The solution was concentrated and 
azeotroped with anhydrous toluene (3 x 3.0 mL). The resulting pale yellow residue 
was dissolved in anhydrous DMF (3.0 mL) and treated with a solution of N,N'-
carbonyldiimidazole (560.0 mg, 3.5 rnmol) in anhydrous DMF (3.0 mL). The 
reaction mixture was stirred under N2 at room temperature for 4.5h. Anhydrous 
methanol (0.5 mL) was added to the reaction, which was stirred under N2 at room 
temperature for 30 mm. The reaction mixture was then treated with a solution of 
phytanyl phosphate, 98, (360.0 mg, 0.9 mmol) in anhydrous DCM (2.0 mL) and the 
reaction mixture was stirred under N2 at room temperature for 4 days after which 
time the solution was concentrated in vacuo to yield a yellow oil. This was purified 
by column chromatography on silica using DCM:MeOH:H20:2M aq NH4CO3, 
9:1:0.1:0.1, as eluent to afford the product, 155, (0.4 g, 91%) as a white foam. 
Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.67; [aID  22.8° (c 0.8, 
CHC13); URMS (FAB) 810.3593 ([M+Na], C34H63015NP2Na requires 810.3591); 
155 
LRMS (FAB) 810 (C34H53015NP2Na), 790 (C34H66015NP2), 379 (C0H04P), 330 
(C14H2008N), 43 (C2H30); 8H (CDC13, 250MHz) 7.48 (2H, hr s, P(OH)2), 7.19 (1H, 
dd, J32 9.8 Hz, J3,4 10.2 Hz, H3), 7.10 (1H, dd, J2,1 2.9 Hz, J2,3 9.8 Hz, H2), 6.24 (1H, 
br d, J 10.5 Hz, NH), 6.14 (1H, dd, JHI.P  7.2 Hz, i1,2 2.9 Hz, Hi), 5.09-5.03 (6H, br 
m, POCH2, H4, H5, H6a, H6b), 4.00, 3.99, 3.93 and 3.91 (4 x 311, 4 x s, 4 x 
COCH3), 3.48-3.41 (2H, m, CH2), 3.28-3.10 (18H, br m, 4 x CH, 7 x CH2), 3.08-2.97 
(411, m, 2 x CH2), 2.81-2.75 (1511, m, 5 x CH3); 3c  (CDC13, 63MHz) 170.9 (2 x CO), 
170.5 and 169.5 (CO), 71.0 (CH), 68.2 (2 x CH), 67.9 (CH), 61.1 (CH2), 51.3 (CH), 
45.6 (4 x CH2), 38.9 and 37.2 (CH2), 37.1 (2 x CH2), 32.4 (2 x CH), 29.3 and 27.6 
(CH), 24.4, 24.1 and 22.2 (CH2), 22.1 (2 x CH3), 21.9 (CH3), 20.2 (2 x CH3), 20.1 (2 
x CH3), 19.2 (2 x CH3); 5p (CDC13, 101MHz) —7.9 (s, P=O) and -11.0 (s, P=O); Vlnax 
(film)/cm' 3019 (CH), 1742 (OC=O), 1058 (P-OH) and 1030 (P-O-P). 
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A stirred solution of Pj-phytanyl-P2-2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-cx-D-
glucopyranosyl pyrophosphate, 155, (52.7 mg, 66.9 p.mol) in anhydrous DCM (2.0 
mL) and anhydrous methanol (1.0 mL) was cooled to 0°C and treated with 
triethylamine (0.6 mL). The reaction was stirred under N2 for 5 min. and then 
concentrated in vacuo. The resulting residue was azeotroped with anhydrous toluene 
(3 x 3.0 mL) and then re-dissolved in anhydrous DCM (2.0 mL) and methanol (1.0 
mL). The reaction was cooled to 0°C, treated with 0.5 M sodium methoxide solution 
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(100.0 pL, 50.0 Jimol) and stirred under N2 for 15 mm. The reaction mixture was 
passed through a H Dowex AG50W-X8 ion exchange resin, which was then washed 
with anhydrous methanol (7 x 1.0 mL). The combined filtrate and washings were 
concentrated in vacuo and azeotroped with anhydrous toluene (3 x 3.0 mL). The 
resulting residue was dissolved in anhydrous DCM (2.0 mL) and anhydrous 
methanol (1.0 mL) and cooled to 0°C, treated with triethylamine (0.6 mL) and stirred 
under N2 for 5 mm. The solution was concentrated in vacuo and azeotroped with 
anhydrous toluene (3 x 3.0 mL) to give a colourless residue. This was dried under 
high vacuum to afford the product, 163, (44.1 mg, 100%) as a white foam. 
Rf (DCM:MeOH:H20:2M aq NH4HCO3, 6.5:3.5:0.4:0.4) 0.31; [a]D 4.1° (c 0.3, 
CHCI3); nilz (FAB) 684.3257 ([M+Na], C23H57012NP2Na requires 684.3254); 
LRMS (FAB) 684 (C28H57012NP2Na), 662 (C28H58012NP2), 379 (C 0FL1 0P); 8H 
(CDC13, 250MHz) 5.56-5.49 (1H, m, CH), 4.22-4.11 (1H, m, CH), 4.00-3.79 (2H, m, 
2 x CH), 3.18-2.97 (2H, m, 2 x CH), 2.01-1.92 (1H, m, CH), 1.32-0.99 (29H, brm, 2 
x CH, 12 x CH2, COCH3), 0.81-0.75 (15H, m, 5 x CR3); 5c (CDC13, 63MHz) 171.4 
(CO), 74.2, 72.2, 68.9 and 65.3 (CH), 62.0 (CH2), 51.9 (CH), 46.1, 39.8, 39.1 and 
37.9 (CR), 37.7 (2 x CR2), 33.2, 32.4 and 30.8 (CH), 30.6, 30.1 and 29.3 (CH2), 
28.4 (CH), 24.8 and 24.1 (CU2), 23.4 (2 x CH3), 20.3 (CR3), 20.1, 19.4 and 18.9 
(CH3); 5p (CDC13, 101MHz) —9.0 (s, P=O) and -11.9 (s, P=O). 
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4.4. Synthesis of protected chitobiose. 
Di-O-benzyl-n-glucal, 173. 
OAc OBn 
AcO-7--l—O 1. NaOMe, MeOH 
ACO-. 2. (Bu3Sn)20. BnO-// 
toluene, reflux 
149 3. BnBr, TBABr 173 
A stirred solution of tri-O-acetyl-o-glucal, 149, (2.0 g, 7.4 mmol) in anhydrous 
MeOH (10.0 mL) was treated with sodium methoxide (0.1 g, 2.2 mmol). The 
reaction mixture was stirred under an atmosphere of N2 for 2h at room temperature 
and then concentrated in vacuo to yield a pale yellow oil. This was purified by 
column chromatography on silica using 20% MeOH in DCM as the eluent to afford 
D-glucal (1.1 g, 100%) as a white foam. The D-glucal thus obtained was dissolved in 
anhydrous toluene (10.0 mL) and treated with bis-tributyl tin oxide (4.2 mL, 8.3 
mmol). The reaction mixture was heated at reflux in a Dean-Stark apparatus for 16h. 
The pale yellow reaction mixture was allowed to cool to room temperature so that 
benzyl bromide (2.9 mL, 20.0 mmol) and tetrabutylammonium bromide (4.8 g, 15.0 
mmol) could be added to the reaction mixture. The reaction was then heated at reflux 
in a Dean-Stark apparatus for a further 16h. The dark brown reaction mixture was 
cooled to room temperature, concentrated in vacuo and the resulting residue was 
dissolved in EtOAc (30.0 mL). The organic layer was washed with water (2 x 30.0 
mL), a saturated solution of NaHCO3 (40.0 mL) and brine (40.0 mL). The organic 
layer was dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield a 
dark brown oil. The crude mixture was separated by column chromatography on 
silica using petroleum ether:ethyl acetate, 6:4, as the eluent but no product was 
isolated. 
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2-Phthalimido-2-deoxy- 1,3,4,6-tetra-O-acety1--D-g1ucopyranose, 177.131 
OH 
NaOMe, MeOH 
phthalic anhydride, Et3N 
OH 
NH,HCI Ac,O, pyridine 
176 48% 
A stirred solution of glucosamine hydrochloride, 176, (10.0 g, 46.4 mmol) in 
anhydrous methanol (80.0 mL) was treated with sodium methoxide (3.0 g, 46.4 
mmol) and stirred under N2 for 30 min at room temperature. The reaction mixture 
was filtered and the filtrate treated with phthalic anhydride (3.5 g, 23.2 mmol). The 
reaction was stirred under N2 at room temperature for 20 min and further quantities 
of phthalic anhydride (3.5 g, 23.2 mmol) and triethylamine (7.6 mL, 55.6 mmol) 
were added. The creamy white solution was stirred under N2 at room temperature for 
10 min and then at 50°C for 30 mm. The resulting mixture was cooled in an ice bath 
for lh and then the white precipitate was removed by vacuum filtration and dried 
under vacuum for 4h. The dry white solid was dissolved in acetic anhydride (45.0 
mL), cooled in an ice bath and slowly treated with pyridine (23.0 mL). The resulting 
yellow solution was stirred under N2 at room temperature for 16h. The reaction 
mixture was diluted with DCM (200.0 mL) and poured onto a mixture of ice and 
water (200.0 mL). The organic layer was separated, washed with 5% aqueous HCI 
(150.0 mL), a saturated solution of NaHCO3 (150.0 mL) and brine (150.0 mL). The 
organic layer was dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
yield a yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyi acetate, 6:4, as the eluent to afford the product, 177, (10.5 g, 
48%) as a white foam. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.21; Mp 48.0-50.0 °C; [a]D  66.3° (c 1.2, 
CHC13) (Lit [aID  68.0 
° (c 0.5, CHC13)'45); HRMS (FAB) 478.1349 ([M+H], 
C22H24011N requires 478.1349); 8H  (CDCI3, 250MHz) 7.91-7.76 (4H, m, ArH, 
NPhth), 6.54 (1H, d, JI,2  8.9 Hz, Hi), 5.91 (1H, dd, J3,2 10.6 Hz, J3,4 9.2 Hz, H3), 
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5.24 (1H, dd, J4,5 10.2 Hz, J4,3 9.2 Hz, H4), 4.49 (1H, dd, J2,3 10.6 Hz, J2,1 8.9 Hz, 
H2), 4.40 (1H, dd, JH6b.i.j a 12.5 Hz, J116b-HS  4.4 Hz, H6b), 4.18 (1H, dd, JH6a.H6b  12.5 
Hz, JH6a-H52.1  Hz, 146a), 4.04-3.97 (1H, m, 145), 2.14, 2.07, 2.03 and 1.89(4 x 3H, 4 
x s, 4 x COCH3); 5C (CDC13, 63MHz) 171.2 and 170.5 (CO), 169.9 (2 x CO), 169.1 
and 167.9 (CO), 134.9 (2 x ArCH), 131.7 (2 x ArC), 124.3 (2 x ArCH), 90.2, 73. 1, 
70.9 and 68.7 (CH), 61.9 (CH2), 53.9 (CH), 21.2 (2 x CR3), 21.1 and 20.9 (CH3); 




.I A-0 OAc 
PhSH, Sn2I4 AcO O\ -... DCM AcO---._-SPh 
177NPhth 74% 178 NPhth 
A stirred solution of 2-phthalimido-2-deoxy- 1,3,4,6-tetra-0-acetyl-f-D- 
glucopyranose, 177, (21.4 g, 44.9 mmol) in anhydrous DCM (200.0 mL) was treated 
with benzenethiol (10.5 mL, 100.0 mmol) and tin tetrachloride (10.0 mL, 15.6 
mmol). The dark brown reaction mixture was stirred under N2 at room temperature 
for 16h. The reaction was then diluted with DCM (100.0 mL) and washed with a 
saturated solution of K2CO3 (2 x 150.0 mL). The organic extract was washed with 
brine (100.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
yield a yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 6:4, as the eluent to afford the product, 178, (17.4 g, 
74%) as a white foam. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.24; Mp 141.0-142.5 °C (Lit 145.0-146.0 
oCl46); [a]D 53.0° (c 1.2, CHC13) (Lit [(XID 53.0 ° (c 1.4, CHCI3)'46); HRMS (FAB) 
528.1314 ([M+H], C26H2609NS requires 528.1318); CHN found %C 58,93, %H 
4.78, %N 2.73 (required %C 59.20, %H 4.74, %N 2.66); 8H (CDC13, 250MHz) 7.9 1-
7.78 (4H, m, ArH, NPhth), 7.46-7.29 (5H, m, ArH, SPh), 5.83 (1H, dd, J3,2  10.2 Hz, 
WGVC 
J3,4 9.2 Hz, H3), 5.75 (1H, d, J1,2 10.6 Hz, Hi), 5.17 (1H, dd, J4,5 10.2 Hz, J43 9.2 Hz, 
144), 4.38 (1H, dd, J2,3 10.2 Hz, J2,1 10.6 Hz, H2), 4.32 (1H, dd, JH6b-H6.  12.3 Hz, JH6b-
H5 5.1 Hz, 146b), 4.24 (1H, dd, JH6a-H6b  12.3 Hz, JH6a-H5 2.4 Hz, 146a), 3.96-3.91 (1H, 
m, H5), 2.13, 2.05 and 1.87 (3 x 3H, 3 x s, 3 x COCH3); 8c (CDC13, 63MHz) 171.1 
(qC), 170.5 (2 x qC), 169.9, 168.2, 167.4 and 162.9 (qC), 134.9 and 134.8 (ArCH), 
133.7 (2 x ArCH), 131.4 (ArC), 129.3 (2 x ArCH), 128.8 (ArCH), 124.1 (2 x ArCH), 
83.5, 76.3, 72.0 and 69.1 (CH), 62.6 (CH2), 53.9 (CH), 21.2, 21.0 and 20.8 (CH3); 





o 1. NaOMe, MeOH Ph 
ACO_ SPh 2.p-TsOH, DMF H SPh 
NPhth C6H4(OMe)2, 50°C 
:~~
178 80% 179 
NPhth 
A stirred solution of 2-phthalimido-2-deoxy-3 ,4,6-tri-O-acetyl- 1-thiopheny1-3-D-
glucopyranoside, 178, (3.8 g, 7.2 mmol) in anhydrous methanol (50.0 mL) was 
treated with sodium methoxide (20.0 mg, 0.7 mmol). The reaction was stirred under 
N2 at room temperature for lh and then neutralised with glacial acetic acid (0.1 mL). 
The solution was concentrated in vacuo to yield a pale yellow foam which was then 
azeotroped with anhydrous toluene (3 x 30.0 mL). The resulting residue was dried 
under vacuum for lb, then dissolved in anhydrous DMF (50.0 mL) and treated with 
benzaldehyde dimethyl acetal (2.5 mL, 16.5 mmol) and p-toluenesulfonic acid (0.3 g, 
1.6 mmol). The reaction was stirred under N2 for lh at 50°C and then cooled to room 
temperature. The reaction was diluted with toluene (50.0 mL) and washed with a 
saturated solution of NaHCO3 (2 x 50.0 mL). The organic layer was washed with 
brine (50.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
yield a yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 6:4, as the eluent to afford the product, 179, (5.4 g, 
80%) as a white foam. 
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Rf (petroleum ether:ethyl acetate, 6:4) 0.29; Mp 61.3-63.6 °C; {U]D 11.70 (c 1.0, 
CHC13) (Lit 34.20 (c 1.3, CHC13)146); HRMS (FAB) 490.1323 ([M+H], C27H2406NS 
requires 490.1324); 6H  (CDC13, 250MHz) 7.94-7.90 (414, m, ArH, NPhth), 7.44-7.36 
(5H, in, ArH), 7.31-7.24 (5H, m, ArH), 5.74 (1H, d, f 1,2 10.5 Hz, Hi), 5.60 (1H, s, 
CH(0)2), 4.68 (1H, m, H3), 4.44 (1H, dd, JH6b-H6;,  10.3 Hz, JH6bFI5  4.7 Hz, 1-I6b), 4.35 
(1H, dd, J2,3 9.5 Hz, J2,1 10.5 Hz, 1-12), 4.21-4.16 (1H, m, H6a), 3.75 (1H, m, 1-15), 
3.65 (1H, dd, J45 9.4 Hz, J4,3 4.1  Hz, H4), 2.99 (1H, br s, OH); 8C (CDC13, 63MHz) 
168.7 and 168.0 (qC), 137.3 (2 x qC), 136.8 (2 x qC), 134.9, 134.7, 134.6, 133.1, 
132.6, 132.2, 132.0, 130.2, 129.8, 129.4, 129.3, 128.8, 128.6 and 126.8 (ArCH), 
102.4 (CH(0)2), 84.7, 82.3, 70.8 and 70.1 (CH), 69.0 (CH2), 56.1 (CH); Vmax 




NaH, BnBr Ph-0 






A stirred solution of 2-phthalimido-2-deoxy-4,6-O-benzylidene- 1-thiophenylj-D-
glucopyranoside, 179, (0.3 g, 0.5 mmol) in anhydrous DMF (5.0 mL) was cooled to 
0°C in an ice bath and treated with sodium hydride (20.0 mg, 0.8 mmol). The 
reaction mixture was stirred under an atmosphere of N2 at 0°C while benzyl bromide 
(90.0 jiL, 0.8 mmol) was added in a dropwise manner over a 2h period. When the 
addition was complete the pale yellow reaction mixture was stirred under N2 at room 
temperature for 16h. The solution was diluted with methanol (2.0 mL) and then 
concentrated in vacuo. The resulting residue was dissolved in DCM (10.0 mL) and 
washed with a saturated solution of NaHCO3 (2 x 15.0 mL) and brine (15.0 mL). The 
organic layer was dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
yield a yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 9:1, as the eluent to afford the product, 185, (67.6 mg, 
19%) as a white foam. 
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Rf (petroleum ether:ethyl acetate, 6:4) 0.53; HRMS (FAB) 580.1803 ([M+H], 
C34H3006NS requires 580.1794); 8H  (CDC13, 250MHz) 7.86-7.61 (41-1, in, AM, 
NPhth), 7.52-7.38 (5H, in, ArH), 7.36-7.21 (5H, in, ArH), 6.98-6.85 (5H, m, ArH), 
5.62 (1H, d, f 1 ,2 10.4 Hz, Hi), 5.61 (1H, S, CH(0)2), 4.74 (1H, dd, JH6b-H6.  12.2 Hz, 
JH6b-H5 3.7 Hz, H6b), 4.50 (2H, s, PhCH20), 4.45 (iH, dd, J3,2 10.2 Hz, J3,4 9.5 Hz, 
H3), 4.39 (1H, dd, J4,3 9.5 Hz, .14,5 10.3 Hz, H4), 4.27 (11-1, dd, J2,1 10.4 Hz, J2,3 10.2 
Hz, 112), 3.75 (1H, dd, JH6aH6b  12.2 Hz, JH6a-J-l5 2.5 Hz, H6a), 3.73-3.68 (1H, m, 1-15); 
öc (CDC13, 63MHz) 167.6 and 167.1 (CO), 137.5 and 137.1 (ArC), 133.9 and 133.7 
(ArCH), 132.6 (3 x ArC), 128.9 and 128.8 (ArCH), 128.4 and 128.2 (2 x ArCH), 
128.0 (2 x ArCH), 127.9 (2 x ArCH), 127.8, 127:5, 127.3, 126.9, 126.2, 125.9, 123.4 
and 123.3 (ArCH), 101.2 (CH(0)2), 83.9, 82.7 and 75.3 (CH), 74.1 (CH2), 70.2 and 
68.5 (CH), 67.9 (CH2). 
2-Phthalirnido-2-deoxy-3-O-acetyl-4,6-O-benzylidene- 1-thiopheny1-3-D-
glucopyranoside, 180. 
X Ac,O, pyridine 
Ph 





A stirred solution of 2-phthalimido-2-deoxy-4,6-O-benzylidene- 1 -thiophenyl-J3-D-
glucopyranoside, 179, (4.7 g, 9.6 mniol) in anhydrous DCM (20.0 mL) was treated 
with acetic anhydride (20.0 mL) and pyridine (10.0 mL). The pale yellow reaction 
mixture was stirred under N2 at room temperature for 16h. The solution was diluted 
with DCM (40.0 mL) and washed with water (50.0 mL), 5% aqueous HC1 (50.0 mL), 
a saturated solution of NaHCO3 (50.0 mL) and brine (50.0 mL). The organic layer 
was dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield a 
yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 6:4, as the eluent to afford the product, 180, (4.9 g, 
97%) as a white foam. 
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Rf (petroleum ether:ethyl acetate, 6:4) 0.42; Mp 90.1-92.3 °C; [a}D 22.90 (c 1.0, 
C11C13); HRMS (FAB) 532.1430 ([M+H], C29H2607NS requires 532.1430); LRMS 
(FAB) 554 (C29H2507NSNa), 532 (C29H2507NS), 422 (C23H2007N); CHN found %C 
65.26, %H 5.03, %N 2.36 (required %C 65.52, %H 4.71, %N 2.64); 5H (CDC13, 
250MHz) 7.87-7.72 (4H, m, ArH, NPhth), 7.44-7.36 (5H, m, ArH), 7.35-7.24 (511, 
m, AM), 5.89 (1H, dd, J3,2  9.7 Hz, J3,4 9.2 Hz, H3), 5.82 (1H, d, J1 ,2 10.6 Hz, Hi), 
5.53 (1H, s, CH(0)2), 4.43 (1H, dd, J45 9.7 Hz, J4,3 9.2 Hz, H4),4.35 (1H, dd, J2,3 9.7 
Hz, J21  10.6 Hz, H2), 3.84-3.81 (1H, m, 115), 3.79 (1 H, dd, JH6bH6a9,7  Hz, JH6b-H5 4.3  
Hz, H6b), 3.77-3.73 (1H, m, H6a), 1.86 (3H, s, COCH3); 8c (CDC13, 63MHz) 170. 1, 
167.7, 167.1, 166.3 and 136.7 (qC), 134.4 and 134.1 (ArCH), 132.9 (2 x ArCH), 
131.5 and 130.9 (qC), 129.1 (ArCH), 128.9 (2 x ArCH), 128.3 (ArCH), 128.1 (2 x 
ArCH), 126.1 (2 x ArCH), 123.6 and 123.5 (ArCH), 101.5 (CH(0)2), 83.7, 78.8, 70.4 
and 70.3 (CH), 68.4 (CH2), 54.1 (CH), 20.4 (CH3); Vmax (filrn)/cm 2986 (CH), 1719 











180 81  
A stirred solution of 2-phthalimido-2-deoxy-3-O-acetyl-4,6-O-benzylidene- 1-
thiophenyl-f3-D-glucopyranoside, 180, (5.7 g, 10.6 mmol) in anhydrous DCM (40.0 
mL) was treated with triethylsilane (8.4 mL, 52.9 mmol) and the reaction mixture 
was cooled to 0°C under N2. Trifluoroacetic acid (4.1 mL, 52.9 mmol) was added, 
the solution was gradually allowed to warm to room temperature and then stirred 
under N2 for 4h. The reaction was diluted with DCM (30.0 mL) and washed with a 
saturated solution of NaHCO3 (2 x 40.0 mL). The organic layer was washed with 
brine (40.0 mL), dried over anhydrous MgSO4, filtered and concentrated in vacuo to 
yield a yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 6:4, as the eluent to afford the product, 181, (4.3 g, 
76%) as a white foam. 
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Rf (petroleum ether:ethyl acetate, 6:4) 0.24; Mp 44.5-46.8 °C; [U]D  31.1° (c 1.1, 
CHC13); HRMS (FAB) 534.1589 ([M+H], C29H2807NS requires 534.1587); LRMS 
(FAB) 556 (C29H2707NSNa), 534 (C29H2807NS), 424 (C23H2207N); 6H  (CDC13, 
250MHz) 7.95-7.77 (4H, m, ArH, NPhth), 7.50-7.41 (5H, m, Al-H), 7.34-7.28 (5H, 
in, AM), 5.86 (1H, d, J1,2  10.5 Hz, Hi), 5.80-5.73 (1H, in, H3),4.68 (2H, d, JA,B  11.8 
Hz, CH2), 4.38 (111, dd, J2,3 9.5 Hz, J2,1 10.5 Hz, H2), 3.95-3.87 (4H, complex m, H4, 
H5, H6a, H6b), 1.98 (3H, s, COCH3); 8c (CDCI3, 63MHz) 171.6 (2 x qC), 168.3, 
167.7 and 138.2 (qC), 134.9, 134.7 and 133.4 (ArCH), 133.2 (2 x ArCH), 132.1 (2 x 
qC), 129.3 (2 x ASCII), 128.9 (2 x ArCH), 128.5 (2 x ArCH), 128.3, 128.2 and 124.2 
(ArCH), 83.6, 78.7 and 74.7 (CH), 74.2 (CH2), 71.5 (CH), 70.7 (CH2), 53.9 (CH), 






Ac SPh DCM,100% SPh 
181 NFhth 182NPhth 
A stirred solution of 2-phthaiirnido-2-deoxy-3-O-acetyl-6-benzyl- 1-thiopheny1-3-D-
glucopyranoside, 181, (0.6 g, 1.1 mmol) in anhydrous DCM (5.0 mL) was treated 
with acetic anhydride (6.0 mL) and pyridine (3.0 mL). The pale yellow reaction 
mixture was stirred under N2 at room temperature for 16h. The solution was diluted 
with DCM (20.0 mL) and washed with water (20.0 mL), 5% aqueous HCI (20.0 mL), 
a saturated solution of NaHCO3 (20.0 mL) and brine (20.0 mL). The organic layer 
was dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield a 
yellow syrup. This was purified by column chromatography on silica using 
petroleum ether:ethyl acetate, 6:4, as the eluent to afford the product, 182, (0.6 g, 
100%) as a white foam. 
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Rf (petroleum ether:ethyl acetate, 6:4) 0.35; Mp 111.0-113.4 °C; [cc]l' 79.6° (c 0. 3, 
CHC13); HRMS (FAB) 576.1698 ([M+H], C31113008NS requires 576.1692); LRMS 
(FAB) 598 (C31 H29O3NSNa), 576 (C311-13008NS), 466 (C25H2408N); 8H  (CDCI3, 
250MHz) 7.89-7.74 (41-1, m, ArH, NPhth), 7.44-7.21 (bR, in, AM), 5.83 (1H, dd, 
J3,2 9.8 Hz, J3,4 9.2 Hz, 1-13), 5.74 (1H, d, J1,2 10.6 Hz, Hi), 5.16 (1H, dd, J4,3 9.2 Hz, 
.14,5 9.2 Hz, 1-14), 4.56 (2H, q, JA,B 11.8 Hz, CH2), 4.37 (11-1, dd, J23 9.8 Hz, J2,1 10.6 
Hz, H2), 3.95-3.86 (111, m, 1-15), 3.65 (21-1, d, J4.1 Hz, H6a, 1-16b), 1.95 and 1.84 (2 x 
3H, 2 x s, 2 x COCH3); 8c (CDC13, 63MHz) 163.4 (2 x qC), 162.8 (2 x qC), 161.0, 
160.2 and 131.0 (qC), 127.6 (ArCH), 126.5 (2 x ArCH), 126.0 (ArCH), 124.6 (qC), 
122.1(2 x ArCH), 121.6 (2 x ArCH), 121.4 (ArCH), 121.0 (2 x ArCH), 120.9 
(ArCH), 116.9 (2 x ArCH), 76.3 and 70.7 (CH), 66.7 (CH2), 64.9 and 62.7 (CH), 
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Ad-
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DCM,  -20°C Ac SPh 
NPhth Ac NPhth NPhth NPhth 
182 181 184 
A stirred solution of 2-phthalimido-2-deoxy-3-O-acetyl-6-benzyl- 1-thiopheny1--n-
glucopyranoside, 181, (66.0 mg, 0.1 mmol) in anhydrous DCM (5.0 mL) was cooled 
to —20°C and treated with a solution of 2-phthalimido-2-deoxy-3,4-O-acetyl-6-
benzyl- 1-thiophenyl-3-D-g1ucopyranoside, 182, (124.1 mg, 0.2 mmol) in anhydrous 
DCM (5.0 mL), NIS (0.1 g, 0.6 mmol) and p-toluenesulfonic acid (11.0 .tL, 0.1 
mmol). The reaction was stirred, while being protected from light, at -20°C under N2 
for 30 mm. The solution was gradually allowed to warm to room temperature and 
stirred for 16h. The dark red reaction mixture was diluted with DCM (15.0 mL), 
washed with water (20.0 mL), a saturated solution of NaHCO3 (20.0 mL) and brine 
(20.0 mL). The organic layer was dried over anhydrous MgSO4, filtered and 
166 
concentrated in vacuo to yield a brown syrup. The crude mixture was separated by 
column chromatography on silica using petroleum ether:ethyl acetate, 6:4, as the 
eluent but no product was isolated. 





DCM, -I 5C Ac 
NPhth 
182 
NPhth 82% 183 
A stirred solution of 2-phthalimido-2-deoxy-3 ,4-O-acetyl-6-benzyl- 1-thiophenyl-j3-
D-glucopyranoside, 182, (2.1 g, 3.6 mmol) in anhydrous DCM (20.0 mL) was cooled 
to -15°C and treated with DAST (960.0 RL, 7.3 mmol). The reaction was stirred 
under N2 for 2 min before the addition of NBS (0.1 g, 5.5 mmol). The solution was 
gradually allowed to warm to room temperature and then stirred under N2 for 16h. 
The reaction was diluted with DCM (10.0 mL) and washed with a saturated solution 
of NaHCO3 (3 x 20.0 mL). The organic layer was washed with brine (20.0 mL), 
dried over anhydrous MgSO4, filtered and concentrated in vacuo to yield a yellow 
syrup. This was purified by column chromatography on silica using petroleum 
ether:ethyl acetate, 8:2, as the eluent to afford the product, 183, (1.4 g, 82%) as a 
white foam. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.11; Mp 52.2-54.4 °C; [ab 37.3° (c 1.0, 
CHCI3); HRMS (FAB) 485.1574 ([M], C25H2408NF requires 485.1476); LRMS 
(FAB) 508 (C25H2408NFNa), 485 (CH2408NF), 466 (C25H2408N); oH (CDCI3, 
250MHz) 7.93-7.78 (4H, m, ArH, NPhth), 7.41-7.34 (5H, m, ArH), 6.13 (114, br dd, 
.11,2 7.8 Hz, JF..HI  52.5 Hz, Hi), 5.93 (111, dd, J3,2 9.8 Hz, J3,4 9.1 Hz, H3), 5.30 (1H, 
dd, J4,3 9.1 Hz, J4,5 9.1 Hz, H4), 4.63 (2H, q, JA,8 12.0 Hz, CH2), 4.54-4.44 (1H, m, 
H2), 4.05-3.97 (1H, in, H5), 3.70-3.68 (2H, m, H6a, H6b), 1.97 and 1.91 (2 x 3H, 2 x 
s, 2 x COCH3); 0c  (CDC13, 63MHz) 170.5, 170.4, 169.8, 169.1, 167.9 and 137.9 
(qC), 134.9 and 132.8 (ArCH), 131.7 (qC), 130.9, 129.8, 129.1, 128.9, 128.4, 128.3 
and 124.2 (ArCH), 90.2 (CH), 74.1 (CH2), 73.7 (CH), 70.5 (d, CH), 69.5 (CH), 68.6 
167 
(CH2), 61.9 (d, CH), 21.0 and 20.8 (CH3); Vmax (film)/cm' 3004, 2967, 2924 (CH), 













91% collidine, DCM, OC 








A stirred solution of silver trifluoromethanesulfon ate (145.0 mg, 0.6 mmol), 
zirconocene dichloride (165.0 mg, 0.6 mmol), collidine (15.0 j.tL, 0.1 mmol) and 3A 
molecular sieves in anhydrous DCM (3.0 mL) was cooled to 0°C and stirred, while 
being protected from light, under N2 for 10 mm. A solution of 2-phthalimido-2-
deoxy-3,4-0-acetyl-6-benzyl-13-n-glucopyranosyl fluoride, 183, (96.0 mg, 0.2 mmol) 
and 2-phthalimido-2-deoxy-3-O-acetyl-6-benzyl- 1 -thiophenyl-J3-D-glucopyranoside, 
181, (61.0 mg, 0.1 mmol) in anhydrous DCM (3.0 mL) was added and the reaction 
mixture was stirred, while being protected from light, at 0°C under N2. The solution 
was gradually allowed to warm to room temperature and stirred for 16h. The grey 
reaction mixture was filtered and the filtrate concentrated in vacuo to yield a yellow 
oil. This was purified by column chromatography on silica using petroleum 
ether:ethyl acetate, 6:4, as the eluent to afford the product, 184, (0.1 g, 91%) as a 
white foam. 
Rf (petroleum ether:ethyl acetate, 6:4) 0.19; Mp 79.0-80.9 °C; [ct]0 38.4° (c 1.0, 
CHCI3); HRMS (FAB) 999.3020 ([M+H], C54H51015N2S requires 999.3010); 
LRMS (FAB) 1022 (C54H5j015N2SNa), 999 (C54H51015N2S), 889 (C481145015N2), 
534 (C29H2307NS), 466 (C25H2408N), 424 (C23H2207N); CHN found %C 61.78, %H 
4.89, %N 2.75 (required %C 64.9 1, %H 5.0 1, %N 2.80); oH (CDC13, 250MHz) 7.78-
7.64 (814, rn, ArH, NPhth), 7.32-7.09 (15H, m, ArH), 5.77 (111, dd, J3,2 9.7 Hz, J3,4  
9.2 Hz, H3), 5.65 (111, dd, J2. 3' 10.8 Hz, J3',4. 10.4 Hz, H3'), 5.51 (11-1, d, f 1',2' 10.5 
Hz, Hi'), 5.39 (1H, d, J1,2 8.4 Hz, Hi). 5.11 (111, dd, J4,5 9.4 Hz, J4,3 9.2 Hz, H4), 
4.54 (11-1, dd, J45 11.9 Hz, J4',3' 10.4 Hz, 114'), 4.43 (11-1, dd, JH6a-H6b 12.0 Hz, JH6aH5 
2.9 Hz, 116a), 4.35 (2H, d, J 8.4 Hz, CH2), 4.27 (21-1, d, J 5.9 Hz, CH2), 4.19 (1H, dd, 
JH6a'-146b' 12.0 Hz, JH6a'-H5' 3.4 Hz, 1-16a'), 4.05 (111, dd, J21  8.4 Hz, J2,3 9.7 Hz, H2), 
3.81-3.75 (11-1, m, H2'), 3.74-3.70 (1H, m, 1-15), 3.49 (21-1, dd, JH6a-H6b  12.0 Hz, JH6b-
H5 3.8 Hz, H6b', 1-16b), 3.42-3.36 (11-1, m, H5'), 1.84-1.74 (91-1, m, 3 x COCH3); 8c 
(CDCI3, 63MHz) 170.9 (qC), 170.0 (2 x qC), 169.5 (qC), 169.3 (2 x qC), 167.6, 
167.1, 138.1 and 137.4 (qC), 134.2 (2 x ArCH), 132.9 and 132.6 (ArCH), 131.5 (2 x 
qC), 131.2 (2 x qC), 128.8 (2 x ArCH), 128.6 (2 x ArCH), 128.3 (2 x ArCH), 128.2 
(2 x ArCH), 128.1 (ArCH), 127.9 (2xArCH), 127.8 (2xArCH), 127.7 (ArCH), 127.6 
(2xArCH), 127.3 (ArCH), 123.5 (2 x ArCH), 96.9, 92.4, 82.8, 78.4, 74.1 and 73.5 
(CH), 72.6 and 70.9 (CH2), 70.7 and 69.4 (CH), 68.2 and 67.6 (CR2), 54.9 and 53.4 
(CH), 20.5, 20.4 and 20.3 (CH3); Vinax (fi1m)/cm 3004, 2967, 2924 (CH), 1714 




AcV\ 0\ N!SJ!9H,.. ACO s S 
SPh 4A molecular sieves AcO..\_.-.._— N3 NPhth 
NPhth -40C NPhth NPhIh 
184 186 
A stirred solution of O-(2-phtha1imido-2-deoxy-3,4-O-acety1-6-benzyl--D-
glucopyranosyl)-( 1 ,4)-2-phthalimido-2-deoxy-3-O-acetyl-6-benzyl- 1-thiopheny1-3-
n-glucopyranoside, 184, (0.6 g, 0.6 mmol) in anhydrous DCM (10.0 mL) was cooled 
to 0°C and treated with 4A molecular sieves, trimethylsilyl azide (0.2 mL, 1.5 
mmol), NIS (91.0 mg, 1.5 mmol) and p-toluenesulfonic acid (11.0 p.L, 0.2 mmol). 
169 
The reaction was gradually allowed to warm to room temperature and then stirred 
under an atmosphere of N2 for 16h. The dark red solution was diluted with a 
saturated solution of sodium thiosulphate (20.0 mL). The organic layer was 
separated, washed with water (20.0 mL), a saturated solution of NaHCO3 (20.0 mL) 
and brine (20.0 mL). The organic layer was dried over anhydrous MgSO4, filtered 
and concentrated in vacuo to yield a yellow syrup. The crude mixture was separated 
by column chromatography on silica using petroleum ether:ethyl acetate, 6:4, as the 
eluent but no product was isolated. 
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